<html class="pb-page" data-request-id="bef0aab2-5982-4751-9676-a10013f2b19d" lang="en"><head data-pb-dropzone="head"><script type="text/javascript" src="https://m.addthis.com/live/red_lojson/300lo.json?si=62727b7aba475c87&amp;bkl=0&amp;bl=1&amp;pdt=741&amp;sid=62727b7aba475c87&amp;pub=xa-4faab26f2cff13a7&amp;rev=v8.28.8-wp&amp;ln=en&amp;pc=men&amp;cb=0&amp;ab=-&amp;dp=pubs.acs.org&amp;fp=doi%2F10.1021%2Facscentsci.0c00601&amp;fr=&amp;of=0&amp;pd=0&amp;irt=1&amp;vcl=1&amp;md=0&amp;ct=1&amp;tct=0&amp;abt=0&amp;cdn=0&amp;pi=1&amp;rb=0&amp;gen=100&amp;chr=UTF-8&amp;colc=1651669882664&amp;jsl=1&amp;uvs=62727b6e4b931844005&amp;skipb=1&amp;callback=addthis.cbs.jsonp__116195534082932260"></script><script type="text/javascript" src="https://v1.addthisedge.com/live/boost/xa-4faab26f2cff13a7/_ate.track.config_resp"></script><script type="text/javascript" src="https://z.moatads.com/addthismoatframe568911941483/moatframe.js"></script><meta name="pbContext" content=";issue:issue:10.1021/acscii.2021.7.issue-1;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;requestedJournal:journal:acscii;article:article:10.1021/acscentsci.0c00601;website:website:acspubs;journal:journal:acscii;pageGroup:string:Publication Pages;subPage:string:Full Text">




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="ACS Central Science"><meta name="dc.Title" content="Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia"><meta name="dc.Creator" content="Dharma  Pally"><meta name="dc.Creator" content="Durjay  Pramanik"><meta name="dc.Creator" content="Shahid  Hussain"><meta name="dc.Creator" content="Shreya  Verma"><meta name="dc.Creator" content="Anagha  Srinivas"><meta name="dc.Creator" content="Rekha V.  Kumar"><meta name="dc.Creator" content="Arun  Everest-Dass"><meta name="dc.Creator" content="Ramray  Bhat"><meta name="dc.Description" content="Heterogeneity in phenotypes of malignantly transformed cells and aberrant glycan expression on their surface are two prominent hallmarks of cancers that have hitherto not been linked to each other...."><meta name="Description" content="Heterogeneity in phenotypes of malignantly transformed cells and aberrant glycan expression on their surface are two prominent hallmarks of cancers that have hitherto not been linked to each other...."><meta name="dc.Description" content="Differential expression of 2,6-linked sialic acids regulates adhesion of breast cancer epithelia to extracellular matrix leading to altered mesenchymal invasion and intratumoral heterogeneity."><meta name="Description" content="Differential expression of 2,6-linked sialic acids regulates adhesion of breast cancer epithelia to extracellular matrix leading to altered mesenchymal invasion and intratumoral heterogeneity."><meta name="dc.Publisher" content="American Chemical Society"><meta name="dc.Date" scheme="WTN8601" content="January 4, 2021"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1021/acscentsci.0c00601"><meta name="dc.Language" content="en"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society"><meta name="citation_fulltext_world_readable" content="">
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facscentsci.0c00601">
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facscentsci.0c00601">
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facscentsci.0c00601">
        
    
    

<title>Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia | ACS Central Science</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive">





    






        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acscentsci.0c00601"><meta property="og:title" content="Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia"><meta property="og:image" content="https://pubs.acs.org/cms/10.1021/acscentsci.0c00601/asset/images/acscentsci.0c00601.social.jpeg_v03"><meta property="og:description" content="Heterogeneity in phenotypes of malignantly transformed cells and aberrant glycan expression on their surface are two prominent hallmarks of cancers that have hitherto not been linked to each other. In this paper, we identify differential levels of a specific glycan linkage: α2,6-linked sialic acids within breast cancer cells in vivo and in culture. Upon sorting out two populations with moderate, and relatively higher, cell surface α2,6-linked sialic acid levels from the triple-negative breast cancer cell line MDA-MB-231, both populations (denoted as medium and high 2,6-Sial cells, respectively) stably retained their levels in early passages. Upon continuous culturing, medium 2,6-Sial cells recapitulated the heterogeneity of the unsorted line whereas high 2,6-Sial cells showed no such tendency. Compared with high 2,6-Sial cells, the medium 2,6-Sial counterparts showed greater adhesion to reconstituted extracellular matrices (ECMs) and invaded faster as single cells. The level of α2,6-linked sialic acids in the two sublines was found to be consistent with the expression of a specific glycosyl transferase, ST6GAL1. Stably knocking down ST6GAL1 in the high 2,6-Sial cells enhanced their invasiveness. When cultured together, medium 2,6-Sial cells differentially migrated to the edge of growing tumoroid-like cocultures, whereas high 2,6-Sial cells formed the central bulk. Multiscale simulations in a Cellular Potts model-based computational environment calibrated to our experimental findings suggest that differential levels of cell–ECM adhesion, likely regulated by α2,6-linked sialic acids, facilitate niches of highly invasive cells to efficiently migrate centrifugally as the invasive front of a malignant breast tumor."><meta property="og:type" content="Article"><meta property="og:site_name" content="ACS Publications"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content="@ACSPublications"><meta name="twitter:image" content="https://pubs.acs.org/cms/10.1021/acscentsci.0c00601/asset/images/acscentsci.0c00601.social.jpeg_v03">
    





    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0">















    

    <meta name="dc.identifier" content="10.1021/acscentsci.0c00601">



<meta name="format-detection" content="telephone=no">




<link rel="stylesheet" type="text/css" href="/wro/l6j1~product.css">

<link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-c7d2282eca032afdc856.css"><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css">




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1640088552890.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1648583148410.css">
<script type="text/javascript" async="" src="//img.en25.com/i/elqCfg.min.js"></script><script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer="" src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon="{&quot;rayId&quot;:&quot;5200035e6e4d5180&quot;,&quot;startTime&quot;:1570117212010}"></script>

            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    , 'auto'
                    );
                
                ga('send', 'pageview');
            </script>
            











    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acscentsci.0c00601">
            
        







    <!-- loading Javascript for using the persistence Service -->
    <script src="/templates/jsp/pb2/js/plugin/thiss-ds.js"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            alt_context: window.location.origin,
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if (ms == undefined || ms === '') {
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            if (results.length == 0) {
                                persistService.entities(self.alt_context).then((res) => {
                                    return resolve(res.data);
                                }, function (err) {
                                    // failed
                                    reject('failed to retrieve entity from local storage (publisher domain): ' + err);
                                });
                            } else {
                                return resolve(results);
                            }
                        }, function (err) {
                            // failed
                            reject('failed to retrieve entity from local storage: ' + err);
                        });
                    // Set up the timeout
                    setTimeout(function () {
                        reject('Promise timed out ' + ms + ' ms');
                    }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                    persistService.update(self.alt_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage (publisher domain) duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            var results = res.data;
                            if (!results) {
                                persistService.remove(self.alt_context, entityId).then((res) => {
                                    return resolve(res);
                                }, function (err) {
                                    // failed
                                    console.log('failed to remove from local storage (publisher domain) duo to: ' + err);
                                });
                            }
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId, entityTitle) {
                return new Promise(function (resolve, reject) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {
                            doi: doi,
                            entityid: entityId,
                            entityTitle: entityTitle,
                            eventGroupKey: 'b9b2cbf5-c78f-4cec-9239-495d052afe88'
                        }

                    }).done(function (status) {
                        return resolve(status);
                    }).fail(function (status) {
                        return reject(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID, ssoInstitution.entity.title)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + ssoInstitution.entity.entityID,err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            }).catch(function (err) {
                                reject(err);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();

                    if ($('.institution-preference-userconsent-checkbox').length > 0) {
                        let institutionPreferenceUserConsentCheckbox = $('.institution-preference-userconsent-checkbox').get(0);
                        if (!$(institutionPreferenceUserConsentCheckbox).is(":checked")) {
                            return;
                        }
                    }

                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err) {
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>







    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY">


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html">

<link rel="shortcut icon" href="/pb-assets/ux3/favicon-1635812676023.ico"><meta http-equiv="origin-trial" content="AxujKG9INjsZ8/gUq8+dTruNvk7RjZQ1oFhhgQbcTJKDnZfbzSTE81wvC2Hzaf3TW4avA76LTZEMdiedF1vIbA4AAABueyJvcmlnaW4iOiJodHRwczovL2ltYXNkay5nb29nbGVhcGlzLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzVGhpcmRQYXJ0eSI6dHJ1ZX0="><meta http-equiv="origin-trial" content="Azuce85ORtSnWe1MZDTv68qpaW3iHyfL9YbLRy0cwcCZwVnePnOmkUJlG8HGikmOwhZU22dElCcfrfX2HhrBPAkAAAB7eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A16nvcdeoOAqrJcmjLRpl1I6f3McDD8EfofAYTt/P/H4/AWwB99nxiPp6kA0fXoiZav908Z8etuL16laFPUdfQsAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="AxBHdr0J44vFBQtZUqX9sjiqf5yWZ/OcHRcRMN3H9TH+t90V/j3ENW6C8+igBZFXMJ7G3Pr8Dd13632aLng42wgAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A88BWHFjcawUfKU3lIejLoryXoyjooBXLgWmGh+hNcqMK44cugvsI5YZbNarYvi3roc1fYbHA1AVbhAtuHZflgEAAAB2eyJvcmlnaW4iOiJodHRwczovL2dvb2dsZS5jb206NDQzIiwiZmVhdHVyZSI6IlRydXN0VG9rZW5zIiwiZXhwaXJ5IjoxNjUyNzc0NDAwLCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv="origin-trial" content="AzoawhTRDevLR66Y6MROu167EDncFPBvcKOaQispTo9ouEt5LvcBjnRFqiAByRT+2cDHG1Yj4dXwpLeIhc98/gIAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv="origin-trial" content="A6+nc62kbJgC46ypOwRsNW6RkDn2x7tgRh0wp7jb3DtFF7oEhu1hhm4rdZHZ6zXvnKZLlYcBlQUImC4d3kKihAcAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv="origin-trial" content="A/9La288e7MDEU2ifusFnMg1C2Ij6uoa/Z/ylwJIXSsWfK37oESIPbxbt4IU86OGqDEPnNVruUiMjfKo65H/CQwAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><script src="https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022042801.js" async=""></script><style type="text/css">.at-icon{fill:#fff;border:0}.at-icon-wrapper{display:inline-block;overflow:hidden}a .at-icon-wrapper{cursor:pointer}.at-rounded,.at-rounded-element .at-icon-wrapper{border-radius:12%}.at-circular,.at-circular-element .at-icon-wrapper{border-radius:50%}.addthis_32x32_style .at-icon{width:2pc;height:2pc}.addthis_24x24_style .at-icon{width:24px;height:24px}.addthis_20x20_style .at-icon{width:20px;height:20px}.addthis_16x16_style .at-icon{width:1pc;height:1pc}#at16lb{display:none;position:absolute;top:0;left:0;width:100%;height:100%;z-index:1001;background-color:#000;opacity:.001}#at_complete,#at_error,#at_share,#at_success{position:static!important}.at15dn{display:none}#at15s,#at16p,#at16p form input,#at16p label,#at16p textarea,#at_share .at_item{font-family:arial,helvetica,tahoma,verdana,sans-serif!important;font-size:9pt!important;outline-style:none;outline-width:0;line-height:1em}* html #at15s.mmborder{position:absolute!important}#at15s.mmborder{position:fixed!important;width:250px!important}#at15s{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);float:none;line-height:1em;margin:0;overflow:visible;padding:5px;text-align:left;position:absolute}#at15s a,#at15s span{outline:0;direction:ltr;text-transform:none}#at15s .at-label{margin-left:5px}#at15s .at-icon-wrapper{width:1pc;height:1pc;vertical-align:middle}#at15s .at-icon{width:1pc;height:1pc}.at4-icon{display:inline-block;background-repeat:no-repeat;background-position:top left;margin:0;overflow:hidden;cursor:pointer}.addthis_16x16_style .at4-icon,.addthis_default_style .at4-icon,.at4-icon,.at-16x16{width:1pc;height:1pc;line-height:1pc;background-size:1pc!important}.addthis_32x32_style .at4-icon,.at-32x32{width:2pc;height:2pc;line-height:2pc;background-size:2pc!important}.addthis_24x24_style .at4-icon,.at-24x24{width:24px;height:24px;line-height:24px;background-size:24px!important}.addthis_20x20_style .at4-icon,.at-20x20{width:20px;height:20px;line-height:20px;background-size:20px!important}.at4-icon.circular,.circular .at4-icon,.circular.aticon{border-radius:50%}.at4-icon.rounded,.rounded .at4-icon{border-radius:4px}.at4-icon-left{float:left}#at15s .at4-icon{text-indent:20px;padding:0;overflow:visible;white-space:nowrap;background-size:1pc;width:1pc;height:1pc;background-position:top left;display:inline-block;line-height:1pc}.addthis_vertical_style .at4-icon,.at4-follow-container .at4-icon{margin-right:5px}html>body #at15s{width:250px!important}#at15s.atm{background:none!important;padding:0!important;width:10pc!important}#at15s_inner{background:#fff;border:1px solid #fff;margin:0}#at15s_head{position:relative;background:#f2f2f2;padding:4px;cursor:default;border-bottom:1px solid #e5e5e5}.at15s_head_success{background:#cafd99!important;border-bottom:1px solid #a9d582!important}.at15s_head_success a,.at15s_head_success span{color:#000!important;text-decoration:none}#at15s_brand,#at15sptx,#at16_brand{position:absolute}#at15s_brand{top:4px;right:4px}.at15s_brandx{right:20px!important}a#at15sptx{top:4px;right:4px;text-decoration:none;color:#4c4c4c;font-weight:700}#at15sptx:hover{text-decoration:underline}#at16_brand{top:5px;right:30px;cursor:default}#at_hover{padding:4px}#at_hover .at_item,#at_share .at_item{background:#fff!important;float:left!important;color:#4c4c4c!important}#at_share .at_item .at-icon-wrapper{margin-right:5px}#at_hover .at_bold{font-weight:700;color:#000!important}#at_hover .at_item{width:7pc!important;padding:2px 3px!important;margin:1px;text-decoration:none!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover{margin:0!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover,#at_share .at_item.athov,#at_share .at_item:hover{background:#f2f2f2!important;border:1px solid #e5e5e5;color:#000!important;text-decoration:none}.ipad #at_hover .at_item:focus{background:#fff!important;border:1px solid #fff}.at15t{display:block!important;height:1pc!important;line-height:1pc!important;padding-left:20px!important;background-position:0 0;text-align:left}.addthis_button,.at15t{cursor:pointer}.addthis_toolbox a.at300b,.addthis_toolbox a.at300m{width:auto}.addthis_toolbox a{margin-bottom:5px;line-height:initial}.addthis_toolbox.addthis_vertical_style{width:200px}.addthis_button_facebook_like .fb_iframe_widget{line-height:100%}.addthis_button_facebook_like iframe.fb_iframe_widget_lift{max-width:none}.addthis_toolbox a.addthis_button_counter,.addthis_toolbox a.addthis_button_facebook_like,.addthis_toolbox a.addthis_button_facebook_send,.addthis_toolbox a.addthis_button_facebook_share,.addthis_toolbox a.addthis_button_foursquare,.addthis_toolbox a.addthis_button_linkedin_counter,.addthis_toolbox a.addthis_button_pinterest_pinit,.addthis_toolbox a.addthis_button_tweet{display:inline-block}.addthis_toolbox span.addthis_follow_label{display:none}.addthis_toolbox.addthis_vertical_style span.addthis_follow_label{display:block;white-space:nowrap}.addthis_toolbox.addthis_vertical_style a{display:block}.addthis_toolbox.addthis_vertical_style.addthis_32x32_style a{line-height:2pc;height:2pc}.addthis_toolbox.addthis_vertical_style .at300bs{margin-right:4px;float:left}.addthis_toolbox.addthis_20x20_style span{line-height:20px}.addthis_toolbox.addthis_32x32_style span{line-height:2pc}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact,.addthis_toolbox.addthis_pill_combo_style a{float:left}.addthis_toolbox.addthis_pill_combo_style a.addthis_button_tweet{margin-top:-2px}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact{margin-right:4px}.addthis_default_style .addthis_separator{margin:0 5px;display:inline}div.atclear{clear:both}.addthis_default_style .addthis_separator,.addthis_default_style .at4-icon,.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300bs,.addthis_default_style .at300m{float:left}.at300b img,.at300bo img{border:0}a.at300b .at4-icon,a.at300m .at4-icon{display:block}.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300m{padding:0 2px}.at300b,.at300bo,.at300bs,.at300m{cursor:pointer}.addthis_button_facebook_like.at300b:hover,.addthis_button_facebook_like.at300bs:hover,.addthis_button_facebook_send.at300b:hover,.addthis_button_facebook_send.at300bs:hover{opacity:1}.addthis_20x20_style .at15t,.addthis_20x20_style .at300bs{overflow:hidden;display:block;height:20px!important;width:20px!important;line-height:20px!important}.addthis_32x32_style .at15t,.addthis_32x32_style .at300bs{overflow:hidden;display:block;height:2pc!important;width:2pc!important;line-height:2pc!important}.at300bs{overflow:hidden;display:block;background-position:0 0;height:1pc;width:1pc;line-height:1pc!important}.addthis_default_style .at15t_compact,.addthis_default_style .at15t_expanded{margin-right:4px}#at_share .at_item{width:123px!important;padding:4px;margin-right:2px;border:1px solid #fff}#at16p{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);z-index:10000001;position:absolute;top:50%;left:50%;width:300px;padding:10px;margin:0 auto;margin-top:-185px;margin-left:-155px;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#5e5e5e}#at_share{margin:0;padding:0}#at16pt{position:relative;background:#f2f2f2;height:13px;padding:5px 10px}#at16pt a,#at16pt h4{font-weight:700}#at16pt h4{display:inline;margin:0;padding:0;font-size:9pt;color:#4c4c4c;cursor:default}#at16pt a{position:absolute;top:5px;right:10px;color:#4c4c4c;text-decoration:none;padding:2px}#at15sptx:focus,#at16pt a:focus{outline:thin dotted}#at15s #at16pf a{top:1px}#_atssh{width:1px!important;height:1px!important;border:0!important}.atm{width:10pc!important;padding:0;margin:0;line-height:9pt;letter-spacing:normal;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#444;background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);padding:4px}.atm-f{text-align:right;border-top:1px solid #ddd;padding:5px 8px}.atm-i{background:#fff;border:1px solid #d5d6d6;padding:0;margin:0;box-shadow:1px 1px 5px rgba(0,0,0,.15)}.atm-s{margin:0!important;padding:0!important}.atm-s a:focus{border:transparent;outline:0;transition:none}#at_hover.atm-s a,.atm-s a{display:block;text-decoration:none;padding:4px 10px;color:#235dab!important;font-weight:400;font-style:normal;transition:none}#at_hover.atm-s .at_bold{color:#235dab!important}#at_hover.atm-s a:hover,.atm-s a:hover{background:#2095f0;text-decoration:none;color:#fff!important}#at_hover.atm-s .at_bold{font-weight:700}#at_hover.atm-s a:hover .at_bold{color:#fff!important}.atm-s a .at-label{vertical-align:middle;margin-left:5px;direction:ltr}.at_PinItButton{display:block;width:40px;height:20px;padding:0;margin:0;background-image:url(//s7.addthis.com/static/t00/pinit00.png);background-repeat:no-repeat}.at_PinItButton:hover{background-position:0 -20px}.addthis_toolbox .addthis_button_pinterest_pinit{position:relative}.at-share-tbx-element .fb_iframe_widget span{vertical-align:baseline!important}#at16pf{height:auto;text-align:right;padding:4px 8px}.at-privacy-info{position:absolute;left:7px;bottom:7px;cursor:pointer;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:10px;line-height:9pt;letter-spacing:.2px;color:#666}.at-privacy-info:hover{color:#000}.body .wsb-social-share .wsb-social-share-button-vert{padding-top:0;padding-bottom:0}.body .wsb-social-share.addthis_counter_style .addthis_button_tweet.wsb-social-share-button{padding-top:40px}.body .wsb-social-share.addthis_counter_style .addthis_button_facebook_like.wsb-social-share-button{padding-top:21px}@media print{#at4-follow,#at4-share,#at4-thankyou,#at4-whatsnext,#at4m-mobile,#at15s,.at4,.at4-recommended{display:none!important}}@media screen and (max-width:400px){.at4win{width:100%}}@media screen and (max-height:700px) and (max-width:400px){.at4-thankyou-inner .at4-recommended-container{height:122px;overflow:hidden}.at4-thankyou-inner .at4-recommended .at4-recommended-item:first-child{border-bottom:1px solid #c5c5c5}}</style><style type="text/css">.at-branding-logo{font-family:helvetica,arial,sans-serif;text-decoration:none;font-size:10px;display:inline-block;margin:2px 0;letter-spacing:.2px}.at-branding-logo .at-branding-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAMAAAC67D+PAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAAZQTFRF////+GlNUkcc1QAAAB1JREFUeNpiYIQDBjQmAwMmkwEM0JnY1WIxFyDAABGeAFEudiZsAAAAAElFTkSuQmCC")}.at-branding-logo .at-branding-icon,.at-branding-logo .at-privacy-icon{display:inline-block;height:10px;width:10px;margin-left:4px;margin-right:3px;margin-bottom:-1px;background-repeat:no-repeat}.at-branding-logo .at-privacy-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAkAAAAKCAMAAABR24SMAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABhQTFRF8fr9ot/xXcfn2/P5AKva////////AKTWodjhjAAAAAd0Uk5T////////ABpLA0YAAAA6SURBVHjaJMzBDQAwCAJAQaj7b9xifV0kUKJ9ciWxlzWEWI5gMF65KUTv0VKkjVeTerqE/x7+9BVgAEXbAWI8QDcfAAAAAElFTkSuQmCC")}.at-branding-logo span{text-decoration:none}.at-branding-logo .at-branding-addthis,.at-branding-logo .at-branding-powered-by{color:#666}.at-branding-logo .at-branding-addthis:hover{color:#333}.at-cv-with-image .at-branding-addthis,.at-cv-with-image .at-branding-addthis:hover{color:#fff}a.at-branding-logo:visited{color:initial}.at-branding-info{display:inline-block;padding:0 5px;color:#666;border:1px solid #666;border-radius:50%;font-size:10px;line-height:9pt;opacity:.7;transition:all .3s ease;text-decoration:none}.at-branding-info span{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.at-branding-info:before{content:'i';font-family:Times New Roman}.at-branding-info:hover{color:#0780df;border-color:#0780df}</style><script src="https://widgets.figshare.com/static/figshare.js?_=1651669882055"></script><script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.107/CcdcJsmolUtilities.min.js?_=1651669882056"></script><script src="https://common.ccdc.cam.ac.uk/jsmol/14.2.7/JSmol.min.nojq.js?_=1651669882057"></script><link type="text/css" rel="stylesheet" href="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.107/CcdcWidget.min.css"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'central_science';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/central_science/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/central_science/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
					console.log("ad display: " + event.creativeId + " " + event.size[0] + "x" + event.size[1]);
				}
				else {
				    console.log("no ad found");
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>

<style>
.articleHeaderDropzone5 .advertisement { display: none; }
.article_header .advertisement {
  margin: -25px auto 25px auto;
}
</style>




        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.107/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&amp;EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Indiana University Libraries - Bloomington</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"><input type="hidden" name="clientID" value="atypon-lives" class="clientID"><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"></a>




        
        <div class="pj-badge"></div><a href="/journal1/acscii" title="ACS Central Science" class="header_article-logo"><img src="/cms/10.1021/acscii/asset/title.png" alt="ACS Central Science"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="acscii" name="SeriesKey" checked="checked" class="all-content"><span>ACS Cent. Sci.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"><select name="quickLinkJournal" class="quick-search_journals-select"><option value="acscii">ACS Central Science</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science &amp; Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials &amp; Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio &amp; Med Chem Au</option><option value="abseba">ACS Biomaterials Science &amp; Engineering</option><option value="accacs">ACS Catalysis</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health &amp; Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&amp;T Engineering</option><option value="aewcaa">ACS ES&amp;T Water</option><option value="afsthl">ACS Food Science &amp; Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic &amp; Inorganic Au</option><option value="aptsfn">ACS Pharmacology &amp; Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry &amp; Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&amp;EN Global Enterprise</option><option value="cenear">Chemical &amp; Engineering News Archive</option><option value="chlseg">Chemical Health &amp; Safety</option><option value="chlseg0">Chemical Health &amp; Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth &amp; Design</option><option value="enfuem">Energy &amp; Fuels</option><option value="esthag">Environmental Science &amp; Technology</option><option value="estlcu">Environmental Science &amp; Technology Letters</option><option value="iepra6.2">I&amp;EC Product Research and Development</option><option value="iechad">Industrial &amp; Engineering Chemistry</option><option value="iecac0">Industrial &amp; Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series</option><option value="iecfa7">Industrial &amp; Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial &amp; Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial &amp; Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial &amp; Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical &amp; Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health &amp; Safety</option><option value="jchsc20">Journal of Chemical Health &amp; Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial &amp; Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research &amp; Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&amp;D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autocomplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autocomplete="false" placeholder="Page" required="required" class="quick-search_page-input"><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden="”true”"></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><ul><li><a href="/doi/full/10.1021/acscentsci.0c01466">Single-Atom Photocatalysts for Emerging Reactions</a></li><li><a href="/doi/full/10.1021/acscentsci.0c01551">Single-Molecule Förster Resonance Energy Transfer-Based Photosensitizer for Synergistic Photodynamic/Photothermal Therapy</a></li><li><a href="/doi/full/10.1021/acscentsci.0c01318">Multifunctional Batteries: Flexible, Transient, and Transparent</a></li><li><a href="/doi/full/10.1021/acscentsci.0c01621">Broad Spectrum Antibiotic Xanthocillin X Effectively Kills Acinetobacter baumannii via Dysregulation of Heme Biosynthesis</a></li><li><a href="/doi/full/10.1021/acscentsci.0c01600">Unprecedented Nonphotomediated Hole (h+) Oxidation System Constructed from Defective Carbon Nanotubes and Superoxides</a></li></ul></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden="”true”"></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden="”true”"></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden="”true”"></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors &amp; Reviewers');">Authors &amp;
                        Reviewers</a></li>
                <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
				<li><a href="https://pubs.acs.org/page/virtual-collections.html" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Virtual Issues');">Virtual Issues</a></li>
                <li><a href="https://preferences.acs.org/journals" onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS &amp; Mobile');">RSS &amp; Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products &amp; Services');">Products &amp; Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos &amp; Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#" onclick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');" class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/who-we-serve/librarians/" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians &amp; Account Managers');">For
                        Librarians &amp; Account Managers</a></li>
            </ul>
        </li>
        <li class="menu-pair-section hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pb/widgets/affiliateDevice">Pair a device</a></li>
                
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pb/widgets/affiliateDevice">Pair a device</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS &amp; Open Access');">ACS &amp; Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="/events" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><!-- Types--><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><!-- Subjects--><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><!--div.pub-modal_right-cover-gallery.hidden-lg.hidden-md//a(href="/coverGallery") Browse Our Cover Art Gallery
--><!-- Publications list--><!-- 'pub-modal_right--inner' adds styling required for IE--><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><!-- The widget data--><input type="hidden" id="ajaxUrl" name="ajaxUrl" value="/pb/widgets/achs-publication-list?widgetId=cabcb15c-6f7a-494b-a19c-eba4fafaee5c&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Facscii.2021.7.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3BrequestedJournal%3Ajournal%3Aacscii%3Barticle%3Aarticle%3A10.1021%2Facscentsci.0c00601%3Bwebsite%3Awebsite%3Aacspubs%3Bjournal%3Ajournal%3Aacscii%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;key=c7ca46a97ce077568c7371697bcd489c0&amp;ajaxRequest=true"><input type="hidden" name="pubModalData" value=""></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facscentsci.0c00601&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facscentsci.0c00601&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acscentsci.0c00601&amp;href=/doi/10.1021/acscentsci.0c00601" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>ACS Cent. Sci.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 7</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 110-125</span></span></span></div></div></div></div></div><input type="hidden" name="acscii" id="copyRights" value="/pb-assets/json/journal-info-1641590078917.json"><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/acscii/7/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acscentsci.0c01488" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Research Article</span><a href="/doi/10.1021/acscentsci.0c01135" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/acscii" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/cms/10.1021/acscii/asset/title.png" alt="Journal Logo"></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dharma Pally</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dharma Pally</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dharma++Pally">Dharma Pally</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid"><a href="http://orcid.org/0000-0003-4814-8875" title="Orcid link">http://orcid.org/0000-0003-4814-8875</a></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Durjay Pramanik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Durjay Pramanik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Durjay++Pramanik">Durjay Pramanik</a></span></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Shahid Hussain</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shahid Hussain</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shahid++Hussain">Shahid Hussain</a></span></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Shreya Verma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shreya Verma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shreya++Verma">Shreya Verma</a></span></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Anagha Srinivas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anagha Srinivas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anagha++Srinivas">Anagha Srinivas</a></span></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Rekha V. Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rekha V. Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore 560029, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rekha+V.++Kumar">Rekha V. Kumar</a></span></div></div></span></li><span class="comma-separator">,&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Arun Everest-Dass</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun Everest-Dass</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Glycomics, Griffith University, Southport, Queensland 4215, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun++Everest-Dass">Arun Everest-Dass</a></span></div></div></span></li><span class="comma-separator">,&nbsp;and&nbsp;</span><li><span><span class="hlFld-ContribAuthor">Ramray Bhat</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramray Bhat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="mailto:ramray@iisc.ac.in">ramray@iisc.ac.in</a>. Phone: 91-80-22932764.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramray++Bhat">Ramray Bhat</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="acscii"><input type="hidden" name="journalNameForjhpLink" value="ACS Central Science"><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facscentsci.0c00601&amp;href=/doi/10.1021%2Facscentsci.0c00601" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>ACS Cent. Sci.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 7</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 110–125</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 3, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 May 2020</li><li><span class="item_label"><b>Published</b> online</span>4 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acscentsci.0c00601" title="DOI URL">https://doi.org/10.1021/acscentsci.0c00601</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS &amp; PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice"><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acscentsci.0c00601"><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3342</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"><input type="hidden" name="clientID" value="atypon-lives" class="clientID"><input type="hidden" class="doi" value="10.1021/acscentsci.0c00601"><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dharma&quot;,&quot;last_name&quot;:&quot;Pally&quot;},{&quot;first_name&quot;:&quot;Durjay&quot;,&quot;last_name&quot;:&quot;Pramanik&quot;},{&quot;first_name&quot;:&quot;Shahid&quot;,&quot;last_name&quot;:&quot;Hussain&quot;},{&quot;first_name&quot;:&quot;Shreya&quot;,&quot;last_name&quot;:&quot;Verma&quot;},{&quot;first_name&quot;:&quot;Anagha&quot;,&quot;last_name&quot;:&quot;Srinivas&quot;},{&quot;first_name&quot;:&quot;Rekha&quot;,&quot;last_name&quot;:&quot;V. Kumar&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Everest-Dass&quot;},{&quot;first_name&quot;:&quot;Ramray&quot;,&quot;last_name&quot;:&quot;Bhat&quot;}],&quot;source&quot;:&quot;ACS Central Science&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;7&quot;,&quot;pages&quot;:&quot;110-125&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acscentsci.0c00601&quot;},&quot;abstract&quot;:&quot;Heterogeneity in phenotypes of malignantly transformed cells and aberrant glycan expression on their surface are two prominent hallmarks of cancers that have hitherto not been linked to each other. In this paper, we identify differential levels of a specific glycan linkage: α2,6-linked sialic acids within breast cancer cells in vivo and in culture. Upon sorting out two populations with moderate, and relatively higher, cell surface α2,6-linked sialic acid levels from the triple-negative breast cancer cell line MDA-MB-231, both populations (denoted as medium and high 2,6-Sial cells, respectively) stably retained their levels in early passages. Upon continuous culturing, medium 2,6-Sial cells recapitulated the heterogeneity of the unsorted line whereas high 2,6-Sial cells showed no such tendency. Compared with high 2,6-Sial cells, the medium 2,6-Sial counterparts showed greater adhesion to reconstituted extracellular matrices (ECMs) and invaded faster as single cells. The level of α2,6-linked sialic acids in the&quot;}" class="meta-data"><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"><input type="hidden" name="pub-access" value="free" class="pub-access"><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"><input type="hidden" name="selected-share-option" class="selected-share-option"></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facscentsci.0c00601&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acscentsci.0c00601" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facscentsci.0c00601&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acscentsci.0c00601" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facscentsci.0c00601&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acscentsci.0c00601" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facscentsci.0c00601&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acscentsci.0c00601&amp;href=/doi/10.1021/acscentsci.0c00601" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acscentsci.0c00601"><a href="/doi/pdf/10.1021/acscentsci.0c00601" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acscentsci.0c00601&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fid%3Ddoi%3A10.1021%252Facscentsci.0c00601%26sid%3Dliteratum%253Aachs%26pmid%3D33532574%26genre%3Darticle%26aulast%3DPally%26date%3D2021%26atitle%3DHeterogeneity%2Bin%2B2%252C6-Linked%2BSialic%2BAcids%2BPotentiates%2BInvasion%2Bof%2BBreast%2BCancer%2BEpithelia%26jtitle%3DACS%2BCentral%2BScience%26title%3DACS%2BCentral%2BScience%26volume%3D7%26issue%3D1%26spage%3D110%26epage%3D125%26issn%3D2374-7943" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"><input type="hidden" name="is-enabled" value="true" class="is-enabled"><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"><!-- TODO: comment out below line:--><!--input.acs-id(type="hidden" name="acs-id" value="31838729")--><input type="hidden" name="pub-code" value="acscii" class="pub-code"><input type="hidden" name="linkout-url" value="https://preferences.acs.org/journals" class="linkout-url"><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acs.org/acscii?ifr=1"></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollduration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292543" title="Extracellular matrix">Extracellular matrix</a>,</li><li><a href="/action/doSearch?ConceptID=290879" title="Chemical biology">Chemical biology</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/acscii/7/1" title="Go to ACS Central Science "><img src="/cms/10.1021/acscii.2021.7.issue-1/asset/acscii.2021.7.issue-1.largecover.jpg" alt="Go to ACS Central Science "></a></div></div>




        
        <!--Article Page E-Alerts-->
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','acscii');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','acscii');
	  }
  });
</script>
<!--End Article Script-->




        
        <div class="pj-badge"><input type="hidden" id="partnerJournalInfo" value="/pb-assets/json/journal-info-1641590078917.json"></div>




        
        <div class="aJhp_link"></div>
<input type="hidden" id="aJhpJournalInfo" value="/pb-assets/json/journal-info-1641590078917.json">
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=acscii" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0007.gif" alt="" id="tgr1"><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Heterogeneity in phenotypes of malignantly transformed cells and aberrant glycan expression on their surface are two prominent hallmarks of cancers that have hitherto not been linked to each other. In this paper, we identify differential levels of a specific glycan linkage: α2,6-linked sialic acids within breast cancer cells <i>in vivo</i> and in culture. Upon sorting out two populations with moderate, and relatively higher, cell surface α2,6-linked sialic acid levels from the triple-negative breast cancer cell line MDA-MB-231, both populations (denoted as medium and high 2,6-Sial cells, respectively) stably retained their levels in early passages. Upon continuous culturing, medium 2,6-Sial cells recapitulated the heterogeneity of the unsorted line whereas high 2,6-Sial cells showed no such tendency. Compared with high 2,6-Sial cells, the medium 2,6-Sial counterparts showed greater adhesion to reconstituted extracellular matrices (ECMs) and invaded faster as single cells. The level of α2,6-linked sialic acids in the two sublines was found to be consistent with the expression of a specific glycosyl transferase, <i>ST6GAL1</i>. Stably knocking down <i>ST6GAL1</i> in the high 2,6-Sial cells enhanced their invasiveness. When cultured together, medium 2,6-Sial cells differentially migrated to the edge of growing tumoroid-like cocultures, whereas high 2,6-Sial cells formed the central bulk. Multiscale simulations in a Cellular Potts model-based computational environment calibrated to our experimental findings suggest that differential levels of cell–ECM adhesion, likely regulated by α2,6-linked sialic acids, facilitate niches of highly invasive cells to efficiently migrate centrifugally as the invasive front of a malignant breast tumor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="hlFld-Abstract synopsis"><h2>Synopsis</h2><span><p class="articleBody_abstractText">Differential expression of 2,6-linked sialic acids regulates adhesion of breast cancer epithelia to extracellular matrix leading to altered mesenchymal invasion and intratumoral heterogeneity.</p></span></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52664" class="dropBlock__holder"></div></div></div></div></div><hr><div class="NLM_p">One of the hallmarks of malignant tumors is heterogeneity in the phenotypes of its constituent transformed epithelia. Observations of phenotypic heterogeneity can be traced back to the demonstration by Hawkins and co-workers of variable expression of the estrogen receptor (ER) among cells within a tumor. With time, evidence of intratumoral variation in expression was discovered for several genes/markers and is responsible for determining clinical behavior and response to treatment. <a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Intratumoral heterogeneity can also contribute to misdiagnosis of the aggressiveness and grade of breast cancer leading to its mistreatment. <a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a></div><div class="NLM_p">A combination of genomic and epigenomic aberrations and loss in a dynamic and reciprocal regulation of homeostasis by the tissue microenvironment and stochasticity leads to diversity in protein expression, localization, and interaction within cells belonging to the same population. This diversity in turn leads to heterogeneity in cellular phenotypes. <a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> However, proteins are not the only molecular species to show such alterations in malignant contexts. Changes in levels of sugars on the surfaces of cancer cells, when compared with their untransformed counterparts, have been demonstrated for a long time. <a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> Further studies show that altered levels of <i>N</i>- and <i>O</i>-linked glycosylations in transformed epithelia and tumor-associated stromal cells impact the progression and metastasis of cancer as well as its response to chemotherapy. <a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> For example, aberrantly glycosylated β1-integrin leads to altered cell–ECM adhesion, thereby aiding cancer cell invasion and metastasis. <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> An increase in Sialyl Lewis<sup>X</sup> enhances adhesion of cancer cells to endothelial cells via selectins, leading to colonization of distant organs. <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><i>O</i>-GlcNAcylated c-Myc can compete with its unglycosylated counterpart in phosphorylation leading to increased stability and thereby increase cancer cell proliferation. <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Hypersialylation is one of the frequently observed changes in cell surface glycosylation seen in many cancer types. <a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Selective enrichment of terminal α2,6-linked sialic acids (referred to here onward as α2,6-Sial), due to overexpression of <i>ST6GAL1</i>, in cancer cell glycocalyces can elicit a wide range of biological outcomes like protection from hypoxia, resistance to chemotherapy, prosurvival and conferral of cancer stem cell phenotype. <a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a></div><div class="NLM_p last">To the best of our knowledge, there is no literature on differential levels of glycans on the surface of transformed cells within growing tumors. In the present study, we investigated this question in the context of sialic acid expression in breast cancer. Using a combination of lectin-based flow cytometry, cytochemistry, and glycomics using mass spectrometry, we demonstrated diverse expression profiles of α2,6-Sial within breast cancer cells <i>in vitro</i> and <i>in vivo</i>. The diversity was glycan-specific: α2,3-Sial or other assessed oligosaccharides did not show such differential expression. We found two distinct cell populations with moderate and high levels of α2,6-Sial in the triple-negative breast cancer cell line MDA-MB-231. Combining cell biological assays with agent-based modeling simulations, we demonstrate how the distinct glycan levels result in differential migration of more invasive epithelia to the invading edge of cultured 3D tumoroids. A better understanding of intratumor glycobiological heterogeneity is certain to impact breast cancer diagnosis and treatment in the future.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88525" class="dropBlock__holder"></div></div></div></div></div><hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Breast Cancer Epithelia Show Differences in α2,6-Sial Levels</h3><div class="NLM_p">We assayed for intercellular differences in α2,6- and α2,3-Sial levels in breast cancer sections using lectin histochemistry. FITC-conjugated <i>Sambucus nigra</i> (SNA) lectin and TRITC-conjugated <i>Maackia amurensis</i> (MAA) lectin were used as probes for α2,6- and α2,3-Sial, respectively. Examination of tumor sections from 6 of 8 patients showed signals for both sugar linkages when compared to appropriate controls (staining from 2 representative patients shown in <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S1</a> and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, although cells in the sections stained uniformly for α2,3-Sial (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, red), cellular staining for α2,6-Sial (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, green) was variegated: rounded patches of cells with high levels of α2,6-Sial were surrounded by dispersed populations with comparatively lower levels (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). This was confirmed through per-cell quantification of cancer cells that revealed a greater variance in cell-specific expression of α2,6-Sial relative to α2,3-Sial (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). Whereas elevated levels of α2,6-Sial in breast cancer epithelia have been previously reported, <a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> our report is the first to document intercellular diversity of expression of a specific sugar linkage (α2,6-Sial) <i>in vivo</i>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0001.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0001.jpeg" id="gr1" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. α2,6-Sialic acid heterogeneity in breast cancer. (A) Confocal micrographs showing α2,6-sialic acid (SNA-FITC, green) and α2,3-sialic acid (MAA-TRITC, red) staining of breast cancer sections from two individuals (top and bottom rows) showing heterogeneity in α2,6-sialic acid linkage expression. The nucleus is stained with DAPI (white) (scale bar: 100 μm). (B) Bar graphs showing quantification of individual sialic acid levels from breast cancer sections shown in part A. Error bars represent mean ± SD. (C) Confocal micrographs showing heterogeneity in α2,6-Sial levels (SNA-FITC green) and uniform α2,3-sialic levels (MAA-TRITC, red) in invasive breast cancer cell line MDA-MB-231 using lectin cytochemical fluorescence. Cells are counterstained for nucleus with DAPI (white) and F-actin with phalloidin (Magenta). Insets of a subfield within the images shown in bottom right corner. (D) Lectin-based flow cytometry profiles of MDA-MB-231 cells show bimodal distribution of α2,6-Sial levels (top left) and unimodal distribution of α2,3-Sial levels (top right). Red inset shows moderate levels of α2,6-Sial (left) and unchanged α2,3-Sial (right) in sorted medium 2,6-Sial cells. Orange inset shows higher α2,6-Sial (left) and unchanged α2,3-Sial (right) levels in sorted high 2,6-Sial cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next asked whether such heterogeneous expression could also be observed within cultured breast cancer cell lines. Lectin cytochemistry of the breast cancer cell line MDA-MB-231, using FITC-conjugated SNA and TRITC-conjugated MAA, revealed higher signals (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C) compared with lactose sugar controls (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S2</a>). Similar to our <i>in vivo</i> findings, we observed marked variation in α2,6-Sial linkage levels between MDA-MB-231 cells in the same field (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C, green, inset). Such variations were not appreciable for α2,3-Sial levels between the same cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C, red, inset). To probe the distinction in sialic acid levels at single-cell resolution (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S3</a>), we combined lectin-binding with flow cytometry and were able to discern two subpopulations of MDA-MB-231 cells with distinct levels of α2,6-Sial, evident from a bimodal distribution of the staining intensity histogram [unstained cells or cells stained with FITC were used as negative control (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figures S4 and S5</a>) (a third subpopulation is a minor fraction that does not stain for α2,6-Sial; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, left, and <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S6</a>)]. The level of α2,3-Sial in the same population showed a sharp unimodal distribution (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, right) confirming our observation from <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C. We confirmed the specificity of lectins used in the study by treating the unsorted MDA-MB-231 cells with sialidase from <i>Clostridium perfringens</i>, which preferentially cleaves α2,3-Sial. We observed a decrease in α2,3-Sial levels upon treatment but not in α2,6-Sial levels (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S7</a>). A wide distribution of α2,6-Sial levels and a comparatively sharper expression of α2,3-Sial levels were also observed for the metastatic triple-negative BT-549 breast cancer cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S8</a>).</div><div class="NLM_p">We then sorted these subpopulations based on α2,6-Sial as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D and will refer to them here onward as low 2,6-Sial (cells that did not stain for α 2,6-Sial), medium 2,6-Sial, and high 2,6-Sial cells. After sorting, the individual populations were cultured separately. In early passages, the medium 2,6-Sial subpopulation continued to show a sharp and unimodal peak of moderate α2,6-Sial levels coincident with the first peak of the bimodal distribution seen in unsorted MDA-MB-231 cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, red inset, left). Early-passage high 2,6-Sial cells also showed a unimodal peak of α2,6-Sial coincident with the second peak of the bimodal distribution seen in the unsorted MDA-MB-231 cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, orange inset, right). To our surprise, low 2,6-Sial cells, upon culture, shifted to stably express α2,6-Sial to levels concurrent with the medium 2,6-Sial subpopulation (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S6</a>, green inset, left). All of the three subpopulations showed similar levels of α2,3-Sial (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, red inset, orange inset, right; and <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S6</a>, green inset, right).</div><div class="NLM_p last">Next, we confirmed the differential levels of α2,6-Sial in the sorted, early-passage cultures of the high and medium 2,6-Sial cells using lectin cytochemical fluorescence (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S9</a>, green), even though α2,3-Sial levels remained unchanged between them (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S9</a>, red). We also probed for other glycans in unsorted MDA-MB-231 cells. Levels of bisecting, bi- (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S10</a>, green, top row), tri-, and tetra-antennary <i>N</i>-linked glycans (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S10</a>, green, middle row) as well as Core 1, mono/di sialyl Core 1 <i>O</i>-linked glycans (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S10</a>, green bottom row) showed uniform expression. Similarly, sharp unimodal distribution was observed when the sorted high and medium 2,6-Sial cells were probed for the above glycans (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S11</a>). Furthermore, we confirmed the existence of α2,6-Sial diversity using mass spectrometry. Released glycans from cell lysate (<i>N</i>-, <i>O</i>- and glycosphingolipid (GSL)-glycans) were identified and characterized using well-established porous graphitized carbon liquid chromatography (PGC-LC) and negative mode electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis. <a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Representative extracted ion chromatograms (EICs) of sialylated structures from <i>N</i>-, <i>O</i>-, and GSL-glycans are shown in <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figures S12 and S13</a>, respectively. The EIC of monosialylated (<i>m</i>/<i>z</i> 965.8<sup>2–</sup> and <i>m</i>/<i>z</i> 1038.8<sup>2–</sup>) and disialylated biantennary structures (<i>m</i>/<i>z</i> 1111.4<sup>2–</sup> and <i>m</i>/<i>z</i> 1184.4<sup>2–</sup>) of the three populations: unsorted, high, and medium 2,6-Sial showed that the relative abundance of the sialylated <i>N</i>-glycans with the terminal α2,6 linkage was higher in the high 2,6-Sial cells relative to medium 2,6-Sial cells, confirming observations of the lectin flow cytometry analysis. Interestingly, the core fucosylated versions of these isomers (<i>m</i>/<i>z</i> 1038.8<sup>2–</sup> and <i>m</i>/<i>z</i> 1184.4<sup>2–</sup>) had a more pronounced difference in the α2,3/6 linkage relative abundance. The representative EICs of the sialylated structures (<i>m</i>/<i>z</i> 1131.4<sup>1–</sup>, <i>m</i>/<i>z</i> 1040.3<sup>1–</sup>, <i>m</i>/<i>z</i> 966.3<sup>1–</sup>, and <i>m</i>/<i>z</i> 675.3<sup>1–</sup>) from <i>O</i>-glycans (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S13</a>, left) did not show any significant difference in their relative abundance of the sialylated species across the different cell types. Moreover, the detected sialylated residues linked to the galactose in the <i>O</i>-glycan analysis were all attributed to α2,3 linkages based on biological pathway processing, retention time, and negative mode fragmentation characterization from previous analysis. <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The α2,6-linked sialylated residues were found to be conjugated to the core GalNAc residue as observed for the structure of <i>m</i>/<i>z</i> 966.3<sup>1–</sup> and the early eluting isomer of <i>m</i>/<i>z</i> 675.3<sup>1–</sup>. Similarly, the GSL sialylated glycans were also all α2,3 linked to the galactose as observed in structures with <i>m</i>/<i>z</i> 634.2<sup>1–</sup>, <i>m</i>/<i>z</i> 925.3<sup>1–</sup>, and <i>m</i>/<i>z</i> 999.3<sup>1–</sup>.The glycan with <i>m</i>/<i>z</i> 925.3<sup>1–</sup> had an additional sialic acid found to be linked to the GM3 ganglioside structure and therefore attributed to the α2,8 linkage (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S13</a>, right). These findings suggest that the intercellular heterogeneity that we observe for α2,6-Sial is specific to sialylated <i>N</i>-linked glycans with little contribution from <i>O</i>-linked and GSL glycoconjugates.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Medium 2,6-Sial Cells Show Greater Plasticity and Invasion than High 2,6-Sial Cells</h3><div class="NLM_p">We next sought to investigate the functional differences between the high and medium 2,6-Sial subpopulations. Upon serial passaging in culture, medium 2,6-Sial cells showed a gradual recapitulation of the bimodal expression seen in flow cytometry of unsorted MDA-MB-231 cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). On the other hand, the high 2,6-Sial cells consistently showed a high and unimodal level of α2,6-Sial (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). We did not observe any changes in α2,3-Sial levels in both medium and high 2,6-Sial cells upon serial passaging (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figures S14 and S15</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0002.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0002.jpeg" id="gr2" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Medium 2,6-Sial cells show greater plasticity, adhere better to, and invade through ECM. (A) Lectin-based flow cytometry profile of α2,6-Sial levels of medium 2,6-Sial population at three passages (20, 70, and 145) of long-term culture showing a gradual recapitulation of bimodal α2,6-Sial distribution after 70 passages. (B) Lectin-based flow cytometry of high 2,6-Sial at three passages (20, 70, and 145) in long-term culture showing no change in α2,6-Sial even after 145 passages. (C) Bar graph showing lower invasion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) that invaded to the other side of lrECM-coated transwells (<i>n</i> = 3). (D) Graph showing lower adhesion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) to lrECM (<i>n</i> = 3). (E) Graph showing lower adhesion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) to Type 1 collagen (<i>n</i> = 3). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, we investigated the ability of these subpopulations to invade through the ECM. Medium 2,6-Sial cells invaded more through lrECM [laminin-rich ECM also called as laminin-rich basement membrane (lrBM)]-coated transwells, when compared with high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Invasion of mesenchymal cells requires strong tethering to ECM substrata. <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Therefore, the adhesion of the sorted populations to both lrBM and the fibrillar Type 1 collagen was assessed. For both matrices, higher adhesion was observed for medium 2,6-Sial cells when compared to high 2,6-Sial cells [<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D,E; BSA-coated surface, as a negative control showing negligible cell adhesion (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S16</a>)]. Higher adhesion to fibrillar Type 1 collagen was also observed for sorted BT-549 cells with lower 2,6-Sial levels (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S17</a>). Furthermore, we assayed for adhesion of medium 2,6-Sial cells at various passages, namely, early passage (P10–15), middle passage (P75–80), and late passage (P155–160). As the passage number of the cells increases, adhesion to both matrices decreased suggesting the role of α2,6-Sial in cell–ECM adhesion (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S18</a>). In addition, we assayed if there is any difference in proliferation rates of medium and high 2,6-Sial cells. We have not observed any significant difference in the number of viable cells at both 24 and 48 h between the populations (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S19</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Medium 2,6-Sial Cells Invade and Disperse Further than High 2,6-Sial Cells</h3><div class="NLM_p">The ability of medium 2,6-Sial cells to adhere better to, and invade more through, ECM than high 2,6-Sial cells led us to ask if the former invade in a collective manner or as single cells (referred to as mesenchymal invasion) wherein adhesion to ECM is crucial. <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> To answer the question, we used a customized 3D assay, wherein clusters of cancer cells are coated with lrBM matrix and then embedded within fibrillar Type 1 collagen to mimic the collagen-rich stromal environment. <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In concurrence with our transwell experiments, single medium 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) were found to radially invade into the Type 1 collagen to a greater extent than high 2,6-Sial cancer cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). Time-lapse bright field microscopy on such cultures allowed us to measure the radial collective cellular migration as well as count the single cells that migrated into the fibrillar ECM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C; <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_004.mp4" class="ext-link">Video S1A,B</a>). Both medium and high 2,6-Sial cells showed comparable collective cell migration (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). However, the number of single medium 2,6-Sial cells that invaded into the collagen as well as their mean migratory velocity were significantly higher than those of high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>E,F).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0003.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0003.jpeg" id="gr3" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Medium 2,6-Sial cells invade faster through a 3D pathotypic multi-ECM microenvironment. (A) Confocal micrographs showing medium 2,6-Sial cells invading into fibrillar Type 1 collagen matrix from lrECM-coated multicellular clusters after 24 h. (B) Confocal micrographs showing high 2,6-Sial cells invading into fibrillar Type 1 collagen matrix from lrECM-coated multicellular clusters after 24 h. (A, B) Cells are counter-stained for the nucleus with DAPI (white) and F-actin with phalloidin (magenta) (scale bar: 200 μm). (C) Bright field images taken at 0, 12, 18, and 24 h from time-lapse videography of lrECM-coated clusters of high and medium 2,6-Sial (top and bottom) invading into surrounding Type 1 collagen. (D) Graph showing insignificant differences in collective cell mode of invasion of high (yellow) and medium (red) 2,6-Sial cells as measured by the increase in cluster size obtained from time-lapse videography (<i>n</i> = 3). (E) Graph showing significantly lower invasion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) as measured by the number of dispersed single cells in Type 1 collagen normalized to the initial cluster size obtained from lapse videography (<i>n</i> = 3). (F) Graph showing significantly lower mean migratory velocity of single high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) as measured by manual tracking dynamics obtained from lapse videography (<i>n</i> = 3, <i>N</i> ≥ 15 cells). (G) Confocal micrographs showing differential sorting of medium 2,6-Sial (green) cells invading and dispersing further into the Type 1 collagen ECM while high 2,6-Sial cells (red) form the core of the cluster when these two cells have been mixed in equal proportion and cultured in 3D. (Cells are counter-stained for the nucleus with DAPI (white) and F-actin with phalloidin (magenta) (scale bar: 200 μm). (H) Histogram showing distribution of intercellular distances between high 2,6-Sial cells (red) compared with medium 2,6-Sial cells (yellow). Intercellular distances between medium α2,6-Sial cells are shifted rightwards indicative of a greater spread and farther invasion within 3D matrix microenvironment compared to high 2,6-Sial cells. Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This prompted us to ask whether differential invasion would cause a population with both high and medium 2,6-Sial cells in a cancer cluster embedded in ECM to self-sort, with the former giving rise to the indolently growing bulk and the latter forming the radially invading front. This was indeed found to be the case (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>G): when the two subpopulations were labeled with constitutively expressing fluorescence reporters, mixed in equal numbers and embedded in lrBM and Type 1 collagen, medium 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>G, green) predominantly were present within the collagen, and high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>G, red) were closely clustered together in the central core. The relatively higher dispersion of the medium 2,6-Sial cells was confirmed by plotting the intercellular distances separately for medium and high 2,6-Sial cells wherein the histogram for the latter showed a leftward skew relative to the former (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>H). Further, we asked if α2,6-Sial levels in medium and high 2,6-Sial cells changed upon being cocultured with each other. Upon cocultivation of a 1:1 ratio of medium and high (RFP) 2,6-Sial cells for 48 h, we probed and did not observe any significant change in α2,6-Sial expression levels for both the populations, indicating that the α2,6-Sial of the two populations is retained in cocultures (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S20</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Medium and High 2,6-Sial Cells Differ in Their Expression of <i>ST6GAL1</i></h3><div class="NLM_p">We next asked whether the distinct α2,6-Sial levels in the two sorted populations could be due to differential expression of genes involved in glycan synthesis and/or sialic acid metabolism. To do so, we examined the expression of genes encoding proteins involved in <i>N</i>-linked glycan synthesis (<i>ALG1</i>, <i>MAN1A1</i>, <i>DPAGT1</i>, <i>ALG3</i>, and <i>GANAB</i>) and sialic acid synthesis and sialidase (<i>CMAS</i>, <i>GNE</i>, <i>NANS</i>, and <i>NEU1</i>) and those coding for 2,3- and 2,6-sialyl transferases (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) using quantitative real-time PCR (qRT-PCR). We did not observe any significant change in the expression of genes involved in <i>N</i>-linked glycosylation, sialic acid synthesis, and sialidase (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B,C) validating our flow cytometry results on the lack of detection of differences in <i>N</i>-linked glycans between the two sorted populations. The expression of genes encoding 2,3-sialyltransferases was not significantly changed confirming the equivalent expression of 2,3-Sial levels in the medium and high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D). We found that <i>ST6GAL1</i> mRNA levels were lower in medium 2,6-Sial cells when compared with high 2,6-Sial cells. In fact, with continuous passaging, as medium 2,6-Sial cells recovered the 2,6-Sial staining of the unsorted cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A), along with a concomitant decrease in ECM adhesion (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S18</a>), we also observed a progressive increase in <i>ST6GAL1</i> expression (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S21</a>). Expression levels of other α2,6-sialyl transferase genes like <i>ST6GALNAC2</i>, <i>ST6GALNAC4</i>, and <i>ST6GALNAC6</i> did not vary significantly between populations (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0004.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0004.jpeg" id="gr4" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Differential expression of the <i>ST6GAL1</i> gene. (A) Schematic depiction of key processes involved in the fate and utilization of sialic acids and the genes encoding the enzymes involved in these processes arranged in the temporal order of their function: <i>N</i>-glycan synthesis, sialic acid metabolism and sialyltransferases. (B) Graphs depicting relative mRNA levels of genes involved in <i>N</i>-linked glycosylation <i>DPAGT1</i>, <i>ALG1</i>, <i>ALG3</i>, <i>GANAB</i>, and <i>MAN1A1</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (C) Graphs depicting relative mRNA levels of genes involved in sialic acid metabolism <i>GNE</i>, <i>NANS</i>, <i>CMAS</i>, and <i>NEU1</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (D) Graphs depicting relative mRNA levels of genes involved in 2,3-sialic acid conjugation <i>ST3GAL3</i> and <i>ST3GAL4</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (E) Graphs depicting relative mRNA levels of genes involved in 2,6-sialic acid conjugation <i>ST6GAL1</i>, <i>ST6GALNAC2</i>, <i>ST6GALNAC4</i>, and <i>ST6GALNAC6</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells for all except <i>ST6GAL1</i>, which is significantly lower in medium 2,6-Sial cells compared to high 2,6-Sial cells. Expression of all genes is plotted as 2<sup>–ΔΔct</sup> normalized to unsorted cells. The <i>18S rRNA</i> gene is used as an internal control. Data shown are from five independent biological experiments with at least duplicate samples run in each experiment. Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (****<i>P</i> &lt; 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Knockdown of <i>ST6GAL1</i> in High 2,6-Sial Cells Enhances Their Mesenchymal Invasion</h3><div class="NLM_p">To establish if the α2,6-sialic acid linkage has a direct effect on cancer cell invasion, we knocked down the expression of <i>ST6GAL1</i> in high 2,6-Sial cells using lentivirally delivered shRNA. <i>ST6GAL1</i> expression was confirmed using qRT-PCR (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Figure S22</a>). Lectin flow cytometry confirmed a resultant decrease of α2,6-Sial levels in high 2,6-Sial cells with <i>ST6GAL1</i> knockdown (sh<i>ST6GAL1</i>-high 2,6-Sial cells) compared with scrambled control cells (shSc-high 2,6-Sial cells) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). As a result of the knockdown, α2,6-Sial levels of sh<i>ST6GAL1</i>-high 2,6-Sial cells were comparable to medium 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0005.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0005.jpeg" id="gr5" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. α2,6-Sial levels regulate mesenchymal invasion of high 2,6-Sial cells. (A) Lectin-based flow cytometry profiles showing decreased α2,6-Sial levels upon <i>ST6GAL1</i> gene knockdown in high 2,6-Sial cells. (B) Bright field images taken at 0, 12, 18, and 24 h from time-lapse videography of lrECM-coated clusters of scrambled control and <i>ST6GAL1</i> knocked down high 2,6-Sial cells (shSc-high 2,6-Sial top and sh<i>ST6GAL1</i>-high 2,6-Sial bottom) invading into surrounding Type 1 collagen. (C) Graph showing insignificant differences in the collective cell mode of invasion of shSc-high 2,6-Sial (yellow) and sh<i>ST6GAL1</i>-high 2,6-Sial (brown) cells as measured by the increase in cluster size obtained from time-lapse videography (<i>n</i> = 3). (D) Graph showing significantly lower invasion of shSc-high 2,6-Sial cells (yellow) compared with sh<i>ST6GAL1</i>-high 2,6-Sial cells (red) as measured by the number of dispersed single cells in Type 1 collagen normalized to the initial cluster size obtained from lapse videography (<i>n</i> = 3). (E) Graph showing significantly lower mean migratory velocity of single shSc-high 2,6-Sial cells (yellow) compared with sh<i>ST6GAL1</i>-high 2,6-Sial cells (red) as measured by manual tracking dynamics obtained from lapse videography (<i>n</i> = 3, <i>N</i> ≥ 15 cells). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">When assayed for invasion from within lrBM to Type 1 collagen, sh<i>ST6GAL1</i>-high 2,6-Sial cells showed greater presence in collagen compared to shSc-high 2,6-Sial cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_003.mp4" class="ext-link">Video S2A,B</a>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Collective cell invasion did not show any difference between knockdown and scrambled control cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). However, the number of invaded single mesenchymal sh<i>ST6GAL1</i>-high 2,6-Sial cells in the collagen and their mean migratory velocity in ECM were greater than those of shSc-high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D,E). These observations suggest that single cell invasion of breast cancer epithelia may be directly regulated by their surface α2,6-Sial levels.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Multiscale Simulations Show That Altered Matrix-Adhesion Dynamics Is Sufficient to Explain Differential Invasion of Cancer Epithelia</h3><div class="NLM_p">Is the greater adhesion of medium 2,6-Sial cancer cells to ECM causal to its enhanced ability for invasion when cultured in 3D separately from, or in coculture with, high 2,6-Sial cells? To answer this, we employed a Cellular Potts-based computational model of cancer cell invasion <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> using the Compucell 3D simulation environment. <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Our model, calibrated to diverse matrix microenvironments and pharmacological perturbations, had earlier been shown to simulate single-cell  and collective-cell invasion (individually and in combination, known as multiscale invasion) through consecutive barriers of lrBM-like collagen-like fibrillar environments, similar to the 3D invasion assay used above. <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The cellular constituents of our model were digital medium and high 2,6-Sial cells (mimicking medium and high 2,6-Sial cells) with the former differing from the latter in exhibiting greater ECM adhesion. The ECM constituents of the model were digital lrBM and digital collagen (mimicking BM and Type 1 collagen) with the only difference being their nonfibrillar and fibrillar structure, respectively. In consonance with our experiments, digital medium 2,6-Sial cells showed greater invasion through model ECM than digital high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A,B).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0006.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0006.jpeg" id="gr6" class="inline-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Multiscale simulations predict that matrix adhesion principally contributes to increased invasion. (A) Snapshots of simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital high 2,6-Sial cells in model Type 1 collagen (green). (B) Snapshots of the simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital medium 2,6-Sial cells in model Type 1 collagen (green). (C) Snapshots of simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital high and medium 2,6-Sial cells mixed in a ratio of 1:1 show a relatively greater invasion and dispersal of digital medium 2,6-Sial cells with digital high 2,6-Sial cells forming the central core. (D) Bar graph showing greater invasion of digital medium 2,6-Sial cells (red) compared with digital high 2,6-Sial cells in their 3D cocultures such as in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C (<i>n</i> = 3). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance. (E) Histograms depicting the intercellular distances of the digital high 2,6-Sial cells (yellow) and those of medium 2,6-Sial cells (red) with the rightward shift of the latter indicating greater dispersal. (F) Graph depicting the invasion of an overall population of cancer cells in 3D (conditions similar to parts A–C) wherein the clusters of digital cells are composed of digital high and medium 2,6-Sial cells in the relative proportion of 100%, 0%; 75%, 25%; 50%, 50%; 25%, 75%; and 0%, 100%, from left to right, respectively. Error bars denote mean ± SEM. Ordinary one-way ANOVA with Tukey’s post-hoc multiple comparisons was performed for statistical significance (*<i>P</i> ≤ 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We next asked whether the computational model would predict the differential radial invasion that the medium 2,6-Sial cells showed, when cultured in an admixture with high 2,6-Sial cells. Even in our simulation framework, digital medium 2,6-Sial cells differentially migrated further to predominantly form the invasive front of mixed digital tumoroid populations, wherein digital high 2,6-Sial cells contributed to the core (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C; quantification of individual digital medium and high 2,6-Sial cell invasion when present within the initial mass in a ratio of 1:1 shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>D and the further dispersion of digital medium 2,6-Sial cells confirmed through the intercellular distance histogram shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>E). Given that the digital cells differ only with respect to their adhesion to the model ECM, the latter property is likely the determinant factor for the differential and greater invasion of real medium 2,6-Sial cells. Upon varying the ratio of digital medium and high 2,6-Sial cells constituting similarly sized initial clusters in our model, we observed that overall invasion was lowest in starting tumor clusters with 100% digital high 2,6-Sial cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>F). A progressive increase in invasion was observed as the proportion of medium cells increased in the digital tumoroid mass, although no significant increase was seen between clusters with 50–100% medium-containing clusters. The distribution of invasion across 10 runs for these three conditions showed that the arrangement of cells within such clusters and the stochasticity of multiple interactions between cells and ECM during the simulation runs contributed to the magnitude of the phenotype. Notably, there were certain arrangements where clusters with as little as 50% digital medium cells “out-invaded” 100% digital medium 2,6-Sial cell clusters.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36000" class="dropBlock__holder"></div></div></div></div></div><hr><div class="NLM_p">In this current study, we establish for the first time the occurrence of intercellular diversity in the expression of a specific sialic acid linkage within malignant tumors and cancer cell lines of the breast. We show that cellular populations with distinct α2,6-Sial levels coexist together within cell lines and may reflect linkage heterogeneity within tumor cell populations <i>in vivo</i>. The bimodal expression of α2,6-Sial shown here can also be evidenced in several reports for MDA-MB-231 as well as other cell lines, but its consequence has not been investigated before. <a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40">(36−40)</a> The α2,6-Sial heterogeneity is counterpoised with relatively homogeneous expression in the same cells for other glycans such as α2,3-Sial, fucose, T/Tn-antigen, bisecting/biantennary complex <i>N</i>-glycans, and tri/tetra antennary complex <i>N</i>-glycans. This suggests that glycan diversity within tumor populations may be specific to the identity of monosaccharides and their linkage to preceding glycan moieties.</div><div class="NLM_p">Several published reports note hypersialylation of cancer cells, including that of the neoplasms of breast cancer. <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Hypersialylation is associated with, and suggested to be causal to, increased aggressiveness, stemness, resistance to chemotherapeutic agents, ability to survive in stressful conditions like hypoxia, and impaired nutrient supply. <a onclick="showRef(event, 'ref24 ref25 ref27 ref41'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref27 ref41">(24,25,27,41)</a> However, when we performed flow cytometry to isolate the two subpopulations showing distinct α2,6-sialic acid levels, the one showing lower levels (which we denoted as medium 2,6-Sial cells) showed greater invasion than high 2,6-Sial cells both in the transwell assay and in 3D cultures. Medium 2,6-Sial cells were also observed to adhere better to both laminin-rich and collagenous ECM, as well as migrate through the latter with higher velocity compared to high 2,6-Sial cells. When cultured together, medium 2,6-Sial cells migrated farther and were dispersed to a greater extent than high 2,6-Sial cells. When α2,6-sialic acid levels in high cells were genetically decreased to levels comparable with medium 2,6-Sial cells, their velocity and dispersal in ECM appropriately increased. Can the difference in invasion be explained by an appropriate difference in adhesion to ECM?</div><div class="NLM_p">To answer this question, we used Cellular Potts model-based computational simulations calibrated with our experimental findings, which predicted that cells with higher adhesion to ECM are able to invade better into a surrounding stromalike fibrillar environment. Our simulations also were able to provide an answer to another question: what advantage do high 2,6-Sial cells confer to tumors in the presence of the more invasive medium 2,6-Sial cells? Simulations performed with different beginning ratios of digital medium and high 2,6-Sial cells showed that the presence of a population of slow invading high 2,6-Sial cells (that exhibit a relatively weaker adhesivity to surrounding ECM) could bias the migration of medium 2,6-Sial cells in a radially centrifugal manner. For specific initial conditions, such mixed cell populations could invade more than populations solely consisting of medium 2,6-Sial cells. The inertial behavior exhibited by high 2,6-Sial cells is prognostic of jamming–unjamming dynamics proposed to play an important role in the physical mechanisms of cancer progression and suggests that the sialic acid heterogeneity could give rise to heterogeneity in the material behavior of tumor subpopulations. In fact, investigating the interconversion of collective to mesenchymal migratory behavior, Ilina and co-workers have recently shown that the cell adhesion along with confinement by matrix may induce single-cell migratory behavior. <a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Our results suggest a concert between the confining ECM and a jammed epithelial core in facilitating the mesenchymal migratory behavior of cancer epithelia. We will actively investigate this aspect in the future. <a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">Our observations made through the assessment of endogenous expression of <i>ST6GAL1</i> (which is positively correlated with 2,6-Sial levels) serve to reconcile the contradiction between reports of increased invasion as a result of forced overexpression of <i>ST6GAL1</i> within cancer cells <a onclick="showRef(event, 'ref24 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref27">(24,27)</a> and an overall decreased level of <i>ST6GAL1</i> expression in breast cancer tissues assessed within The Cancer Genome Atlas. <a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> We posit that, within a population with heterogeneous expression of α2,6-sialic acids, those with a moderate expression will escape faster through a mesenchymal invasive process. At the same time, the medium 2,6-Sial cells will continue to give rise to the high 2,6-Sial populations, as demonstrated by our flow cytometric experiments on continuously passaged sorted cells. In this study, we have not investigated whether there are differences in the set of cell surface proteins to which the 2,6-sialic acids are conjugated, between the sorted populations. The deployment, in the future, of synthetic sialylated glycopolymers on cancer cell surfaces and their effects on cell adhesion could be used to ascertain whether the effect of sialic acids on adhesion is a direct one or based on downstream signaling. In conclusion, our results show not only that the intercellular sialic acid heterogeneity and breast cancer cell invasion are spatiotemporally coincident but also that these two processes actively drive each other. It will be imperative to break the link between the two by targeting sialic acids through novel therapeutic strategies such as precision glyco-editing <a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and sialic acid–siglec-based immunotherapy. <a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48251" class="dropBlock__holder"></div></div></div></div></div><hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell Culture</h3><div class="NLM_p last">MDA-MB-231 cells were maintained in DMEM:F12 (1:1) (HiMedia AT140) along with 10% fetal bovine serum (Gibco, 10270) in a 5% carbon dioxide, 37 °C temperature humidified incubator.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Lectin Histochemistry</h3><div class="NLM_p last">Breast tumor and normal sections were made from paraffin-embedded blocks at Kidwai cancer institute, Bangalore, after obtaining necessary approval from the Institutional Human Ethics committee and consent from patients. Sections were incubated at 65 °C overnight to remove wax. Immediately, samples were rehydrated gradually incubating in decreasing concentrations of alcohol: 2 × 5 min Xylene, 2 × 5 min 100% ethanol, 2 × 5 min 90% ethanol, 1 × 10 min 80% ethanol, and 1 × 10 min 70% ethanol and finally in distilled water for 10 min. Antigen retrieval was performed using citrate buffer pH 6.0 in the microwave for 30 min and allowed to cool down to room temperature. Sections were blocked using 1× Carbo-Free blocking buffer (Vector laboratories, SP-5040) made in PBS pH 7.4 for 1 h at room temperature. Fluorescently labeled SNA (Vector Laboratories, FL-1301) and MAA (bioWORLD, 21511106-1) were added to sections at 1:100 dilution and incubated overnight at 4 °C. Lectins preincubated with 250 mM lactose (HiMedia, RM565G) were used as a negative control. Sections were washed with 1× PBS for 5 min at room temperature thrice. Sections were counterstained with 1 μg/mL DAPI (Thermo Fisher Scientific, D1306) for 10 min, washed to remove excess stain, and mounted for imaging. CellProfiler software was used for per cell quantification. A pipeline was built where the nucleus, α2,6- and α2,3-Sial channels were separated. The cell nuclei mask was obtained using a thresholding for the diameter of the nucleus between 20 and 35. Particles outside this diameter range and near the border of the image were discarded. Clumps of the nucleus were resolved using the shape algorithm available in the software. Such obtained nucleus masks were overlaid onto the α2,6-Sial/α2,3-Sial image channel, and integrated intensity per cell was calculated.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Lectin Cytochemistry</h3><div class="NLM_p last">Cells (15 000) were seeded in an 8-well chamber cover glass (Eppendorf, 0030742036). After 24 h, spent medium was removed and cells were washed with cold 1× PBS once and fixed using 4% formaldehyde at 4 °C for 20 min. Excess fixative was removed and neutralized with 2% glycine for 30 min at room temperature. Cells were washed thrice with 1× PBS and blocked using 1× Carbo-Free blocking buffer for 1 h at room temperature. Fluorescent conjugated SNA and MAA were added to cells at 1:500 dilution in blocking buffer and incubated for 3 h at room temperature or overnight at 4 °C. Cells were with 1× PBS for 5 min thrice, counterstained with 1 μg/mL DAPI and 1:500 Alexa Fluor<sup>TM</sup>633-conjugated phalloidin (Thermo Fisher Scientific, A22284) for 1 h at room temperature. Finally, cells were washed with 1× PBS for 5 min twice and imaged.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Lectin Flow Cytometry and Sorting</h3><div class="NLM_p last">MDA-MB-231 cells were trypsinized and counted. 0.3 × 10<sup>6</sup> cells for analysis and 10<sup>6</sup> cells for sorting were taken in a polypropylene FACS tube in 100 and 500 μL for analysis and sorting, respectively, in 1× Carbo-Free blocking buffer. Cells were incubated with fluorescently labeled SNA and MAA at a 20 μg per 10<sup>6</sup> cells concentration for 20 min at room temperature. Lectin incubated with 250 mM lactose overnight at 4 °C overnight or FITC was used as the negative control. Finally, cells were diluted to 10<sup>6</sup>/mL using Carbo-Free blocking buffer and analyzed/sorted using a BD influx flow cytometer. For analysis, at least 10 000 total events were acquired. For sorting, single-cell purity mode was used. Lectins used in this study are listed in <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Table S1</a>. The following gating strategy was employed to analyze the flow cytometry data. Briefly, a total of 10 000 events were recorded with forward scatter (FSC) on the <i>X</i>-axis (linear scale) and side scatter (SSC) on the <i>Y</i>-axis (log scale). Potential cells were gated and labeled as P1. To obtain single cells, cells from P1 were plotted on another dot plot, where the <i>X</i>-axis represented the forward scatter area (FSC-A), and the <i>Y</i>-axis represented forward scatter (FSC) both in the linear scale. Cells from P1 present along the diagonal were gated and labeled as P2. For further analysis, cells from only P2 were considered.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> ECM Coating for the Adhesion Assay</h3><div class="NLM_p last">96-well plates were coated with 50 μg/mL reconstituted basement membrane (rBM or lrBM) (Corning, 354230) or 50 μg/mL neutralized rat tail collagen (rich in Type 1 collagen) (Gibco, A1048301) for 2 h at 37 °C. Excess matrix was removed, allowed to dry for 30 min at 37 °C, and blocked with 0.5% BSA (HiMedia, MB083) overnight at 37 °C. After overnight blocking, excess BSA was removed, and plates were used for the adhesion assay. The 0.5% BSA overnight coating at 37 °C was used as a negative control.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Adhesion Assay</h3><div class="NLM_p last">MDA-MB-231 high and medium α-2,6-sialic acid cells were trypsinized. After counting, 30 000 cells per well were incubated in BSA- and ECM-coated wells for 30 min at 37 °C. Unadhered cells were removed carefully, and wells were washed with 1× phosphate buffered saline pH 7.4 (PBS) thrice to remove unadhered cells. Cells were fixed using 100% methanol for 10 min at room temperature. After fixing, cells were washed with 1× PBS thrice, stained with 50 μg/mL propidium iodide (HiMedia, TC252) for 30 min at room temperature, and washed thrice with 1× PBS. Using the plate reader, fluorescence was read at Ex 535 nm/Em 617 nm. BSA or ECM without cells was used as the blank. The assay was done in triplicates and repeated three times independently.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Quantitative Real-Time PCR</h3><div class="NLM_p last">Total RNA was isolated from high and medium α-2,6-Sial cells using TRIzol as per the manufacturer’s protocol (Invitrogen, 15596078). Total RNA was quantified using a UV–vis spectrophotometer (NanoDrop, Thermo Fisher Scientific). Total RNA (1 μg) was reverse transcribed using a Verso cDNA synthesis kit as per the manufacturer’s protocol (Thermo Scientific, AB-1453). Real-time PCR was performed with 1:2 diluted cDNA using a SYBR green detection system (Thermo Fisher Scientific, F415L) and Rotorgene Q (Qiagen, 9001560). The <i>18S rRNA</i> gene was used as the internal control for normalization. Relative gene expression was calculated using the comparative Ct method, and gene expression was normalized to unsorted cells. All the genes analyzed along with sequence are mentioned in <a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">Table S2</a>. Appropriate no template and no-RT control were included in each experiment. All the samples were analyzed in duplicates/triplicates and repeated three times independently.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Genetic Perturbation of the <i>ST6GAL1</i> Gene</h3><div class="NLM_p last">The <i>ST6GAL1</i> gene shRNA clone was obtained from the MISSION shRNA library (Sigma Merck). Plasmid containing shRNA or scrambled control was packaged into lentivirus using packaging vectors pMD2.G and psPAX2 (packaging vectors were a kind gift from Dr. Deepak K Saini). The plasmids were transfected into 293FT cells (Thermo Fisher Scientific, R70007) using TurboFect (Thermo Fisher Scientific, R0533). Cells were cultured in DMEM supplemented with 10% FBS; conditioned medium containing viral particles was collected at 48 and 72 h. After filtering through a 0.45 μm filter, viral particles were concentrated using the Lenti-X concentrator as mentioned in the manufacturer’s protocol (TaKaRa, 631232). Concentrated virus was aliquoted and stored at −80 °C until use. High α2,6-Sial cells were seeded in a 24-well plate at 50–60% confluence and transduced with viral particles containing shRNA or scrambled control along with polybrene (4 μg/mL) for 24 h. After 72 h, transduced cells were selected using 5 μg/mL puromycin (HiMedia, CMS8861). The knockdown of the gene was assayed using real-time PCR and lectin flow cytometry as described earlier.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Transwell Invasion Assay</h3><div class="NLM_p last">Polycarbonate transwell inserts (8 μm pore-size) were obtained from HiMedia (TCP083). Transwells were coated with 200 μg/mL reconstituted basement membrane (rBM or lrBM) (Corning, 354230) as per the manufacturer’s protocol. In each transwell, 3 × 10<sup>4</sup> cells were seeded in 200 μL of serum-free DMEM:F12 (1:1) medium. The bottom well was filled with 1 mL of 10% serum containing DMEM:F12 (1:1) and incubated for 24 h at 37 °C, in a 5% carbon dioxide-containing humidified chamber. Carefully, medium from the transwell was removed and washed with 1× PBS once, and cells were fixed using 100% methanol for 10 min. After fixing, cells were washed once again with 1× PBS, and noninvading cells were carefully removed with a moistened cotton swab. Transwells were stained with 1% crystal violet for 15 min and washed to remove excess dye. Membranes were dried and imaged under a microscope using 40× total magnification. At least 5 independent fields were imaged per transwell, and the numbers of cells were counted. Each experiment has been performed in duplicates and repeated three times.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3D Invasion Assay</h3><div class="NLM_p last">A 3D invasion assay was performed as described previously by our group. <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Briefly, cancer clusters were made using 30 000 cells in a polyHEMA-coated (Sigma, P3932), 96-well plate, defined medium <a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> supplemented with 4% rBM. After 48 h, clusters were collected and embedded in polymerizing rat tail collagen in a chambered cover glass. 3D cultures were grown for 24 h in a 37 °C humidified incubator with 5% carbon dioxide. End point imaging was done after fixing 3D cancer clusters, counterstained with DAPI, Alexa Fluor<sup>TM</sup> 633–phalloidin, and imaged using a Carl Zeiss LSM880 confocal microscope with system optimized settings. Bright field time-lapse imaging of invading cancer clusters was performed on an Olympus IX73 fluorescence microscope fitted with a stage top incubator and 5% carbon dioxide. Images were collected for 24 h with every 10 min interval.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Glycan Extraction and Mass Spectrometry</h3><div class="NLM_p">Glycan extraction and enzymatic release of glycans from proteins and lipids were slightly modified from previous protocols. <a onclick="showRef(event, 'ref30 ref31 ref49'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref49">(30,31,49)</a> Cells were harvested with a nonenzymatic method, such as scraping from plates using cell dissociation buffer (13151014, Gibco) for 5–10 min. A 1× lysis solution was prepared using RIPA buffer (Genesearch; cat. no. 9806S), and the Roche complete protease inhibitor cocktail (CO-RO, Roche; Merck 11697498001) was used. 500 μL of RIPA buffer was added to each tube and left at 4 °C overnight. Samples were sonicated for 10 min in a sonication bath. Then, they were centrifuged for 10 min at 16 000<i>g</i>, and the supernatant was collected in new a microfuge tube. A triphasic liquid of chloroform:methanol:water (1:2:2) was used to separate the lipids, glycolipids, and proteins. Samples were vortexed and left on ice for 1 h. The samples were then centrifuged for 10 min at 10 000 rpm using a table-top centrifuge. The aqueous top layer containing the glycolipids was separated, and then, two volumes of methanol were added to each sample and vortexed to precipitate the proteins. Then, samples were centrifuged for 10 min at 10 000 rpm. The top layer (lipids) was carefully removed, while the pellet was resuspended in 100 μL of 4 M urea and 3% SDS and quantified using the BCA assay. Protein lysate (20 μg) from each of the replicates was independently dot blotted onto EtOH-wetted PVDF membrane (20 μg of BSA and bovine fetuin were included as the glycan negative and positive controls, respectively) and dried overnight (RT). Dried dot blots were then washed in MeOH (15 min, shaking, RT) and further washed in water (15 min, shaking, RT). To qualitatively confirm and visualize the immobilized protein, the dot blotted membrane was stained with direct blue staining solution for 3 min and then destained, and the membrane was placed in water. Protein-laden spots of 6 mm diameter were excised from the PVDF membrane and submerged into wells containing 100 μL of 1% PVP40 where they were incubated for 5 min and then washed thrice with 200 μL of water. For the removal of <i>N</i>-linked glycans, 2 μL of PNGase F (1000 U) (NEB) and 8 μL of water were added to each well and incubated overnight at 37 °C. After incubating overnight, the 96-well plate was sonicated for 5 min in an ultrasonic cleaner sonicating water bath (Unisonics). The wells were then rinsed with 20 μL of water and the solutions collected. The samples were then acidified with 10 μL of 100 mM ammonium acetate (pH 5) and incubated for 1 h, RT. Released <i>N</i>-glycans were reduced in alkaline conditions by the addition of 20 μL of 1.25 M NaBH4 in 100 mM KOH and incubated for 3 h at 50 °C. After cooling to RT, the reaction was neutralized with 2 μL of glacial acetic acid.</div><div class="NLM_p">Sodium salts of <i>N</i>-glycan solutions were removed by passage through and subsequent washing of cation exchange microcolumns constituted by packing 25 μL of Dowex 50W X8 (Sigma-Aldrich) in a ZipTip C18 tip (Merck Millipore), activated with 50 μL of 1 M HCl prior to the addition of sample. Solutions were passed through columns using a benchtop microcentrifuge at full speed for 15–30 s. Sodium-desalted samples were vacuum-dried in a Savant SPD131DDA SpeedVacTM concentrator (ThermoFisher). Samples were then washed and dried three times with 100 μL of methanol to remove residual borate.</div><div class="NLM_p">Desalted samples were further purified by porous graphitized carbon (PGC) chromatography. Columns were constituted with 5 μL of PGC material from HyperSep Hypercarb cartridges (ThermoFisher) in methanol and deposited in a ZipTip C18 tip. Prior to the addition of the sample, columns were washed with elution buffer [80% v/v acetonitrile (ACN), 0.1% v/v trifluoroacetic acid (TFA)] and subsequently equilibrated in loading buffer (0.1% v/v TFA). Dried sample was dissolved in 50 μL of loading buffer and passed through columns, with flow through reloaded into the columns. Enriched glycans were eluted in 50 μL of elution buffer and vacuum-dried. Dried, purified enriched glycans were stored at −20 °C until analysis using MS.</div><div class="NLM_p">The <i>O</i>-glycans were sequentially released from the PVDF blotted proteins after the <i>N</i>-glycan release by PNGase-F by chemical beta-elimination. The immobilized proteins were subjected to high-alkaline conditions by the addition of 30 μL of 0.5 M NaBH4 in 100 mM KOH and incubated for 16 h at 50 °C. After cooling to RT, the reaction was neutralized with 2 μL of glacial acetic acid. The <i>O</i>-glycans were desalted and purified identically as described for the <i>N</i>-glycans.</div><div class="NLM_p">Similarly, to release the glycans linked to glycolipids, the glycolipid-containing aqueous fraction was evaporated to dryness. The extract was redissolved in 100 μL of 50 mM sodium acetate containing 0.1% sodium taurodeoxycholate, and 2 μL (4 mU) of endoglycoceramidase II (Sigma) was added to each sample followed by 16 h of incubation at 37 °C. Subsequently, 1 mL of chloroform/methanol/water (8:4:3, v/v/v) was added to each sample. The upper methanol:water layer containing the released oligosaccharides was transferred into a new microfuge tube and dried. The released glycans were reduced to alditols identical to the <i>N</i>-glycan method described above. Finally, purified glycan alditols were resuspended in 30 μL of water prior to MS analysis. Sample handling and injections were performed using an Ultimate 3000 UHPLC instrument (Thermo Scientific). Samples were injected in loading buffer (10 mM NH<sub>4</sub>HCO<sub>3</sub>) through a PGC precolumn (3 μm Hypercarb, 320 μm ID × 100 mm) at a flow rate of 6 μL/min and subsequently a PGC analytical column (3 μm Hypercarb, 75 μm ID × 100 mm) at a flow rate of 300 nL/min. Chromatographic separation was achieved using an 85 min gradient for <i>N</i>-glycans (0–70% v/v ACN) and 75 min (0–70% v/v ACN) gradient for <i>O</i>-linked and GSL-glycans. The eluting glycans were detected using an amaZon ETD speed ion trap (Bruker, Bremen, Germany) in the negative ion mode using a captive spray source. An <i>m</i>/<i>z</i> range 320–1500 was fixed for data-dependent precursor scanning. Both MS and MS/MS data were recorded in the instrument’s ultrascan mode with an ICC target of 30 000 and accumulation time of 200 ms. Capillary exit voltage was set to 140 V, dry gas temperature at 77 °C, and flow rate at 300 L/min. HV capillary voltage was set to 1300 V and the HV end plate offset to 500 V. Collision induced dissociation (CID) fragmentation was performed on the five most intense precursors of each MS scan.</div><div class="NLM_p last">Data analyses were carried out in Compass Data Analysis 4.2 (Bruker Corporation) for structural assignment and in Skyline 20.1 for quantitation. Quantitation was performed for each isomer identified by MS2 spectra and retention time by calculating the area under the curve (AUC).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Compucell 3D Model and MATLAB Analysis</h3><div class="NLM_p">The simulations performed were based on an earlier-established computational model in Compucell3D. <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compucell3D (CC3D) is an environment that comprises the lattice-based GGH model [GGH: Glazier–Graner–Hogeweg also known as the Cellular Potts model (CPM)] with solvers for partial differential equations in order to simulate biological processes, wherein molecules, cells, and cellular ensembles may behave concurrently across distinct spatial scales. <a onclick="showRef(event, 'ref35 ref50'); return false;" href="javascript:void(0);" class="ref ref35 ref50">(35,50)</a> The software divides the whole simulation lattice into “cells” (collection of pixels). A specific “cell type” is assigned to each of them. All cells having the same cell type share the same properties. Hence, the minimalistic target tissue-system can be broken down into cell types representing the main constituents of the system. Interaction parameters between cell types can be made to approximate biological constraints between components, similar to that of the original <i>in vitro</i> or <i>in vivo</i> biological system. Such constraints or parameters regulate the simulation through the effective energy or Hamiltonian (<i>H</i>) calculated at each Monte Carlo step (MCS). The initial conditions and the behavior of cells in the model have been calibrated based on the invasive behavior of cancer cells in different types of ECM and upon treatment with pharmacological agents. The chief constituents of the model include cancer cells, nonfibrillar BM matrix, fibrillar Type 1 collagen matrix, degraded and newly synthesized cancer ECM, the diffusible activator of ECM (such as MMPs), and its diffusible inhibitor (TIMP). <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Contact energies related to adhesion between each of these constituents and diffusion and cooperative interaction between the molecules determine the behavior of the simulation and the end stage phenotype and are based on calibrations with experiments involving tumoroids cultured in diverse matrix microenvironments and pharmacological perturbations (Pally et al, 2019). In this paper, we implemented an additional chemotaxis plugin to be able to simulate the movement of cells in response to attractant cues of the surrounding fibrillar ECM. Several parameter values, such as contact energy between the “cell” and “medium”, and diffusion coefficients of ECM proteolysis regulators were taken from previous published efforts by other computational groups that studied cancer cell migration through the ECM in order to conceptually integrate our model with the existent relevant literature. <a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51−54)</a></div><div class="NLM_p">Key differences with the previously mentioned version of the model are as follows:<table class="listgroup" list-type="label" width="95%" border="0"><tbody><tr class="li1"><td valign="top">(1)</td><td colspan="5" class="paragraph" valign="top"><p class="last">Simulated cancer cells have two cell types assigned to them. They correspond to high and medium 2,6-Sial cells in the heterogeneous population.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" class="paragraph" valign="top"><p class="last">The two different cancer cells have differential adhesion to ECM, where medium 2,6-Sial cells have relatively higher adhesion (1.5-fold based on our experimental findings) to all ECM cells like BM (basement membrane, bloblike), Type 1 collagen (collagen 1, fibrillar), newly synthesized collagen-like ECM, and degraded ECM. Widening or narrowing the fold change in ECM adhesion could lead to dramatic or subtler alterations in sorting dynamics between the differentially adhering cells, respectively. All other biological cancer cell-like properties are the same for the digital high and medium 2,6-Sial cells.</p></td></tr></tbody></table></div><div class="NLM_p">At the initial spatial configuration (marked by MCS 0), both digital high and medium 2,6-Sial cells are located centrally encapsulated by BM cells, and that is further surrounded by Type 1 collagen cells. After the Monte Carlo step (MCS) reaches 600, the cancer cells already invade the matrix with reconstitution of the localized matrix through reaction-diffusion dynamics of MMPs and their inhibitors such as TIMPs. An image of the simulation at MCS 600 is collected for analysis in MATLAB.</div><div class="NLM_p last">Two different methods of analysis were used; the first one, “Area of minimal enclosing circle”, detailed in the previous publication <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> calculates the smallest possible circle, which encloses all cells of a certain cell type and can be considered as a quantification of invasion corresponding to that cell type in that initial configuration. The collected simulation images can be binarized for digital high 2,6-Sial cells (orange), digital medium 2,6-Sial cells (red), or both (orange and red; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>F) depending on the analysis. The second method calculates distances between cells in simulation images binarized with respect to either high or medium cell type. After identifying centroids of the cells in the binarized image, a MATLAB function “pdist” was used to calculate distances between all the pairs of centroids and plotted in a histogram (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>E) [<a href="https://in.mathworks.com/help/stats/pdist.html" class="extLink">https://in.mathworks.com/help/stats/pdist.html</a>].</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Statistical Analysis</h3><div class="NLM_p last">All experiments were performed in duplicates or more. All experiments were repeated thrice independently. Prism software (GraphPad Prism 6.0) was used for the generation of graphs and analysis. For all experiments, results are represented as mean ± SEM unless mentioned. For statistical analysis, an unpaired, two-tailed Student’s <i>t</i> test or ordinary one-way ANOVA followed by post hoc Tukey test for the comparison of multiple groups was performed. Significance (<i>p</i> value) is represented as *, where * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001, and **** &lt; 0.0001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Supporting Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71201" class="dropBlock__holder"></div></div></div></div></div><hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acscentsci.0c00601?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acscentsci.0c00601</a>.</p><ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Negative/sugar control for lectin histochemistry, lectin cytochemistry, lectin-based flow cytometry, gating of single cells in flow cytometry, the specificity of SNA and MAA lectins, α2,6- and α2,3- Sial linkage profiles and adhesion of BT-549 to type 1 collagen; extracted ion chromatograms for <i>N</i>-glycans, <i>O</i>-glycans, and glycosphingolipids; and lectins and primers used in the study (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Video S1: Time-lapse videography of high 2,6-Sial cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_004.mp4" class="ext-link">MP4</a>)</p></li><li><p class="inline">Video S2: Time-lapse videography of medium 2,6-Sial cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_003.mp4" class="ext-link">MP4</a>)</p></li><li><p class="inline">Video S3: Time-lapse videography of shSc-high 2,6-Sial cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_002.mp4" class="ext-link">MP4</a>)</p></li><li><p class="inline">Video S4: Time-lapse videography of sh<i>ST6GAL1</i>-high 2,6-Sial cells (<a href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_005.mp4" class="ext-link">MP4</a>)</p></li></ul><p></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf">oc0c00601_si_001.pdf (1.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_002.mp4">oc0c00601_si_002.mp4 (7.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_003.mp4">oc0c00601_si_003.mp4 (6.3 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_004.mp4">oc0c00601_si_004.mp4 (6.85 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_005.mp4">oc0c00601_si_005.mp4 (7.36 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acscentsci.0c00601" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms &amp; Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13125" class="dropBlock__holder"></div></div></div></div></div><hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramray Bhat</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span>;&nbsp;
    <span class="author-email">
                Email: <a href="mailto:ramray@iisc.ac.in">ramray@iisc.ac.in</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dharma Pally</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span>;&nbsp;
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid"><a href="http://orcid.org/0000-0003-4814-8875" title="Orcid link">http://orcid.org/0000-0003-4814-8875</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Durjay Pramanik</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shahid Hussain</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shreya Verma</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anagha Srinivas</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rekha V. Kumar</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology, Kidwai Memorial Institute
of Oncology, Bangalore 560029, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun Everest-Dass</span> - <span class="hlFld-Affiliation affiliation">Institute
for Glycomics, Griffith University, Southport, Queensland 4215, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br></div></li></ul></div><div class="ack" id="ACK-d7e1506-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63201" class="dropBlock__holder"></div></div></div></div></div><hr><p class="last">We thank the Bioimaging facility at Division of Biological Science, Indian Institute of Science for help with confocal microscopy. We thank Bhaskar Kumawat for help with biostatistics. D. Pally is supported by Senior Research Fellowship (SRF) from MHRD, India. This work was supported by the Wellcome Trust/DBT India Alliance Fellowship/Grant [grant number IA/I/17/2/ 503312] awarded to R.B. In addition, this work was supported by funds from the Department of Biotechnology, India [BT/ 909 PR26526/GET/119/92/2017], SERB[ECR/2015/000280], DBT-IISc partnership program (BT/PR27952/INF/22/212/2018), and the Institute of Eminence grant (IE/CARE-19-0319). D. Pramanik acknowledges KVPY for the scholarship.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21870" class="dropBlock__holder"></div></div></div></div></div><hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poudel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyamundanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheang, M. C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span> <span> </span><span class="NLM_article-title">Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses</span>. <i>NPJ. breast cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">21</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41523-019-0116-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41523-019-0116-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31396557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MvmtlOmug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=5&amp;publication_year=2019&amp;pages=21&amp;author=P.+Poudelauthor=G.+Nyamundandaauthor=Y.+Patilauthor=M.+C.+U.+Cheangauthor=A.+Sadanandam&amp;title=Heterocellular+gene+signatures+reveal+luminal-A+breast+cancer+heterogeneity+and+differential+therapeutic+responses&amp;doi=10.1038%2Fs41523-019-0116-8" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses</span></div><div class="casAuthors">Poudel Pawan; Nyamundanda Gift; Patil Yatish; Sadanandam Anguraj; Nyamundanda Gift; Patil Yatish; Sadanandam Anguraj; Cheang Maggie Chon U</div><div class="citationInfo"><span class="NLM_cas:title">NPJ breast cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21</span>
        ISSN:<span class="NLM_cas:issn">2374-4677</span>.
    </div><div class="casAbstract">Breast cancer is a highly heterogeneous disease.  Although differences between intrinsic breast cancer subtypes have been well studied, heterogeneity within each subtype, especially luminal-A cancers, requires further interrogation to personalize disease management.  Here, we applied well-characterized and cancer-associated heterocellular signatures representing stem, mesenchymal, stromal, immune, and epithelial cell types to breast cancer.  This analysis stratified the luminal-A breast cancer samples into five subtypes with a majority of them enriched for a subtype (stem-like) that has increased stem and stromal cell gene signatures, representing potential luminal progenitor origin.  The enrichment of immune checkpoint genes and other immune cell types in two (including stem-like) of the five heterocellular subtypes of luminal-A tumors suggest their potential response to immunotherapy.  These immune-enriched subtypes of luminal-A tumors (containing only estrogen receptor positive samples) showed good or intermediate prognosis along with the two other differentiated subtypes as assessed using recurrence-free and distant metastasis-free patient survival outcomes.  On the other hand, a partially differentiated subtype of luminal-A breast cancer with transit-amplifying colon-crypt characteristics showed poor prognosis.  Furthermore, published luminal-A subtypes associated with specific somatic copy number alterations and mutations shared similar cellular and mutational characteristics to colorectal cancer subtypes where the heterocellular signatures were derived.  These heterocellular subtypes reveal transcriptome and cell-type based heterogeneity of luminal-A and other breast cancer subtypes that may be useful for additional understanding of the cancer type and potential patient stratification and personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrJ96Nuqm03zEC-75aqa5AfW6udTcc2ebbiQbTcOLIn7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MvmtlOmug%253D%253D&amp;md5=f016fee7c1d25cdff7e0a9a02aa18102</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41523-019-0116-8&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41523-019-0116-8%26sid%3Dliteratum%253Aachs%26aulast%3DPoudel%26aufirst%3DP.%26aulast%3DNyamundanda%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DY.%26aulast%3DCheang%26aufirst%3DM.%2BC.%2BU.%26aulast%3DSadanandam%26aufirst%3DA.%26atitle%3DHeterocellular%2520gene%2520signatures%2520reveal%2520luminal-A%2520breast%2520cancer%2520heterogeneity%2520and%2520differential%2520therapeutic%2520responses%26jtitle%3DNPJ.%2520breast%2520cancer%26date%3D2019%26volume%3D5%26spage%3D21%26doi%3D10.1038%2Fs41523-019-0116-8" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegh, W.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Heterogeneity in signaling pathway activity within primary breast cancer and between primary and metastases</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">15s</span>),  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">589</span>, <span class="refDoi">&nbsp;DOI: 10.1200/JCO.2019.37.15_suppl.589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1200%2FJCO.2019.37.15_suppl.589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=30653422" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=37&amp;publication_year=2019&amp;pages=589-589&amp;issue=15s&amp;author=W.+Verhaegh&amp;title=Heterogeneity+in+signaling+pathway+activity+within+primary+breast+cancer+and+between+primary+and+metastases&amp;doi=10.1200%2FJCO.2019.37.15_suppl.589" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2019.37.15_suppl.589&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2019.37.15_suppl.589%26sid%3Dliteratum%253Aachs%26aulast%3DVerhaegh%26aufirst%3DW.%26atitle%3DHeterogeneity%2520in%2520signaling%2520pathway%2520activity%2520within%2520primary%2520breast%2520cancer%2520and%2520between%2520primary%2520and%2520metastases%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D15s%26spage%3D589%26epage%3D589%26doi%3D10.1200%2FJCO.2019.37.15_suppl.589" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">766</span>, <span class="refDoi">&nbsp;DOI: 10.1309/AJCPIRL4GUVGK3YX</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1309%2FAJCPIRL4GUVGK3YX" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=25389328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2M3nsVKhsQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=142&amp;publication_year=2014&amp;pages=755-766&amp;issue=6&amp;author=H.+J.+Lee&amp;title=HER2+heterogeneity+affects+trastuzumab+responses+and+survival+in+patients+with+HER2-positive+metastatic+breast+cancer&amp;doi=10.1309%2FAJCPIRL4GUVGK3YX" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer</span></div><div class="casAuthors">Lee Hee Jin; Park So Yeon; Seo An Na; Kim Eun Joo; Jang Min Hye; Suh Koung Jin; Ryu Han Suk; Gong Gyungyub; Kim Yu Jung; Kim Jee Hyun; Im Seock-Ah; Jung Kyung Hae; Park In Ae</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Heterogeneity of HER2 gene amplification is found in a subset of breast cancers.  We investigated the impact of HER2 heterogeneity on trastuzumab responses and clinical outcomes in 112 patients with HER2-positive metastatic breast cancer.  METHODS:  Regional and genetic heterogeneity of HER2 gene amplification was determined in three different areas of each tumor by immunohistochemistry and silver in situ hybridization.  We also assessed the overall levels of HER2 amplification and the proportion of tumor cells with a HER2/CEP17 ratio of more than 2.2 or strong and complete membranous (3+) expression of HER2 protein.  RESULTS:  HER2 regional and genetic heterogeneity based on the HER2/CEP17 ratio was confirmed in 8.7% and 2.7% of cases, respectively.  Poor response to trastuzumab was associated with overall low-level or equivocal amplification, HER2 regional heterogeneity by the HER2/CEP17 ratio, the HER2/CEP17 ratio of more than 2.2 in less than 80% of tumor cells, and HER2 immunohistochemical expression of 3+ in less than 75% of tumor cells.  In survival analyses, low-level or equivocal HER2 amplification, HER2 regional heterogeneity based on the HER2/CEP17 ratio, and the HER2/CEP17 ratio of more than 2.2 in less than 80% of tumor cells were associated with shorter time to progression and lower overall survival in univariate and multivariate analyses.  CONCLUSIONS:  These results suggest that accurate assessment of HER2 status, including HER2 heterogeneity, is important in predicting trastuzumab responses and outcomes in patients with HER2-positive metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK20E-hdrxgBLDWw4HIq2sfW6udTcc2eY4AgfS4sWak7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2M3nsVKhsQ%253D%253D&amp;md5=9735037fa9dad674389e91699d2eac17</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1309%2FAJCPIRL4GUVGK3YX&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FAJCPIRL4GUVGK3YX%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DHER2%2520heterogeneity%2520affects%2520trastuzumab%2520responses%2520and%2520survival%2520in%2520patients%2520with%2520HER2-positive%2520metastatic%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2014%26volume%3D142%26issue%3D6%26spage%3D755%26epage%3D766%26doi%3D10.1309%2FAJCPIRL4GUVGK3YX" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rye, I. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi">&nbsp;DOI: 10.1002/1878-0261.12375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1002%2F1878-0261.12375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=30133130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKlu7c%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2018&amp;pages=1838-1855&amp;issue=11&amp;author=I.+H.+Rye&amp;title=Intratumor+heterogeneity+defines+treatment-resistant+HER2%2B+breast+tumors&amp;doi=10.1002%2F1878-0261.12375" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors</span></div><div class="casAuthors">Rye, Inga H.; Trinh, Anne; Saetersdal, Anna B.; Nebdal, Daniel; Lingjaerde, Ole Christian; Almendro, Vanessa; Polyak, Kornelia; Borresen-Dale, Anne-Lise; Helland, Aaslaug; Markowetz, Florian; Russnes, Hege G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1838-1855</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1878-0261</span>.
    
            (<span class="NLM_cas:orgname">John Wiley &amp; Sons Ltd.</span>)
        </div><div class="casAbstract">Targeted therapy for patients with HER2-pos. (HER2+) breast cancer has improved overall survival, but many patients still suffer relapse and death from the disease.  Intratumor heterogeneity of both estrogen receptor (ER) and HER2 expression has been proposed to play a key role in treatment failure, but little work has been done to comprehensively study this heterogeneity at the single-cell level.  In this study, we explored the clin. impact of intratumor heterogeneity of ER protein expression, HER2 protein expression, and HER2 gene copy no. alterations.  Using combined immunofluorescence and in situ hybridization on tissue sections followed by a validated computational approach, we analyzed more than 13 000 single tumor cells across 37 HER2+ breast tumors.  The samples were taken both before and after neoadjuvant chemotherapy plus HER2-targeted treatment, enabling us to study tumor evolution as well.  We found that intratumor heterogeneity for HER2 copy no. varied substantially between patient samples.  Highly heterogeneous tumors were assocd. with significantly shorter disease-free survival and fewer long-term survivors.  Patients for which HER2 characteristics did not change during treatment had a significantly worse outcome.  This work shows the impact of intratumor heterogeneity in mol. diagnostics for treatment selection in HER2+ breast cancer patients and the power of computational scoring methods to evaluate in situ mol. markers in tissue biopsies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcc-n07s2ikbVg90H21EOLACvtfcHk0lgWyeoJXcZkRQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXitlKlu7c%253D&amp;md5=10453b2252b82540f88988cbf9d59280</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F1878-0261.12375&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1878-0261.12375%26sid%3Dliteratum%253Aachs%26aulast%3DRye%26aufirst%3DI.%2BH.%26atitle%3DIntratumor%2520heterogeneity%2520defines%2520treatment-resistant%2520HER2%252B%2520breast%2520tumors%26jtitle%3DMol.%2520Oncol.%26date%3D2018%26volume%3D12%26issue%3D11%26spage%3D1838%26epage%3D1855%26doi%3D10.1002%2F1878-0261.12375" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi">&nbsp;DOI: 10.1016/0009-8981(88)90038-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2F0009-8981%2888%2990038-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=3168286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADyaL1M%252FgtlKgtA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=175&amp;publication_year=1988&amp;pages=89-96&amp;issue=1&amp;author=R.+A.+Hawkins&amp;title=Oestrogen+receptors%2C+lactate+dehydrogenase+and+cellularity+in+human+breast+cancer&amp;doi=10.1016%2F0009-8981%2888%2990038-1" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer</span></div><div class="casAuthors">Hawkins R A; Killen E; Tesdale A L; Sangster K; Thomson M; Steele R J; Blackie R A</div><div class="citationInfo"><span class="NLM_cas:title">Clinica chimica acta; international journal of clinical chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    </div><div class="casAbstract">Oestrogen receptor (ER) concentrations in breast tissues are almost universally expressed in relation to total soluble protein, though the latter does not fully correct for gross variations in receptor concentration due to variations in tissue cellularity.  It was considered possible that the concentration of a specific glycolytic enzyme might be a better index and reflection of tumour cellularity.  Measurements of the concentrations of lactate dehydrogenase (LDH), oestrogen receptor and total soluble protein and estimates of tumour cellularity were therefore performed on 98 breast tissues (80 breast cancers, 18 benign tissues).  Cellularity and the concentrations of oestrogen receptor, lactate dehydrogenase and total soluble protein were significantly higher in breast cancers than in the benign tissues.  The concentration of oestrogen receptors (positives only) was, as expected, related to tissue cellularity (correlation coefficient, r = 0.35).  The concentrations of both LDH and total soluble protein were also both strongly related to tissue cellularity (correlation coefficients r = 0.67 and 0.75, respectively), and to each other (r = 0.78).  These results suggest that (1) total soluble protein concentration is a good index of cellularity and (2) there is unlikely to be any additional value in expressing receptor concentrations relative to LDH since the latter appears to be a 'typical' soluble protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_XpsLloQrfresJRIHUP1ofW6udTcc2eaVPKyi_92JPbntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADyaL1M%252FgtlKgtA%253D%253D&amp;md5=c2fc7dd6127b114dfbc7e96746cadfcc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0009-8981%2888%2990038-1&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-8981%252888%252990038-1%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DR.%2BA.%26atitle%3DOestrogen%2520receptors%252C%2520lactate%2520dehydrogenase%2520and%2520cellularity%2520in%2520human%2520breast%2520cancer%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D1988%26volume%3D175%26issue%3D1%26spage%3D89%26epage%3D96%26doi%3D10.1016%2F0009-8981%2888%2990038-1" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGranahan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, C.</span></span> <span> </span><span class="NLM_article-title">Biological and therapeutic impact of intratumor heterogeneity in cancer evolution</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">26</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.ccell.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.ccell.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=25584892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVKgug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=27&amp;publication_year=2015&amp;pages=15-26&amp;issue=1&amp;author=N.+McGranahanauthor=C.+Swanton&amp;title=Biological+and+therapeutic+impact+of+intratumor+heterogeneity+in+cancer+evolution&amp;doi=10.1016%2Fj.ccell.2014.12.001" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution</span></div><div class="casAuthors">McGranahan, Nicholas; Swanton, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-26</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Precision medicine requires an understanding of cancer genes and mutational processes, as well as an appreciation of the extent to which these are found heterogeneously in cancer cells during tumor evolution.  Here, we explore the processes shaping the cancer genome, placing these within the context of tumor evolution and their impact on intratumor heterogeneity and drug development.  We review evidence for constraints and contingencies to tumor evolution and highlight the clin. implications of diversity within tumors.  We outline the limitations of genome-driven targeted therapies and explore future strategies, including immune and adaptive approaches, to address this therapeutic challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoad-qEfzG2kLVg90H21EOLACvtfcHk0li2K5THEpE4uA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXntVKgug%253D%253D&amp;md5=2b1cd91dfac32a9b8cab36bdd9af3650</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2014.12.001&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DMcGranahan%26aufirst%3DN.%26aulast%3DSwanton%26aufirst%3DC.%26atitle%3DBiological%2520and%2520therapeutic%2520impact%2520of%2520intratumor%2520heterogeneity%2520in%2520cancer%2520evolution%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26issue%3D1%26spage%3D15%26epage%3D26%26doi%3D10.1016%2Fj.ccell.2014.12.001" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagogo-Jack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Tumour heterogeneity and resistance to cancer therapies</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">94</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrclinonc.2017.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrclinonc.2017.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29115304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOntLbN" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=15&amp;publication_year=2018&amp;pages=81-94&amp;issue=2&amp;author=I.+Dagogo-Jackauthor=A.+T.+Shaw&amp;title=Tumour+heterogeneity+and+resistance+to+cancer+therapies&amp;doi=10.1038%2Fnrclinonc.2017.166" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour heterogeneity and resistance to cancer therapies</span></div><div class="casAuthors">Dagogo-Jack, Ibiayi; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Cancer is a dynamic disease.  During the course of disease, cancers generally become more heterogeneous.  As a result of this heterogeneity, the bulk tumor might include a diverse collection of cells harbouring distinct mol. signatures with differential levels of sensitivity to treatment.  This heterogeneity might result in a non-uniform distribution of genetically distinct tumor-cell subpopulations across and within disease sites (spatial heterogeneity) or temporal variations in the mol. makeup of cancer cells (temporal heterogeneity).  Heterogeneity provides the fuel for resistance; therefore, an accurate assessment of tumor heterogeneity is essential for the development of effective therapies.  Multiregion sequencing, single-cell sequencing, anal. of autopsy samples, and longitudinal anal. of liq. biopsy samples are all emerging technologies with considerable potential to dissect the complex clonal architecture of cancers.  In this Review, we discuss the driving forces behind intratumoral heterogeneity and the current approaches used to combat this heterogeneity and its consequences.  We also explore how clin. assessments of tumor heterogeneity might facilitate the development of more-effective personalized therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGLb_pO6DBXrVg90H21EOLACvtfcHk0li2K5THEpE4uA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXhslOntLbN&amp;md5=11d4a70d028f0f37ed90ccef34432961</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2017.166&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2017.166%26sid%3Dliteratum%253Aachs%26aulast%3DDagogo-Jack%26aufirst%3DI.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTumour%2520heterogeneity%2520and%2520resistance%2520to%2520cancer%2520therapies%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26issue%3D2%26spage%3D81%26epage%3D94%26doi%3D10.1038%2Fnrclinonc.2017.166" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, C.</span></span> <span> </span><span class="NLM_article-title">Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome</span>. <i>American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi">&nbsp;DOI: 10.1200/EDBK_158930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1200%2FEDBK_158930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27249716" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=35&amp;publication_year=2016&amp;pages=e141-149&amp;author=S.+Venkatesanauthor=C.+Swanton&amp;title=Tumor+Evolutionary+Principles%3A+How+Intratumor+Heterogeneity+Influences+Cancer+Treatment+and+Outcome&amp;doi=10.1200%2FEDBK_158930" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FEDBK_158930&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FEDBK_158930%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DS.%26aulast%3DSwanton%26aufirst%3DC.%26atitle%3DTumor%2520Evolutionary%2520Principles%253A%2520How%2520Intratumor%2520Heterogeneity%2520Influences%2520Cancer%2520Treatment%2520and%2520Outcome%26jtitle%3DAmerican%2520Society%2520of%2520Clinical%2520Oncology%2520educational%2520book.%2520American%2520Society%2520of%2520Clinical%2520Oncology.%2520Annual%2520Meeting%26date%3D2016%26volume%3D35%26spage%3De141%26epage%3D149%26doi%3D10.1200%2FEDBK_158930" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgoulis, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halazonetis, T. D.</span></span> <span> </span><span class="NLM_article-title">Genomic instability--an evolving hallmark of cancer</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">228</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrm2858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrm2858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=20177397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlaisb4%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2010&amp;pages=220-228&amp;issue=3&amp;author=S.+Negriniauthor=V.+G.+Gorgoulisauthor=T.+D.+Halazonetis&amp;title=Genomic+instability%2D%2Dan+evolving+hallmark+of+cancer&amp;doi=10.1038%2Fnrm2858" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic instability - an evolving hallmark of cancer</span></div><div class="casAuthors">Negrini, Simona; Gorgoulis, Vassilis G.; Halazonetis, Thanos D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-228</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genomic instability is a characteristic of most cancers.  In hereditary cancers, genomic instability results from mutations in DNA repair genes and drives cancer development, as predicted by the mutator hypothesis.  In sporadic (non-hereditary) cancers the mol. basis of genomic instability remains unclear, but recent high-throughput sequencing studies suggest that mutations in DNA repair genes are infrequent before therapy, arguing against the mutator hypothesis for these cancers.  Instead, the mutation patterns of the tumor suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwLmWpqeZ3LVg90H21EOLACvtfcHk0lipd6TedozA5g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXitlaisb4%253D&amp;md5=c1e1e2ae6a160b377e1f2a512a91a802</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2858&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2858%26sid%3Dliteratum%253Aachs%26aulast%3DNegrini%26aufirst%3DS.%26aulast%3DGorgoulis%26aufirst%3DV.%2BG.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DGenomic%2520instability--an%2520evolving%2520hallmark%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26issue%3D3%26spage%3D220%26epage%3D228%26doi%3D10.1038%2Fnrm2858" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span> <span> </span><span class="NLM_article-title">Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">26148</span>, <span class="refDoi">&nbsp;DOI: 10.7554/eLife.26148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.7554%2FeLife.26148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSjtb7F" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2018&amp;pages=26148&amp;author=S.+Furutaauthor=G.+Renauthor=J.+H.+Maoauthor=M.+J.+Bissell&amp;title=Laminin+signals+initiate+the+reciprocal+loop+that+informs+breast-specific+gene+expression+and+homeostasis+by+activating+NO%2C+p53+and+microRNAs&amp;doi=10.7554%2FeLife.26148" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs</span></div><div class="casAuthors">Furuta, Saori; Ren, Gang; Mao, Jian-Hua; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e26148/1-e26148/40</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">How mammalian tissues maintain their architecture and tissue-specificity is poorly understood.  Previously, we documented both the indispensable role of the extracellular matrix (ECM) protein, laminin-111 (LN1), in the formation of normal breast acini, and the phenotypic reversion of cancer cells to acini-like structures in 3-dimensional (3D) gels with inhibitors of oncogenic pathways.  Here, we asked how laminin (LN) proteins integrate the signaling pathways necessary for morphogenesis.  We report a surprising reciprocal circuitry comprising pos. players: laminin-5 (LN5), nitric oxide (NO), p53, HOXD10 and three microRNAs (miRNAs) - that are involved in the formation of mammary acini in 3D.  Significantly, cancer cells on either 2-dimensional (2D) or 3D and non-malignant cells on 2D plastic do not produce NO and upregulate neg. players: NFκB, EIF5A2, SCA1 and MMP-9 - that disrupt the network.  Introducing exogenous NO, LN5 or individual miRNAs to cancer cells reintegrates these pathways and induces phenotypic reversion in 3D.  These findings uncover the essential elements of breast epithelial architecture, where the balance between pos.- and neg.-players leads to homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cPoIZ_RZJrVg90H21EOLACvtfcHk0lipd6TedozA5g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXisVSjtb7F&amp;md5=edacfb6b133c837436b93f3b4cadebdc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7554%2FeLife.26148&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.26148%26sid%3Dliteratum%253Aachs%26aulast%3DFuruta%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DG.%26aulast%3DMao%26aufirst%3DJ.%2BH.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DLaminin%2520signals%2520initiate%2520the%2520reciprocal%2520loop%2520that%2520informs%2520breast-specific%2520gene%2520expression%2520and%2520homeostasis%2520by%2520activating%2520NO%252C%2520p53%2520and%2520microRNAs%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26spage%3D26148%26doi%3D10.7554%2FeLife.26148" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Weimann, S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2010</span>– <span class="NLM_lpage">2020</span>, <span class="refDoi">&nbsp;DOI: 10.18632/oncotarget.1451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18632%2Foncotarget.1451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24243820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2c7nvFCjsQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=4&amp;publication_year=2013&amp;pages=2010-2020&amp;issue=11&amp;author=S.+Becker-Weimann&amp;title=NFkB+disrupts+tissue+polarity+in+3D+by+preventing+integration+of+microenvironmental+signals&amp;doi=10.18632%2Foncotarget.1451" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals</span></div><div class="casAuthors">Becker-Weimann Sabine; Xiong Gaofeng; Furuta Saori; Han Ju; Kuhn Irene; Akavia Uri-David; Pe'er Dana; Bissell Mina J; Xu Ren</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2010-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The microenvironment of cells controls their phenotype, and thereby the architecture of the emerging multicellular structure or tissue.  We have reported more than a dozen microenvironmental factors whose signaling must be integrated in order to effect an organized, functional tissue morphology.  However, the factors that prevent integration of signaling pathways that merge form and function are still largely unknown.  We have identified nuclear factor kappa B (NFkB) as a transcriptional regulator that disrupts important microenvironmental cues necessary for tissue organization.  We compared the gene expression of organized and disorganized epithelial cells of the HMT-3522 breast cancer progression series: the non-malignant S1 cells that form polarized spheres ('acini'), the malignant T4-2 cells that form large tumor-like clusters, and the 'phenotypically reverted' T4-2 cells that polarize as a result of correction of the microenvironmental signaling.  We identified 180 genes that display an increased expression in disorganized compared to polarized structures.  Network, GSEA and transcription factor binding site analyses suggested that NFkB is a common activator for the 180 genes.  NFkB was found to be activated in disorganized breast cancer cells, and inhibition of microenvironmental signaling via EGFR, beta1 integrin, MMPs, or their downstream signals suppressed its activation.  The postulated role of NFkB was experimentally verified: Blocking the NFkB pathway with a specific chemical inhibitor or shRNA induced polarization and inhibited invasion of breast cancer cells in 3D cultures.  These results may explain why NFkB holds promise as a target for therapeutic intervention: Its inhibition can reverse the oncogenic signaling involved in breast cancer progression and integrate the essential microenvironmental control of tissue architecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUGj0HxqTGKnwOGIfWJ7-GfW6udTcc2eZoc_ZwveANR7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2c7nvFCjsQ%253D%253D&amp;md5=b49a3b2679487cfb643e126a44b0c1bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1451&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1451%26sid%3Dliteratum%253Aachs%26aulast%3DBecker-Weimann%26aufirst%3DS.%26atitle%3DNFkB%2520disrupts%2520tissue%2520polarity%2520in%25203D%2520by%2520preventing%2520integration%2520of%2520microenvironmental%2520signals%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26issue%3D11%26spage%3D2010%26epage%3D2020%26doi%3D10.18632%2Foncotarget.1451" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">E4820</span>– <span class="NLM_lpage">4827</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.1609135113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.1609135113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27496330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12nsbrI" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=113&amp;publication_year=2016&amp;pages=E4820-4827&amp;issue=33&amp;author=R.+Bhat&amp;title=Nuclear+repartitioning+of+galectin-1+by+an+extracellular+glycan+switch+regulates+mammary+morphogenesis&amp;doi=10.1073%2Fpnas.1609135113" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis</span></div><div class="casAuthors">Bhat, Ramray; Belardi, Brian; Mori, Hidetoshi; Kuo, Peiwen; Tam, Andrew; Hines, William C.; Le, Quynh-Thu; Bertozzi, Carolyn R.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E4820-E4827</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Branching morphogenesis in the mammary gland is achieved by the migration of epithelial cells through a microenvironment consisting of stromal cells and extracellular matrix (ECM).  Here we show that galectin-1 (Gal-1), an endogenous lectin that recognizes glycans bearing N-acetyllactosamine (LacNAc) epitopes, induces branching migration of mammary epithelia in vivo, ex vivo, and in 3D organotypic cultures.  Surprisingly, Gal-1's effects on mammary patterning were independent of its glycan-binding ability and instead required localization within the nuclei of mammary epithelia.  Nuclear translocation of Gal-1, in turn, was regulated by discrete cell-surface glycans restricted to the front of the mammary end buds.  Specifically, α2,6-sialylation of terminal LacNAc residues in the end buds masked Gal-1 ligands, thereby liberating the protein for nuclear translocation.  Within mammary epithelia, Gal-1 localized within nuclear Gemini bodies and drove epithelial invasiveness.  Conversely, unsialylated LacNAc glycans, enriched in the epithelial ducts, sequestered Gal-1 in the extracellular environment, ultimately attenuating invasive potential.  We also found that malignant breast cells possess higher levels of nuclear Gal-1 and α2,6-SA and lower levels of LacNAc than nonmalignant cells in culture and in vivo and that nuclear localization of Gal-1 promotes a transformed phenotype.  Our findings suggest that differential glycosylation at the level of tissue microanatomy regulates the nuclear function of Gal-1 in the context of mammary gland morphogenesis and in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDomeGTxqfgrVg90H21EOLACvtfcHk0lipd6TedozA5g"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28Xht12nsbrI&amp;md5=9cf6d1c1d61f38f972a444b92d94d1e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1609135113&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1609135113%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DNuclear%2520repartitioning%2520of%2520galectin-1%2520by%2520an%2520extracellular%2520glycan%2520switch%2520regulates%2520mammary%2520morphogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D33%26spage%3DE4820%26epage%3D4827%26doi%3D10.1073%2Fpnas.1609135113" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aub, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span> <span> </span><span class="NLM_article-title">Reactions of normal and leukemic cell surfaces to a wheat germ agglutinin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">402</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.54.2.400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.54.2.400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=5217427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF2MXkvVaqurY%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=54&amp;publication_year=1965&amp;pages=400-402&amp;issue=2&amp;author=J.+C.+Aubauthor=B.+H.+Sanfordauthor=L.+H.+Wang&amp;title=Reactions+of+normal+and+leukemic+cell+surfaces+to+a+wheat+germ+agglutinin&amp;doi=10.1073%2Fpnas.54.2.400" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of normal and leukemic cell surfaces to a wheat germ agglutinin</span></div><div class="casAuthors">Aub, Joseph C.; Sanford, Barbara H.; Wang, Li-Hsia</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">400-2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">After treatment with wheat germ agglutinin, the leukocytes from patients with chronic lymphocytic leukemia exhibited less clumping than controls, while leukocytes from patients with chronic granulocytic leukemia exhibited more clumping.  When relatively pure lymphocytic prepns. were compared with total white cell prepns. from the same control donor, the lymphocyte suspension exhibited significantly less clumping.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9poSrs9iKR7Vg90H21EOLACvtfcHk0lhQS2R-BRK26w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF2MXkvVaqurY%253D&amp;md5=c635e03858a1a33139062841a53d2298</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.54.2.400&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.54.2.400%26sid%3Dliteratum%253Aachs%26aulast%3DAub%26aufirst%3DJ.%2BC.%26aulast%3DSanford%26aufirst%3DB.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BH.%26atitle%3DReactions%2520of%2520normal%2520and%2520leukemic%2520cell%2520surfaces%2520to%2520a%2520wheat%2520germ%2520agglutinin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1965%26volume%3D54%26issue%3D2%26spage%3D400%26epage%3D402%26doi%3D10.1073%2Fpnas.54.2.400" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aub, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M. N.</span></span> <span> </span><span class="NLM_article-title">Studies on reactivity of tumor and normal cells to a wheat germ agglutinin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">399</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.54.2.396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.54.2.396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=5217426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF2MXkslCru7w%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=54&amp;publication_year=1965&amp;pages=396-399&amp;issue=2&amp;author=J.+C.+Aubauthor=B.+H.+Sanfordauthor=M.+N.+Cote&amp;title=Studies+on+reactivity+of+tumor+and+normal+cells+to+a+wheat+germ+agglutinin&amp;doi=10.1073%2Fpnas.54.2.396" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity of tumor and normal cells to a wheat germ agglutinin</span></div><div class="casAuthors">Aub, Joseph D.; Sanford, Barbara H.; Cote, Marilyn N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">396-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">One mg. of wheat germ agglutinin (I) caused more clumping of L #2 lymphoma cells than of spleen cells from adult strain A mice and caused more clumping of 6C3HED tumor cells than of speen cells from either adult or newborn C3H mice.  Tumor prepns. showed 3-dimensional clumping rather than the monolayer effect seen in normal spleen prepns.  Slight aggregation spontaneously occurring in normal and regenerating liver or epidermis cells was not increased by incubation with I.  Thymus gland, lung, and bone marrow cells gave a slight but definite clumping when exposed to I.  I appeared to detect a cell surface component present in high concn. in ascites tumor cells and in lesser concn. on cells from certain normal tissues.  The difference in reactivity between tumor and normal cells seemed to be due to a cell surface property related to neoplasia rather than to rapid cell growth and division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzc6P_ABuU7Vg90H21EOLACvtfcHk0lhQS2R-BRK26w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF2MXkslCru7w%253D&amp;md5=986ea88261d10a9787ff1179e1a4d18b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.54.2.396&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.54.2.396%26sid%3Dliteratum%253Aachs%26aulast%3DAub%26aufirst%3DJ.%2BC.%26aulast%3DSanford%26aufirst%3DB.%2BH.%26aulast%3DCote%26aufirst%3DM.%2BN.%26atitle%3DStudies%2520on%2520reactivity%2520of%2520tumor%2520and%2520normal%2520cells%2520to%2520a%2520wheat%2520germ%2520agglutinin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1965%26volume%3D54%26issue%3D2%26spage%3D396%26epage%3D399%26doi%3D10.1073%2Fpnas.54.2.396" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doljanski, F.</span></span> <span> </span><span class="NLM_article-title">Agglutination of normal and rous sarcoma virus-transformed chick embryo cells by concanavalin A and wheat germ agglutinin</span>. <i>Nature: New biology</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>235</i></span> (<span class="NLM_issue">58</span>),  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi">&nbsp;DOI: 10.1038/newbio235184a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnewbio235184a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=4334195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaE38Xht1Giu7s%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=235&amp;publication_year=1972&amp;pages=184-185&amp;issue=58&amp;author=M.+Kapellerauthor=F.+Doljanski&amp;title=Agglutination+of+normal+and+rous+sarcoma+virus-transformed+chick+embryo+cells+by+concanavalin+A+and+wheat+germ+agglutinin&amp;doi=10.1038%2Fnewbio235184a0" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Agglutination of normal and Rous sarcoma virus-transformed chick embryo cells by concanavalin A and wheat germ agglutinin</span></div><div class="casAuthors">Kapeller, M.; Doljanski, F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">58</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Rous sarcoma virus-transformed chick embryo cells were agglutinated in vitro by concanavalin A and by wheat germ agglutinin to a greater degree than normal embryo cells.  Treatment of normal cells with trypsin increased their agglutinability.  Treatment of both normal and transformed embryo cells with neuraminidase decreased the agglutinability of these cells to wheat germ agglutinin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSqaoyNlQH37Vg90H21EOLACvtfcHk0lhQS2R-BRK26w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaE38Xht1Giu7s%253D&amp;md5=69dafe4b85c951b64006c1b4dc31bd27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnewbio235184a0&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio235184a0%26sid%3Dliteratum%253Aachs%26aulast%3DKapeller%26aufirst%3DM.%26aulast%3DDoljanski%26aufirst%3DF.%26atitle%3DAgglutination%2520of%2520normal%2520and%2520rous%2520sarcoma%2520virus-transformed%2520chick%2520embryo%2520cells%2520by%2520concanavalin%2520A%2520and%2520wheat%2520germ%2520agglutinin%26jtitle%3DNature%253A%2520New%2520biology%26date%3D1972%26volume%3D235%26issue%3D58%26spage%3D184%26epage%3D185%26doi%3D10.1038%2Fnewbio235184a0" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meezan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, P. W.</span></span> <span> </span><span class="NLM_article-title">Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2518</span>– <span class="NLM_lpage">2524</span>, <span class="refDoi">&nbsp;DOI: 10.1021/bi00834a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00834a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF1MXktlOjtLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=8&amp;publication_year=1969&amp;pages=2518-2524&amp;issue=6&amp;author=E.+Meezanauthor=H.+C.+Wuauthor=P.+H.+Blackauthor=P.+W.+Robbins&amp;title=Comparative+studies+on+the+carbohydrate-containing+membrane+components+of+normal+and+virus-transformed+mouse+fibroblasts.+II.+Separation+of+glycoproteins+and+glycopeptides+by+sephadex+chromatography&amp;doi=10.1021%2Fbi00834a039" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts.  II.  Separation of glycoproteins and glycopeptides by Sephadex chromatography</span></div><div class="casAuthors">Meezan, Elias; Wu, Henry C.; Black, Paul H.; Robbins, Phillips W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2518-24</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Anal. of membrane carbohydrates has revealed that following SV-40 virus transformation of mouse fibroblast 3T3, there is a marked decrease in most neutral and amino sugars, especially sialic acid and N-acetylgalactosamine.  To examine this change in the compn. of membrane glycoproteins in greater detail, we have fractionated the labeled membrane fractions derived from 3T3 and transformed 3T3 lines on Sephadex G-150 in the presence of Na dodecyl sulfate.  In addn., membrane glycoproteins were digested with the proteolytic enzyme, Pronase, followed by the fractionation of the glycopeptide mixt. on Sephadex G-50.  The possible mechanisms by which these changes in the compn. of membrane glycoproteins are brought about are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQQLTKZLAh9LVg90H21EOLACvtfcHk0lhQS2R-BRK26w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF1MXktlOjtLc%253D&amp;md5=9909b8f880ff079c00b57266eda89a45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00834a039&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00834a039%26sid%3Dliteratum%253Aachs%26aulast%3DMeezan%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%2BC.%26aulast%3DBlack%26aufirst%3DP.%2BH.%26aulast%3DRobbins%26aufirst%3DP.%2BW.%26atitle%3DComparative%2520studies%2520on%2520the%2520carbohydrate-containing%2520membrane%2520components%2520of%2520normal%2520and%2520virus-transformed%2520mouse%2520fibroblasts.%2520II.%2520Separation%2520of%2520glycoproteins%2520and%2520glycopeptides%2520by%2520sephadex%2520chromatography%26jtitle%3DBiochemistry%26date%3D1969%26volume%3D8%26issue%3D6%26spage%3D2518%26epage%3D2524%26doi%3D10.1021%2Fbi00834a039" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghorne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerbel, R. S.</span></span> <span> </span><span class="NLM_article-title">Beta 1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>236</i></span> (<span class="NLM_issue">4801</span>),  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">585</span>, <span class="refDoi">&nbsp;DOI: 10.1126/science.2953071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1126%2Fscience.2953071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=2953071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaL2sXkt1Wgu7o%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=236&amp;publication_year=1987&amp;pages=582-585&amp;issue=4801&amp;author=J.+W.+Dennisauthor=S.+Laferteauthor=C.+Waghorneauthor=M.+L.+Breitmanauthor=R.+S.+Kerbel&amp;title=Beta+1%E2%80%936+branching+of+Asn-linked+oligosaccharides+is+directly+associated+with+metastasis&amp;doi=10.1126%2Fscience.2953071" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">β1-6 Branching of Asn-linked oligosaccharides is directly associated with metastasis</span></div><div class="casAuthors">Dennis, James W.; Laferte, Suzanne; Waghorne, Carol; Breitman, Martin L.; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">4801</span>),
    <span class="NLM_cas:pages">582-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Glycosylation mutants of a metastatic murine tumor cell line were selected that are deficient in both β1-6 GlcNAc transferase activity and metastatic potential in situ.  Moreover, induction of increased β1-6 branching in clones of a nonmetastatic murine mammary carcinoma correlated strongly with acquisition of metastatic potential.  Increased β1-6-linked branching of complex-type oligosaccharides on cell surface glycoprotein gp130 may be an important feature of tumor progression related to increased metastatic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPNUWfQDx1Z7Vg90H21EOLACvtfcHk0lhv8NaGrrsgoQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL2sXkt1Wgu7o%253D&amp;md5=c21edc2e9759a677349d0985f7c0f855</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.2953071&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2953071%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DLaferte%26aufirst%3DS.%26aulast%3DWaghorne%26aufirst%3DC.%26aulast%3DBreitman%26aufirst%3DM.%2BL.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DBeta%25201%25E2%2580%25936%2520branching%2520of%2520Asn-linked%2520oligosaccharides%2520is%2520directly%2520associated%2520with%2520metastasis%26jtitle%3DScience%26date%3D1987%26volume%3D236%26issue%3D4801%26spage%3D582%26epage%3D585%26doi%3D10.1126%2Fscience.2953071" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span> <span> </span><span class="NLM_article-title">N-Glycans in cancer progression</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">760</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cwn071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcwn071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=18701722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOgtL3O" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=18&amp;publication_year=2008&amp;pages=750-760&amp;issue=10&amp;author=K.+S.+Lauauthor=J.+W.+Dennis&amp;title=N-Glycans+in+cancer+progression&amp;doi=10.1093%2Fglycob%2Fcwn071" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-Glycans in cancer progression</span></div><div class="casAuthors">Lau, Ken S.; Dennis, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">750-760</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  N-Glycan branching in the medial-Golgi generates ligands for lattice-forming lectins (e.g., galectins) that regulate surface levels of glycoproteins including epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) receptors.  Moreover, functional classes of glycoproteins differ in N-glycan multiplicities (no. of N-glycans/peptide), a genetically encoded feature of glycoproteins that interacts with metabolic flux (UDP-GlcNAc) and N-glycan branching to differentially regulate surface levels.  Oncogenesis increases β1,6-N-acetylglucosaminyltransferase V (encoded by Mgat5) expression, and its high-affinity galectin ligands promote surface retention of growth receptors with a reduced dependence on UDP-GlcNAc.  Mgat5-/- tumor cells are less metastatic in vivo and less responsive to cytokines in vitro, but undergo secondary changes that support tumor cell proliferation.  These include loss of Caveolin-1, a neg. regulator of EGF signaling, and increased reactive oxygen species, an inhibitor of phosphotyrosine phosphatases.  These studies suggest a systems approach to cancer treatment where the surface distribution of receptors is targeted through metab. and N-glycan branching to induce growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDXBMo0EpfuLVg90H21EOLACvtfcHk0lhv8NaGrrsgoQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOgtL3O&amp;md5=c4acb5992531f12a072445c6a4540d9d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwn071&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwn071%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DK.%2BS.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26atitle%3DN-Glycans%2520in%2520cancer%2520progression%26jtitle%3DGlycobiology%26date%3D2008%26volume%3D18%26issue%3D10%26spage%3D750%26epage%3D760%26doi%3D10.1093%2Fglycob%2Fcwn071" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M.</span></span> <span> </span><span class="NLM_article-title">Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration</span>. <i>Cancer research</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6837</span>– <span class="NLM_lpage">6845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12460896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahs7w%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=62&amp;publication_year=2002&amp;pages=6837-6845&amp;issue=23&amp;author=H.+B.+Guoauthor=I.+Leeauthor=M.+Kamarauthor=S.+K.+Akiyamaauthor=M.+Pierce&amp;title=Aberrant+N-glycosylation+of+beta1+integrin+causes+reduced+alpha5beta1+integrin+clustering+and+stimulates+cell+migration" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant N-glycosylation of β1 integrin causes reduced α5β1 integrin clustering and stimulates cell migration</span></div><div class="casAuthors">Guo, Hua-Bei; Lee, Intaek; Kamar, Maria; Akiyama, Steven K.; Pierce, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6837-6845</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Altered expression of cell surface N-linked oligosaccharides is assocd. with the oncogenic transformation of many types of animal cells.  One of the most common forms of glycosylation in transformed cells and human tumors is the highly elevated β1,6 branching of N-linked oligosaccharides caused by increased transcription of N-acetylglucosaminyltransferase V (GnT-V).  To characterize the effects of increased β1,6 branching on cell-matrix adhesion-mediated phenotypes, human fibrosarcoma HT1080 cells were transfected with retroviral systems encoding GnT-V that used both noninducible and tetracycline-inducible promoters.  Increased GnT-V expression resulted in a &gt;25% inhibition of cell attachment to and a &gt;50% inhibition of cell spreading on fibronectin.  Both cell adhesion and spreading were suppressed by function-blocking antibodies specific for the α5 and β1 integrin subunits of the fibronectin receptor.  Cell migration toward fibronectin and invasion through Matrigel were both substantially stimulated in cells with induced expression of GnT-V.  Induction of GnT-V had no effect on the level of cell surface expression of α5 and β1 integrin subunits but did result in a more diffuse staining of the α5 and β1 integrin subunits on the cell surface, suggesting that inhibition of integrin clustering may be causing these cells to be less adhesive and more motile.  Surprisingly, there was no detectable expression of N-linked β1,6 branching on the α5 subunit purified from HT1080 cells before and after induction of GnT-V; by contrast, however, the β1 subunit showed a basal level of β1,6 branching that was greatly increased after induction of GnT-V.  These results suggest that changes in N-linked β1,6 branching that occur during oncogenesis alter cell-matrix adhesion and migration by modulating integrin clustering and subsequent signal transduction pathways.  These effects most likely result from altered N-linked carbohydrate expression on the β1 integrin subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNmfa-r3MsNrVg90H21EOLACvtfcHk0lhv8NaGrrsgoQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XpsVahs7w%253D&amp;md5=39c475975156814c578867376b757aa3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%2BB.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DKamar%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DS.%2BK.%26aulast%3DPierce%26aufirst%3DM.%26atitle%3DAberrant%2520N-glycosylation%2520of%2520beta1%2520integrin%2520causes%2520reduced%2520alpha5beta1%2520integrin%2520clustering%2520and%2520stimulates%2520cell%2520migration%26jtitle%3DCancer%2520research%26date%3D2002%26volume%3D62%26issue%3D23%26spage%3D6837%26epage%3D6845" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ugorski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskowska, A.</span></span> <span> </span><span class="NLM_article-title">Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells</span>. <i>Acta biochimica Polonica</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi">&nbsp;DOI: 10.18388/abp.2002_3788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18388%2Fabp.2002_3788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12362971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFCrtbo%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=49&amp;publication_year=2002&amp;pages=303-311&amp;issue=2&amp;author=M.+Ugorskiauthor=A.+Laskowska&amp;title=Sialyl+Lewis%28a%29%3A+a+tumor-associated+carbohydrate+antigen+involved+in+adhesion+and+metastatic+potential+of+cancer+cells&amp;doi=10.18388%2Fabp.2002_3788" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sialyl Lewisa: a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells</span></div><div class="casAuthors">Ugorski, Maciej; Laskowska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Neoplastic transformation is often assocd. with characteristic changes in the expression of the sialyl Lewisa and sialyl Lewisx antigens, representing typical tumor-assocd. carbohydrate antigens.  High amts. of sialyl Lewisa are present in human adenocarcinomas of the colon, pancreas and stomach.  A growing amt. of data suggests that this carbohydrate structure is the ligand for E-selectin.  Sialylated Lewis structures present on the surface of tumor cells are carried by the carbohydrate chains of glycoproteins and glycolipids.  There are several lines of evidence showing that sialyl Lewisa is responsible for the adhesion of human cancer cells to endothelium.  E-selectin present on endothelial cells mediates these interactions.  Selectins and their carbohydrate ligands can thus play an important role in the selective homing of tumor cells during metastasis.  However, the presence of sialyl Lewisa antigen on the surface of tumor cells and their adhesion to E-selectin-expressing cells in in vitro adhesion assay by itself can not be directly related to metastatic properties of all cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8aHkD0BR_V7Vg90H21EOLACvtfcHk0lhv8NaGrrsgoQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XlsFCrtbo%253D&amp;md5=9fb132cc58516488e6c85e8410c25e1c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.18388%2Fabp.2002_3788&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2002_3788%26sid%3Dliteratum%253Aachs%26aulast%3DUgorski%26aufirst%3DM.%26aulast%3DLaskowska%26aufirst%3DA.%26atitle%3DSialyl%2520Lewis%2528a%2529%253A%2520a%2520tumor-associated%2520carbohydrate%2520antigen%2520involved%2520in%2520adhesion%2520and%2520metastatic%2520potential%2520of%2520cancer%2520cells%26jtitle%3DActa%2520biochimica%2520Polonica%26date%3D2002%26volume%3D49%26issue%3D2%26spage%3D303%26epage%3D311%26doi%3D10.18388%2Fabp.2002_3788" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, D. J.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of glycosylation in cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">35478</span>– <span class="NLM_lpage">35489</span>, <span class="refDoi">&nbsp;DOI: 10.18632/oncotarget.8155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18632%2Foncotarget.8155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27007155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC28fivFSquw%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2016&amp;pages=35478-35489&amp;issue=23&amp;author=J.+Munkleyauthor=D.+J.+Elliott&amp;title=Hallmarks+of+glycosylation+in+cancer&amp;doi=10.18632%2Foncotarget.8155" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of glycosylation in cancer</span></div><div class="casAuthors">Munkley Jennifer; Elliott David J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">35478-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aberrant glycosylation plays a fundamental role in key pathological steps of tumour development and progression.  Glycans have roles in cancer cell signalling, tumour cell dissociation and invasion, cell-matrix interactions, angiogenesis, metastasis and immune modulation.  Aberrant glycosylation is often cited as a 'hallmark of cancer' but is notably absent from both the original hallmarks of cancer and from the next generation of emerging hallmarks.  This review discusses how glycosylation is clearly an enabling characteristic that is causally associated with the acquisition of all the hallmark capabilities.  Rather than aberrant glycosylation being itself a hallmark of cancer, another perspective is that glycans play a role in every recognised cancer hallmark.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1KZr0A02av5SWdIdmEou5fW6udTcc2ebteelqPEhWFbntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC28fivFSquw%253D%253D&amp;md5=defcd3e7c63c03725d2846f730288713</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8155&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8155%26sid%3Dliteratum%253Aachs%26aulast%3DMunkley%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DD.%2BJ.%26atitle%3DHallmarks%2520of%2520glycosylation%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D23%26spage%3D35478%26epage%3D35489%26doi%3D10.18632%2Foncotarget.8155" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Brok, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span> <span> </span><span class="NLM_article-title">Sialic acids sweeten a tumor’s life</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3199</span>– <span class="NLM_lpage">3204</span>, <span class="refDoi">&nbsp;DOI: 10.1158/0008-5472.CAN-14-0728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1158%2F0008-5472.CAN-14-0728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24830719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2cjjtVyquw%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=74&amp;publication_year=2014&amp;pages=3199-3204&amp;issue=12&amp;author=C.+Bullauthor=M.+A.+Stoelauthor=M.+H.+den+Brokauthor=G.+J.+Adema&amp;title=Sialic+acids+sweeten+a+tumor%E2%80%99s+life&amp;doi=10.1158%2F0008-5472.CAN-14-0728" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids sweeten a tumor's life</span></div><div class="casAuthors">Bull Christian; Stoel Marieke A; den Brok Martijn H; Adema Gosse J</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3199-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over four decades ago, specific tumor characteristics were ascribed to the increased expression of sialic acid sugars on the surface of cancer cells, and this led to the definition of sialic acids as potential therapeutic targets.  Recent advances in glycobiology and cancer research have defined the key processes underlying aberrant expression of sialic acids in cancer, and its consequences, more precisely.  These consequences include effects on tumor growth, escape from apoptosis, metastasis formation, and resistance to therapy.  Collectively, these novel insights provide further rationale for the design and development of therapeutic approaches that interfere with excessively high expression of sialic acids in cancer cells.  Strategies to target aberrant sialylation in cancer, however, have evolved comparatively slowly.  Here, we review recent findings that emphasize the detrimental effects of hypersialylation on multiple aspects of tumor growth and behavior.  We also discuss novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNLUHKArjTl4FEOhA_Im3cfW6udTcc2ebteelqPEhWFbntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2cjjtVyquw%253D%253D&amp;md5=2bdc9202b38cecb569cb9e061ebd0202</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0728&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0728%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DC.%26aulast%3DStoel%26aufirst%3DM.%2BA.%26aulast%3Dden%2BBrok%26aufirst%3DM.%2BH.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26atitle%3DSialic%2520acids%2520sweeten%2520a%2520tumor%25E2%2580%2599s%2520life%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D12%26spage%3D3199%26epage%3D3204%26doi%3D10.1158%2F0008-5472.CAN-14-0728" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas</span>. <i>Cancer research</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4605</span>– <span class="NLM_lpage">4611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=11389097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlWjsb4%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=61&amp;publication_year=2001&amp;pages=4605-4611&amp;issue=11&amp;author=F.+Schneider&amp;title=Overexpression+of+sialyltransferase+CMP-sialic+acid%3AGalbeta1%2C3GalNAc-R+alpha6-Sialyltransferase+is+related+to+poor+patient+survival+in+human+colorectal+carcinomas" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of sialyltransferase CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinomas</span></div><div class="casAuthors">Schneider, Frank; Kemmner, Wolfgang; Haensch, Wolfgang; Franke, Gudrun; Gretschel, Stephan; Karsten, Uwe; Schlag, Peter Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4605-4611</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thomsen-Friedenreich (TF)-related blood group antigens, such as TF, Tn, and their sialylated variants, belong to a family of tumor-assocd. carbohydrates.  The aim of the present study was to examine tumor-assocd. alterations of glycosyltransferases involved in the biosynthesis of the TF glycotope in colorectal carcinomas.  To this end, glycosyltransferase expression was examd. in 40 cases of colorectal carcinoma specimens classified according to the WHO/Union International Contre Cancer guidelines and in "normal" mucosa of the same patients.  Occurrence of TF glycotope was examd. by immunohistochem. with the monoclonal antibody A78-G/A7.  Expression of sialyltransferases CMP-sialic acid:Galβ1,3GalNAc-R α3-sialyltransferase I and II (ST3Gal-I and ST3Gal-II) and CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase (ST6GalNAc-II) and of core 2 β1,6-N-acetylglucosaminyltransferase was detd. by reverse transcription-PCR in the same cryostat sections used for immunohistochem.  Addnl., α2,3-sialyltransferase enzyme activity was studied in each of these tissues.  The TF glycotope was detected in 7% of the normal mucosa, but in 57% of the carcinoma samples.  Expression of α2,3-sialyltransferases ST3Gal-I, ST3Gal-II, and enzyme activity of α2,3-sialyltransferase was significantly increased (P &lt; 0.001) in carcinoma specimens compared with normal mucosa.  ST3Gal-I mRNA expression was significantly increased (P = 0.05) in cases showing invasion of lymph vessels.  Expression of ST6GalNAc-II was significantly increased (P = 0.04) in cases with metastases to lymph nodes along the vascular trunk.  Moreover, ST6GalNAc-II expression provides an prognostic factor for patient survival (log rank, P = 0.02).  In an attempt to study the functional relevance of the glycosyltransferases for TF biosynthesis, SW480 colorectal cells were transfected with each of the enzymes, and cell surface expression of the TF glycotope was examd. by flow cytometry.  The presence of TF was not altered by transfection of the cells with either sialyltransferase ST3Gal-I or ST3Gal-II.  However, successful transfection with core 2 β1,6-N-acetylglucosaminyltransferase led to reduced expression of TF.  In contrast, increased cell surface expression of TF was found after ST6GalNAc-II transfection.  Thus, expression of TF on the cell surface of SW480 colorectal carcinoma cells depends on the ratio of core 2 β1,6-N-acetylglucosaminyltransferase and ST6GalNAc-II.  Earlier immunohistol. studies demonstrated that TF is a prognostic factor for patient survival.  Our results suggest that sialyltransferase ST6GalNAc-II is of crucial relevance for the prognostic significance of TF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruG_wEv86DVbVg90H21EOLACvtfcHk0lhdySfssx4Zdw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3MXktlWjsb4%253D&amp;md5=42be917413cddb7ad36fe03b8a3a78c6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26atitle%3DOverexpression%2520of%2520sialyltransferase%2520CMP-sialic%2520acid%253AGalbeta1%252C3GalNAc-R%2520alpha6-Sialyltransferase%2520is%2520related%2520to%2520poor%2520patient%2520survival%2520in%2520human%2520colorectal%2520carcinomas%26jtitle%3DCancer%2520research%26date%3D2001%26volume%3D61%26issue%3D11%26spage%3D4605%26epage%3D4611" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4663</span>– <span class="NLM_lpage">4673</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M116.763862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M116.763862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=28154177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVClt7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=292&amp;publication_year=2017&amp;pages=4663-4673&amp;issue=11&amp;author=C.+M.+Britainauthor=K.+A.+Dorsettauthor=S.+L.+Bellis&amp;title=The+Glycosyltransferase+ST6Gal-I+Protects+Tumor+Cells+against+Serum+Growth+Factor+Withdrawal+by+Enhancing+Survival+Signaling+and+Proliferative+Potential&amp;doi=10.1074%2Fjbc.M116.763862" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential</span></div><div class="casAuthors">Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4663-4673</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A hallmark of cancer cells is the ability to survive and proliferate when challenged with stressors such as growth factor insufficiency.  In this study, we report a novel glycosylation-dependent mechanism that protects tumor cells from serum growth factor withdrawal.  Our results suggest that the β-galactoside α-2,6-sialyltransferase 1 (ST6Gal-I) sialyltransferase, which is up-regulated in numerous cancers, promotes the survival of serum-starved cells.  Using ovarian and pancreatic cancer cell models with ST6Gal-I overexpression or knockdown, we find that serum-starved cells with high ST6Gal-I levels exhibit increased activation of prosurvival signaling mols., including pAkt, p-p70S6K, and pNFκB.  Correspondingly, ST6Gal-I activity augments the expression of tumor-promoting pNFκB transcriptional targets such as IL-6, IL-8, and the apoptosis inhibitor cIAP2.  ST6Gal-I also potentiates expression of the cell cycle regulator cyclin D2, leading to increased phosphorylation and inactivation of the cell cycle inhibitor pRb.  Consistent with these results, serum-starved cells with high ST6Gal-I expression maintain a greater no. of S phase cells compared with low ST6Gal-I expressors, reflecting enhanced proliferation.  Finally, selective enrichment in clonal variants with high ST6Gal-I expression is obsd. upon prolonged serum deprivation, supporting the concept that ST6Gal-I confers a survival advantage.  Collectively, these results implicate a functional role for ST6Gal-I in fostering tumor cell survival within the serum-depleted tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdlfzgyqvv5bVg90H21EOLACvtfcHk0lhdySfssx4Zdw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXksVClt7k%253D&amp;md5=40b8a982cab7c622eea8df4edcf67a4d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.763862&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.763862%26sid%3Dliteratum%253Aachs%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Glycosyltransferase%2520ST6Gal-I%2520Protects%2520Tumor%2520Cells%2520against%2520Serum%2520Growth%2520Factor%2520Withdrawal%2520by%2520Enhancing%2520Survival%2520Signaling%2520and%2520Proliferative%2520Potential%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D11%26spage%3D4663%26epage%3D4673%26doi%3D10.1074%2Fjbc.M116.763862" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdbrooks, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death</span>. <i>J. Ovarian Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>, <span class="refDoi">&nbsp;DOI: 10.1186/s13048-018-0385-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1186%2Fs13048-018-0385-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29402301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtlKgt78%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2018&amp;pages=12&amp;issue=1&amp;author=C.+M.+Britainauthor=A.+T.+Holdbrooksauthor=J.+C.+Andersonauthor=C.+D.+Willeyauthor=S.+L.+Bellis&amp;title=Sialylation+of+EGFR+by+the+ST6Gal-I+sialyltransferase+promotes+EGFR+activation+and+resistance+to+gefitinib-mediated+cell+death&amp;doi=10.1186%2Fs13048-018-0385-0" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death</span></div><div class="casAuthors">Britain, Colleen M.; Holdbrooks, Andrew T.; Anderson, Joshua C.; Willey, Christopher D.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ovarian Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12/1-12/11</span>CODEN:
                <span class="NLM_cas:coden">JOROBL</span>;
        ISSN:<span class="NLM_cas:issn">1757-2215</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The ST6Gal-I sialyltransferase is upregulated in numerous cancers, and high expression of this enzyme correlates with poor patient prognosis in various malignancies, including ovarian cancer.  Through its sialylation of a select cohort of cell surface receptors, ST6Gal-I modulates cell signaling to promote tumor cell survival.  The goal of the present study was to investigate the influence of ST6Gal-I on another important receptor that controls cancer cell behavior, EGFR.  Addnl., the effect of ST6Gal-I on cancer cells treated with the common EGFR inhibitor, gefitinib, was evaluated.  Results: Using the OV4 ovarian cancer cell line, which lacks endogenous ST6Gal-I expression, a kinomics assay revealed that cells with forced overexpression of ST6Gal-I exhibited increased global tyrosine kinase activity, a finding confirmed by immunoblotting whole cell lysates with an anti-phosphotyrosine antibody.  Interestingly, the kinomics assay suggested that one of the most highly activated tyrosine kinases in ST6Gal-I-overexpressing OV4 cells was EGFR.  Based on these findings, addnl. analyses were performed to investigate the effect of ST6Gal-I on EGFR activation.  To this end, we utilized, in addn. to OV4 cells, the SKOV3 ovarian cancer cell line, engineered with both ST6Gal-I overexpression and knockdown, as well as the BxPC3 pancreatic cancer cell line with knockdown of ST6Gal-I.  In all three cell lines, we detd. that EGFR is a substrate of ST6Gal-I, and that the sialylation status of EGFR directly correlates with ST6Gal-I expression.  Cells with differential ST6Gal-I expression were subsequently evaluated for EGFR tyrosine phosphorylation.  Cells with high ST6Gal-I expression were found to have elevated levels of basal and EGF-induced EGFR activation.  Conversely, knockdown of ST6Gal-I greatly attenuated EGFR activation, both basally and post EGF treatment.  Finally, to illustrate the functional importance of ST6Gal-I in regulating EGFR-dependent survival, cells were treated with gefitinib, an EGFR inhibitor widely used for cancer therapy.  These studies showed that ST6Gal-I promotes resistance to gefitinib-mediated apoptosis, as measured by caspase activity assays.  Conclusion: Results herein indicate that ST6Gal-I promotes EGFR activation and protects against gefitinib-mediated cell death.  Establishing the tumor-assocd. ST6Gal-I sialyltransferase as a regulator of EGFR provides novel insight into the role of glycosylation in growth factor signaling and chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkYMTfSrx9MLVg90H21EOLACvtfcHk0liMSW-iCsqHTw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXjtlKgt78%253D&amp;md5=2f4046fe0062a90b1f9e9aa8a0f42b3a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13048-018-0385-0&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13048-018-0385-0%26sid%3Dliteratum%253Aachs%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DHoldbrooks%26aufirst%3DA.%2BT.%26aulast%3DAnderson%26aufirst%3DJ.%2BC.%26aulast%3DWilley%26aufirst%3DC.%2BD.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DSialylation%2520of%2520EGFR%2520by%2520the%2520ST6Gal-I%2520sialyltransferase%2520promotes%2520EGFR%2520activation%2520and%2520resistance%2520to%2520gefitinib-mediated%2520cell%2520death%26jtitle%3DJ.%2520Ovarian%2520Res.%26date%3D2018%26volume%3D11%26issue%3D1%26spage%3D12%26doi%3D10.1186%2Fs13048-018-0385-0" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holdbrooks, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1622</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M117.801480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M117.801480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29233887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVygtbc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=293&amp;publication_year=2018&amp;pages=1610-1622&amp;issue=5&amp;author=A.+T.+Holdbrooksauthor=C.+M.+Britainauthor=S.+L.+Bellis&amp;title=ST6Gal-I+sialyltransferase+promotes+tumor+necrosis+factor+%28TNF%29-mediated+cancer+cell+survival+via+sialylation+of+the+TNF+receptor+1+%28TNFR1%29+death+receptor&amp;doi=10.1074%2Fjbc.M117.801480" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor</span></div><div class="casAuthors">Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1610-1622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of the tumor necrosis factor receptor 1 (TNFR1) death receptor by TNF induces either cell survival or cell death.  However, the mechanisms mediating these distinct outcomes remain poorly understood.  In this study, we report that the ST6Gal-I sialyltransferase, an enzyme up-regulated in numerous cancers, sialylates TNFR1 and thereby protects tumor cells from TNF-induced apoptosis.  Using pancreatic and ovarian cancer cells with ST6Gal-I knockdown or overexpression, we detd. that α2-6 sialylation of TNFR1 had no effect on early TNF-induced signaling events, including the rapid activation of NF-κB, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and Akt (occurring within 15 min).  However, upon extended TNF treatment (6-24 h), cells with high ST6Gal-I levels exhibited resistance to TNF-induced apoptosis, as indicated by morphol. evidence of cell death and decreased activation of caspases 8 and 3.  Correspondingly, at these later time points, high ST6Gal-I expressers displayed sustained activation of the survival mols. Akt and NF-κB.  Addnl., extended TNF treatment resulted in the selective enrichment of clonal variants with high ST6Gal-I expression, further substantiating a role for ST6Gal-I in cell survival.  Given that TNFR1 internalization is known to be essential for apoptosis induction, whereas survival signaling is initiated by TNFR1 at the plasma membrane, we examd. TNFR1 localization.  The α2-6 sialylation of TNFR1 was found to inhibit TNF-induced TNFR1 internalization.  Thus, by restraining TNFR1 at the cell surface via sialylation, ST6Gal-I acts as a functional switch to divert signaling toward survival.  These collective findings point to a novel glycosylation-dependent mechanism that regulates the cellular response to TNF and may promote cancer cell survival within TNF-rich tumor microenvironments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCCVFycP7j7Vg90H21EOLACvtfcHk0liMSW-iCsqHTw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXnsVygtbc%253D&amp;md5=b84f832eb8a9c3d4143bb03fe796a945</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.801480&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.801480%26sid%3Dliteratum%253Aachs%26aulast%3DHoldbrooks%26aufirst%3DA.%2BT.%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DST6Gal-I%2520sialyltransferase%2520promotes%2520tumor%2520necrosis%2520factor%2520%2528TNF%2529-mediated%2520cancer%2520cell%2520survival%2520via%2520sialylation%2520of%2520the%2520TNF%2520receptor%25201%2520%2528TNFR1%2529%2520death%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D5%26spage%3D1610%26epage%3D1622%26doi%3D10.1074%2Fjbc.M117.801480" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmeland, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1alpha signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5659</span>– <span class="NLM_lpage">5667</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.RA117.001194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.RA117.001194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29475939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCnt78%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=293&amp;publication_year=2018&amp;pages=5659-5667&amp;issue=15&amp;author=R.+B.+Jonesauthor=K.+A.+Dorsettauthor=A.+B.+Hjelmelandauthor=S.+L.+Bellis&amp;title=The+ST6Gal-I+sialyltransferase+protects+tumor+cells+against+hypoxia+by+enhancing+HIF-1alpha+signaling&amp;doi=10.1074%2Fjbc.RA117.001194" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling</span></div><div class="casAuthors">Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5659-5667</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant cell surface glycosylation is prevalent in tumor cells, and there is ample evidence that glycans have functional roles in carcinogenesis.  Nonetheless, many mol. details remain unclear.  Tumor cells frequently exhibit increased α2-6 sialylation on N-glycans, a modification that is added by the ST6Gal-I sialyltransferase, and emerging evidence suggests that ST6Gal-I-mediated sialylation promotes the survival of tumor cells exposed to various cell stressors.  Here we report that ST6Gal-I protects cancer cells from hypoxic stress.  It is well known that hypoxia-inducible factor 1α (HIF-1α) is stabilized in hypoxic cells, and, in turn, HIF-1α directs the transcription of genes important for cell survival.  To investigate a putative role for ST6Gal-I in the hypoxic response, we examd. HIF-1α accumulation in ovarian and pancreatic cancer cells in ST6Gal-I overexpression or knockdown expts.  We found that ST6Gal-I activity augmented HIF-1α accumulation in cells grown in a hypoxic environment or treated with two chem. hypoxia mimetics, deferoxamine and dimethyloxalylglycine.  Correspondingly, hypoxic cells with high ST6Gal-I expression had increased mRNA levels of HIF-1α transcriptional targets, including the glucose transporter genes GLUT1 and GLUT3 and the glycolytic enzyme gene PDHK1.  Interestingly, high ST6Gal-I-expressing cells also had an increased pool of HIF-1α mRNA, suggesting that ST6Gal-I may influence HIF-1α expression.  Finally, cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function.  Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaqolpN98gCbVg90H21EOLACvtfcHk0liMSW-iCsqHTw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCnt78%253D&amp;md5=7575dac1c67ed0ea6868841d70ccc92b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.001194&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.001194%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BB.%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DThe%2520ST6Gal-I%2520sialyltransferase%2520protects%2520tumor%2520cells%2520against%2520hypoxia%2520by%2520enhancing%2520HIF-1alpha%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D15%26spage%3D5659%26epage%3D5667%26doi%3D10.1074%2Fjbc.RA117.001194" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Recchi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harduin-Lepers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boilly-Marer, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delannoy, P.</span></span> <span> </span><span class="NLM_article-title">Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">27</span>, <span class="refDoi">&nbsp;DOI: 10.1023/A:1006983214918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1023%2FA%3A1006983214918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=9530953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1WmsLw%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=15&amp;publication_year=1998&amp;pages=19-27&amp;issue=1&amp;author=M.+A.+Recchiauthor=A.+Harduin-Lepersauthor=Y.+Boilly-Marerauthor=A.+Verbertauthor=P.+Delannoy&amp;title=Multiplex+RT-PCR+method+for+the+analysis+of+the+expression+of+human+sialyltransferases%3A+application+to+breast+cancer+cells&amp;doi=10.1023%2FA%3A1006983214918" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells</span></div><div class="casAuthors">Recchi, Marie-Ange; Harduin-Lepers, Anne; Boilly-Marer, Yolande; Verbert, Andre; Delannoy, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Chapman &amp; Hall</span>)
        </div><div class="casAbstract">In many cases of human cancer, the appearance of hypersialylated glycan structures is related to a precise stage of the disease; this may depend on altered regulation of one or more sialyltransferases genes.  Since several distinct sialyltransferase enzymes arising from different unique genes transfer sialic acid residues in the same linkage onto the same acceptor, it is impossible to precisely det. which enzyme is involved in the obsd. phenotype based on enzymic assays.  We have developed a very sensitive and highly reproducible multiplex reverse transcriptase-polymerase chain reaction technique in order to monitor the expression of four human sialyltransferases genes ST6Gal I, ST3Gal I, ST3Gal III and ST3GaL IV in small cell samples.  Multiplex PCR amplification using specific primers for each sialyltransferase and detection of amplification products by PAGE is a method that is fast and easy to handle and has proven to be useful for establishing sialyltransferase patterns of expression in breast immortalized cell line HBL 100 as well as in breast cancer cell lines MCF-7/6, MCF-7/AZ and MDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRIkb5nv21nrVg90H21EOLACvtfcHk0linLBXHjDhXng"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK1cXhs1WmsLw%253D&amp;md5=34e9db11dbc2af4ea3c51531448be7e6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006983214918&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006983214918%26sid%3Dliteratum%253Aachs%26aulast%3DRecchi%26aufirst%3DM.%2BA.%26aulast%3DHarduin-Lepers%26aufirst%3DA.%26aulast%3DBoilly-Marer%26aufirst%3DY.%26aulast%3DVerbert%26aufirst%3DA.%26aulast%3DDelannoy%26aufirst%3DP.%26atitle%3DMultiplex%2520RT-PCR%2520method%2520for%2520the%2520analysis%2520of%2520the%2520expression%2520of%2520human%2520sialyltransferases%253A%2520application%2520to%2520breast%2520cancer%2520cells%26jtitle%3DGlycoconjugate%2520J.%26date%3D1998%26volume%3D15%26issue%3D1%26spage%3D19%26epage%3D27%26doi%3D10.1023%2FA%3A1006983214918" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">dos-Santos, P. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool</span>. <i>International journal of clinical and experimental pathology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2337</span>– <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24966944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2cfmvFeisQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2014&amp;pages=2337-2349&amp;issue=5&amp;author=P.+B.+dos-Santos&amp;title=Lectin+histochemistry+reveals+SNA+as+a+prognostic+carbohydrate-dependent+probe+for+invasive+ductal+carcinoma+of+the+breast%3A+a+clinicopathological+and+immunohistochemical+auxiliary+tool" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool</span></div><div class="casAuthors">dos-Santos Petra B; Vieira-de-Mello Gabriela S; Zanetti Juliana S; Ribeiro-Silva A Alfredo; Rego Moacyr B M; Beltrao Eduardo Isidoro Carneiro</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2337-49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased sialylation and β1,6-branched oligosaccharides has been associated with a variety of structural changes in cell surface carbohydrates, most notably in tumorigenesis.  Lectins are defined as proteins that preferentially recognize and bind carbohydrate complexes protruding from glycolipids and glycoproteins.  This interaction with carbohydrates can be as specific as the interaction between antigen and antibody.  Due to this type of interaction lectins have been used as experimental auxiliary tools in histopathological diagnosis of cancer.  This study was designed to evaluate the differential expression of sialic acids and β1,6-N-acetylglucosaminyltransferase V (MGAT5) in invasive (IDC) and in situ (DCIS) ductal carcinoma of the breast and its possible application as prognostic biomarkers.  A possible transition between pre-malign and malign lesions was evaluated using DCIS samples.  Biopsies were analyzed regarding the expression of MUC1, p53, Ki-67, estrogen receptor, progesterone receptor, HER-2 and MGAT5. α2,6-linked sialic acids residues recognized by SNA lectin was overexpressed in 33.3% of IDC samples and it was related with Ki-67 (p=0.042), PR (p=0.029), lymphnodes status (p=0.017) and death (p=0.011).  Regarding survival analysis SNA was the only lectin able to correlate with specific-disease survival and disease-free survival (p=0.024 and p=0.041, respectively), besides, it presents itself as an independent variable by Cox Regression analysis (p= 0.004).  Comparing IDC and DCIS cases, only SNA showed different staining pattern (p=0.034).  The presence of sialic acids on tumor cell surface can be an indicative of poor prognosis and our study provides further evidence that SNA lectin can be used as a prognostic probe in IDC and DCIS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREjKhcKo39aLmQt-ICR3qNfW6udTcc2eYdNwzVvLE9H7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2cfmvFeisQ%253D%253D&amp;md5=f70c8693719bb839ef6e13e40913a84b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Ddos-Santos%26aufirst%3DP.%2BB.%26atitle%3DLectin%2520histochemistry%2520reveals%2520SNA%2520as%2520a%2520prognostic%2520carbohydrate-dependent%2520probe%2520for%2520invasive%2520ductal%2520carcinoma%2520of%2520the%2520breast%253A%2520a%2520clinicopathological%2520and%2520immunohistochemical%2520auxiliary%2520tool%26jtitle%3DInternational%2520journal%2520of%2520clinical%2520and%2520experimental%2520pathology%26date%3D2014%26volume%3D7%26issue%3D5%26spage%3D2337%26epage%3D2349" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolarich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. P.</span></span> <span> </span><span class="NLM_article-title">Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">906</span>, <span class="refDoi">&nbsp;DOI: 10.1007/s13361-013-0610-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1007%2Fs13361-013-0610-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=23605685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWnu74%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=24&amp;publication_year=2013&amp;pages=895-906&amp;issue=6&amp;author=A.+V.+Everest-Dassauthor=J.+L.+Abrahamsauthor=D.+Kolarichauthor=N.+H.+Packerauthor=M.+P.+Campbell&amp;title=Structural+feature+ions+for+distinguishing+N-+and+O-linked+glycan+isomers+by+LC-ESI-IT+MS%2FMS&amp;doi=10.1007%2Fs13361-013-0610-4" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Feature Ions for Distinguishing N- and O-Linked Glycan Isomers by LC-ESI-IT MS/MS</span></div><div class="casAuthors">Everest-Dass, Arun V.; Abrahams, Jodie L.; Kolarich, Daniel; Packer, Nicolle H.; Campbell, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">895-906</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glycomics is the comprehensive study of glycan expression in an organism, cell, or tissue that relies on effective anal. technologies to understand glycan structure-function relationships.  Owing to the macro- and micro-heterogeneity of oligosaccharides, detailed structure characterization has required an orthogonal approach, such as a combination of specific exoglycosidase digestions, LC-MS/MS, and the development of bioinformatic resources to comprehensively profile a complex biol. sample.  Liq. chromatog.-electrospray ionization-mass spectrometry (LC-ESI-MS/MS) has emerged as a key tool in the structural anal. of oligosaccharides because of its high sensitivity, resoln., and robustness.  Here, we present a strategy that uses LC-ESI-MS/MS to characterize over 200 N- and O-glycans from human saliva glycoproteins, complemented by sequential exoglycosidase treatment, to further verify the annotated glycan structures.  Fragment-specific substructure diagnostic ions were collated from an extensive screen of the literature available on the detailed structural characterization of oligosaccharides and, together with other specific glycan structure feature ions derived from cross-ring and glycosidic-linkage fragmentation, were used to characterize the glycans and differentiate isomers.  The availability of such annotated mass spectrometric fragmentation spectral libraries of glycan structures, together with such substructure diagnostic ions, will be key inputs for the future development of the automated elucidation of oligosaccharide structures from MS/MS data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRDmrLxquDobVg90H21EOLACvtfcHk0linLBXHjDhXng"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWnu74%253D&amp;md5=c95e05a8b094cfbe74d5ff369492122a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs13361-013-0610-4&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13361-013-0610-4%26sid%3Dliteratum%253Aachs%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26aulast%3DAbrahams%26aufirst%3DJ.%2BL.%26aulast%3DKolarich%26aufirst%3DD.%26aulast%3DPacker%26aufirst%3DN.%2BH.%26aulast%3DCampbell%26aufirst%3DM.%2BP.%26atitle%3DStructural%2520feature%2520ions%2520for%2520distinguishing%2520N-%2520and%2520O-linked%2520glycan%2520isomers%2520by%2520LC-ESI-IT%2520MS%252FMS%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2013%26volume%3D24%26issue%3D6%26spage%3D895%26epage%3D906%26doi%3D10.1007%2Fs13361-013-0610-4" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anugraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, N. H.</span></span> <span> </span><span class="NLM_article-title">A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">561</span>, <span class="refDoi">&nbsp;DOI: 10.1002/rcm.7130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1002%2Frcm.7130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26212272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsl2ltLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=29&amp;publication_year=2015&amp;pages=545-561&amp;issue=7&amp;author=M.+Anugrahamauthor=A.+V.+Everest-Dassauthor=F.+Jacobauthor=N.+H.+Packer&amp;title=A+platform+for+the+structural+characterization+of+glycans+enzymatically+released+from+glycosphingolipids+extracted+from+tissue+and+cells&amp;doi=10.1002%2Frcm.7130" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells</span></div><div class="casAuthors">Anugraham, Merrina; Everest-Dass, Arun Vijay; Jacob, Francis; Packer, Nicolle H.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">545-561</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley &amp; Sons Ltd.</span>)
        </div><div class="casAbstract">Glycosphingolipids (GSLs) constitute a highly diverse class of glyco-conjugates which are involved in many aspects of cell membrane function and disease.  The isolation, detection and structural characterization of the carbohydrate (glycan) component of GSLs are particularly challenging given their structural heterogeneity and thus rely on the development of sensitive, anal. technologies.  Neutral and acidic GSL stds. were immobilized onto polyvinylidene difluoride (PVDF) membranes and glycans were enzymically released using endoglycoceramidase II (EGCase II), sepd. by porous graphitized carbon (PGC) liq. chromatog. and structurally characterized by neg. ion mode electrospray ionization tandem mass spectrometry (PGC-LC/ESI-MS/MS).  This approach was then employed for GSLs isolated from 100 mg of serous and endometrioid cancer tissue and from cell line (107 cells) samples.  Glycans were released from GSL stds. comprised of ganglio-, asialo-ganglio- and the relatively resistant globo-series glycans, using as little as 1 mU of enzyme and 2 μg of GSL.  The platform of anal. was then applied to GSLs isolated from tissue and cell line samples and the released isomeric and isobaric glycan structures were chromatog. resolved on PGC and characterized by comparison with the MS2 fragment ion spectra of the glycan stds. and by application of known structural MS2 fragment ions.  This approach identified several (neo-)lacto-, globo- and ganglio-series glycans and facilitated the discrimination of isomeric structures contg. Lewis A, H type 1 and type 2 blood group antigens and sialyl-tetraosylceramides.  Thus, the authors describe a relatively simple, detergent-free, enzymic release of glycans from PVDF-immobilized GSLs, followed by the detailed structural anal. afforded by PGC-LC-ESI-MS/MS, to offer a versatile method for the anal. of tumor and cell-derived GSL-glycans.  The method uses the potential of MS2 fragmentation in neg. ion ESI mode to characterize, in detail, the biol. relevant glycan structures derived from GSLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg26oLtoZ6CrVg90H21EOLACvtfcHk0lgwJ9fdlUGTZQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXnsl2ltLc%253D&amp;md5=3b57e3a5e6bb1e56c4cbcf351c166d4f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Frcm.7130&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.7130%26sid%3Dliteratum%253Aachs%26aulast%3DAnugraham%26aufirst%3DM.%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26aulast%3DJacob%26aufirst%3DF.%26aulast%3DPacker%26aufirst%3DN.%2BH.%26atitle%3DA%2520platform%2520for%2520the%2520structural%2520characterization%2520of%2520glycans%2520enzymatically%2520released%2520from%2520glycosphingolipids%2520extracted%2520from%2520tissue%2520and%2520cells%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D545%26epage%3D561%26doi%3D10.1002%2Frcm.7130" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, K.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>160</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">277</span>, <span class="refDoi">&nbsp;DOI: 10.1083/jcb.200209006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1083%2Fjcb.200209006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12527751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntValtg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=160&amp;publication_year=2003&amp;pages=267-277&amp;issue=2&amp;author=K.+Wolf&amp;title=Compensation+mechanism+in+tumor+cell+migration%3A+mesenchymal-amoeboid+transition+after+blocking+of+pericellular+proteolysis&amp;doi=10.1083%2Fjcb.200209006" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis</span></div><div class="casAuthors">Wolf, Katarina; Mazo, Irina; Leung, Harry; Engelke, Katharina; von Andrian, Ulrich H.; Deryugina, Elena I.; Strongin, Alex Y.; Brocker, Eva-B.; Friedl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Invasive tumor dissemination in vitro and in vivo involves the proteolytic degrdn. of ECM barriers.  This process, however, is only incompletely attenuated by protease inhibitor-based treatment, suggesting the existence of migratory compensation strategies.  In three-dimensional collagen matrixes, spindle-shaped proteolytically potent HT-1080 fibrosarcoma and MDA-MB-231 carcinoma cells exhibited a constitutive mesenchymal-type movement including the coclustering of β1 integrins and MT1-matrix metalloproteinase (MMP) at fiber binding sites and the generation of tube-like proteolytic degrdn. tracks.  Near-total inhibition of MMPs, serine proteases, cathepsins, and other proteases, however, induced a conversion toward spherical morphol. at near undiminished migration rates.  Sustained protease-independent migration resulted from a flexible amoeba-like shape change, i.e., propulsive squeezing through preexisting matrix gaps and formation of constriction rings in the absence of matrix degrdn., concomitant loss of clustered β1 integrins and MT1-MMP from fiber binding sites, and a diffuse cortical distribution of the actin cytoskeleton.  Acquisition of protease-independent amoeboid dissemination was confirmed for HT-1080 cells injected into the mouse dermis monitored by intravital multiphoton microscopy.  In conclusion, the transition from proteolytic mesenchymal toward nonproteolytic amoeboid movement highlights a supramol. plasticity mechanism in cell migration and further represents a putative escape mechanism in tumor cell dissemination after abrogation of pericellular proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZ7CU1-dKYLVg90H21EOLACvtfcHk0lgwJ9fdlUGTZQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3sXntValtg%253D%253D&amp;md5=a0142d3cd1f3875bdf38bbc791f84f00</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200209006&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200209006%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DK.%26atitle%3DCompensation%2520mechanism%2520in%2520tumor%2520cell%2520migration%253A%2520mesenchymal-amoeboid%2520transition%2520after%2520blocking%2520of%2520pericellular%2520proteolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D160%26issue%3D2%26spage%3D267%26epage%3D277%26doi%3D10.1083%2Fjcb.200209006" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussos, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condeelis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patsialou, A.</span></span> <span> </span><span class="NLM_article-title">Chemotaxis in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">587</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrc3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrc3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=21779009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqu7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2011&amp;pages=573-587&amp;issue=8&amp;author=E.+T.+Roussosauthor=J.+S.+Condeelisauthor=A.+Patsialou&amp;title=Chemotaxis+in+cancer&amp;doi=10.1038%2Fnrc3078" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotaxis in cancer</span></div><div class="casAuthors">Roussos, Evanthia T.; Condeelis, John S.; Patsialou, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-587</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotaxis of tumor cells and stromal cells in the surrounding microenvironment is an essential component of tumor dissemination during progression and metastasis.  This Review summarizes how chemotaxis directs the different behaviors of tumor cells and stromal cells in vivo, how mol. pathways regulate chemotaxis in tumor cells and how chemotaxis choreographs cell behavior to shape the tumor microenvironment and to det. metastatic spread.  The central importance of chemotaxis in cancer progression is highlighted by discussion of the use of chemotaxis as a prognostic marker, a treatment end point and a target of therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZGjvz9RLTLVg90H21EOLACvtfcHk0lgwJ9fdlUGTZQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqu7k%253D&amp;md5=5e5add3b8567ced0d8593005f5dda63e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrc3078&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3078%26sid%3Dliteratum%253Aachs%26aulast%3DRoussos%26aufirst%3DE.%2BT.%26aulast%3DCondeelis%26aufirst%3DJ.%2BS.%26aulast%3DPatsialou%26aufirst%3DA.%26atitle%3DChemotaxis%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D8%26spage%3D573%26epage%3D587%26doi%3D10.1038%2Fnrc3078" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pally, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramanik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span> <span> </span><span class="NLM_article-title">An Interplay Between Reaction-Diffusion and Cell-Matrix Adhesion Regulates Multiscale Invasion in Early Breast Carcinomatosis</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">790</span>, <span class="refDoi">&nbsp;DOI: 10.3389/fphys.2019.00790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3389%2Ffphys.2019.00790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31456688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MritlGnug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=10&amp;publication_year=2019&amp;pages=790&amp;author=D.+Pallyauthor=D.+Pramanikauthor=R.+Bhat&amp;title=An+Interplay+Between+Reaction-Diffusion+and+Cell-Matrix+Adhesion+Regulates+Multiscale+Invasion+in+Early+Breast+Carcinomatosis&amp;doi=10.3389%2Ffphys.2019.00790" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">An Interplay Between Reaction-Diffusion and Cell-Matrix Adhesion Regulates Multiscale Invasion in Early Breast Carcinomatosis</span></div><div class="casAuthors">Pally Dharma; Pramanik Durjay; Bhat Ramray</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">790</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">The progression of cancer in the breast involves multiple reciprocal interactions between malignantly transformed epithelia, surrounding untransformed but affected stromal cells, and the extracellular matrix (ECM) that is remodeled during the process.  A quantitative understanding of the relative contribution of such interactions to phenotypes associated with cancer cells can be arrived at through the construction of increasingly complex experimental and computational models.  Herein, we introduce a multiscale three-dimensional (3D) organo- and pathotypic experimental assay that approximates, to an unprecedented extent, the histopathological complexity of a tumor disseminating into its surrounding stromal milieu via both bulk and solitary motility dynamics.  End point and time-lapse microscopic observations of this assay allow us to study the earliest steps of cancer invasion as well as the dynamical interactions between the epithelial and stromal compartments.  We then simulate our experimental observations using the modeling environment Compucell3D that is based on the Glazier-Graner-Hogeweg model.  The computational model, which comprises adhesion between cancer cells and the matrices, cell proliferation and apoptosis, and matrix remodeling through reaction-diffusion-based morphogen dynamics, is first trained to phenocopy controls run with the experimental model, wherein one or the other matrices have been removed.  The trained computational model successfully predicts phenotypes of the experimental counterparts that are subjected to pharmacological treatments (inhibition of N-linked glycosylation and matrix metalloproteinase activity) and scaffold modulation (alteration of collagen density).  Further parametric exploration-based simulations suggest that specific permissive regimes of cell-cell and cell-matrix adhesions, operating in the context of a reaction-diffusion-regulated ECM dynamics, promote multiscale invasion of breast cancer cells and determine the extent to which the latter migrate through their surrounding stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrPMdFlkaVVKqcneEtCi92fW6udTcc2ea2IsX0ZD4fNrntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MritlGnug%253D%253D&amp;md5=59032af92ede895ef6c4d9ed669ccb33</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2019.00790&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2019.00790%26sid%3Dliteratum%253Aachs%26aulast%3DPally%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DD.%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DAn%2520Interplay%2520Between%2520Reaction-Diffusion%2520and%2520Cell-Matrix%2520Adhesion%2520Regulates%2520Multiscale%2520Invasion%2520in%2520Early%2520Breast%2520Carcinomatosis%26jtitle%3DFront.%2520Physiol.%26date%3D2019%26volume%3D10%26spage%3D790%26doi%3D10.3389%2Ffphys.2019.00790" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swat, M. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Multi-scale modeling of tissues using CompuCell3D</span>. <i>Methods Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">366</span>, <span class="refDoi">&nbsp;DOI: 10.1016/B978-0-12-388403-9.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2FB978-0-12-388403-9.00013-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=22482955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC38rjtVWmtA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=110&amp;publication_year=2012&amp;pages=325-366&amp;author=M.+H.+Swat&amp;title=Multi-scale+modeling+of+tissues+using+CompuCell3D&amp;doi=10.1016%2FB978-0-12-388403-9.00013-8" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-scale modeling of tissues using CompuCell3D</span></div><div class="casAuthors">Swat Maciej H; Thomas Gilberto L; Belmonte Julio M; Shirinifard Abbas; Hmeljak Dimitrij; Glazier James A</div><div class="citationInfo"><span class="NLM_cas:title">Methods in cell biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">325-66</span>
        ISSN:<span class="NLM_cas:issn">0091-679X</span>.
    </div><div class="casAbstract">The study of how cells interact to produce tissue development, homeostasis, or diseases was, until recently, almost purely experimental.  Now, multi-cell computer simulation methods, ranging from relatively simple cellular automata to complex immersed-boundary and finite-element mechanistic models, allow in silico study of multi-cell phenomena at the tissue scale based on biologically observed cell behaviors and interactions such as movement, adhesion, growth, death, mitosis, secretion of chemicals, chemotaxis, etc.  This tutorial introduces the lattice-based Glazier-Graner-Hogeweg (GGH) Monte Carlo multi-cell modeling and the open-source GGH-based CompuCell3D simulation environment that allows rapid and intuitive modeling and simulation of cellular and multi-cellular behaviors in the context of tissue formation and subsequent dynamics.  We also present a walkthrough of four biological models and their associated simulations that demonstrate the capabilities of the GGH and CompuCell3D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStC5HD2PcSO1HFYivNCdPRfW6udTcc2eZ3f0y8qsGDibntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC38rjtVWmtA%253D%253D&amp;md5=066d92984b194f748c0a24791efdf5e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-388403-9.00013-8&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-388403-9.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DSwat%26aufirst%3DM.%2BH.%26atitle%3DMulti-scale%2520modeling%2520of%2520tissues%2520using%2520CompuCell3D%26jtitle%3DMethods%2520Cell%2520Biol.%26date%3D2012%26volume%3D110%26spage%3D325%26epage%3D366%26doi%3D10.1016%2FB978-0-12-388403-9.00013-8" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, J. P.</span></span> <span> </span><span class="NLM_article-title">Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the sigma1 Cell Attachment Protein and Can Be Overcome by Mutation of sigma1</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">01380-19</span>, <span class="refDoi">&nbsp;DOI: 10.1128/JVI.01380-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1128%2FJVI.01380-19" title="">Crossref</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=93&amp;publication_year=2019&amp;pages=01380-19&amp;issue=22&amp;author=J.+P.+Fernandes&amp;title=Breast+Tumor-Associated+Metalloproteases+Restrict+Reovirus+Oncolysis+by+Cleaving+the+sigma1+Cell+Attachment+Protein+and+Can+Be+Overcome+by+Mutation+of+sigma1&amp;doi=10.1128%2FJVI.01380-19" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FJVI.01380-19&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01380-19%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DJ.%2BP.%26atitle%3DBreast%2520Tumor-Associated%2520Metalloproteases%2520Restrict%2520Reovirus%2520Oncolysis%2520by%2520Cleaving%2520the%2520sigma1%2520Cell%2520Attachment%2520Protein%2520and%2520Can%2520Be%2520Overcome%2520by%2520Mutation%2520of%2520sigma1%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26issue%3D22%26spage%3D01380-19%26doi%3D10.1128%2FJVI.01380-19" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. Y.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">483</span>, <span class="refDoi">&nbsp;DOI: 10.1158/0008-5472.CAN-10-1303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1158%2F0008-5472.CAN-10-1303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=21224350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKlsg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=71&amp;publication_year=2011&amp;pages=473-483&amp;issue=2&amp;author=J.+Y.+Chen&amp;title=A+novel+sialyltransferase+inhibitor+suppresses+FAK%2Fpaxillin+signaling+and+cancer+angiogenesis+and+metastasis+pathways&amp;doi=10.1158%2F0008-5472.CAN-10-1303" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways</span></div><div class="casAuthors">Chen, Jia-Yang; Tang, Yen-An; Huang, Sin-Ming; Juan, Hsueh-Fen; Wu, Li-Wha; Sun, Ying-Chieh; Wang, Szu-Chi; Wu, Kuan-Wei; Balraj, Gopula; Chang, Tzu-Ting; Li, Wen-Shan; Cheng, Hung-Chi; Wang, Yi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">473-483</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increased sialyltransferase (ST) activity promotes cancer cell metastasis, and overexpression of cell surface sialic acid correlates with poor prognosis in cancer patients.  To seek therapies targeting metastasis for cancer treatment, the authors developed a novel ST inhibitor, Lith-O-Asp, and investigated its antimetastatic and antiangiogenic effects and mechanisms.  The authors found that cells treated with Lith-O-Asp showed a redn. of activity on various ST enzymes by in vitro and cell-based activity analyses.  Lith-O-Asp inhibited migration and invasion abilities in various cancer cell lines and showed inhibitory effect on the angiogenic activity of human umbilical vein endothelial cells.  Indeed, Lith-O-Asp treatment consequently delayed cancer cell metastasis in exptl. and spontaneous metastasis assays in animal models.  Importantly, Lith-O-Asp decreased the sialic acid modification of integrin-β1 and inhibited the expression of phospho-FAK, phospho-paxillin, and the matrix metalloprotease (MMP) 2 and MMP9.  Lith-O-Asp attenuated the Rho GTPase activity leading to actin dynamic impairment.  In addn., 2DE-MS/MS and immunoblotting analyses showed that Lith-O-Asp altered the protein expression level and phosphorylation status of various proteins involved in crucial metastasis and angiogenesis pathways such as vimentin and RNase/angiogenin inhibitor RNH1.  Furthermore, Lith-O-Asp treatment significantly inhibited the invasive ability exerted by ectopic overexpression of various ST enzymes catalyzing α-2,6- or α-2,3-sialylation.  The authors' results provide compelling evidence that the potential pan-ST inhibitor, Lith-O-Asp, suppressed cancer cell metastasis likely by inhibiting FAK/paxillin signaling and expressing anti-angiogenesis factors.  Lith-O-Asp is worthy for further testing as a novel anti-metastasis drug for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHsvswFr4pJrVg90H21EOLACvtfcHk0lgVjwdRDW9Kww"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKlsg%253D%253D&amp;md5=85a6f8640aee350afc36180d7765a3ab</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1303&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1303%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BY.%26atitle%3DA%2520novel%2520sialyltransferase%2520inhibitor%2520suppresses%2520FAK%252Fpaxillin%2520signaling%2520and%2520cancer%2520angiogenesis%2520and%2520metastasis%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D2%26spage%3D473%26epage%3D483%26doi%3D10.1158%2F0008-5472.CAN-10-1303" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Expression of N-Acetylglucosaminyltransferase III Suppresses alpha2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to alpha2,6-Sialylation Levels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5708</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M115.712836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M115.712836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26801611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFKhsbY%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=291&amp;publication_year=2016&amp;pages=5708-5720&amp;issue=11&amp;author=J.+Lu&amp;title=Expression+of+N-Acetylglucosaminyltransferase+III+Suppresses+alpha2%2C3-Sialylation%2C+and+Its+Distinctive+Functions+in+Cell+Migration+Are+Attributed+to+alpha2%2C6-Sialylation+Levels&amp;doi=10.1074%2Fjbc.M115.712836" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels</span></div><div class="casAuthors">Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Kameyama, Akihiko; Gu, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5708-5720</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Acetylglucosaminyltransferase III (GnT-III), which catalyzes the addn. of the bisecting GlcNAc branch on N-glycans, is usually described as a metastasis suppressor.  Overexpression of GnT-III inhibited migration in multiple types of tumor cells.  However, these results seem controversial to the clin. observations for the increased expression of GnT-III in human hepatomas, glioma, and ovarian cancers.  Here, we present evidence that these inconsistencies are mainly attributed to the different expression pattern of cell sialylation.  In detail, we show that overexpression of GnT-III significantly inhibits α2,3-sialylation but not α2,6-sialylation.  The migratory ability of cells without or with a low level of α2,6-sialylation is consistently suppressed after GnT-III overexpression.  In contrast, the effects of GnT-III overexpression are variable in tumor cells that are highly α2,6-sialylated.  Overexpression of GnT-III promotes the cell migration in glioma cells U-251 and hepatoma cells HepG2, although it has little influence in human breast cancer cell MDA-MB-231 and gastric cancer cell MKN-45.  Interestingly, up-regulation of α2,6-sialylation by overexpressing β-galactoside α2,6-sialyltransferase 1 in the α2,6-hyposialylated HeLa-S3 cells abolishes the anti-migratory effects of GnT-III.  Conversely, depletion of α2,6-sialylation by knock-out of β-galactoside α2,6-sialyltranferase 1 in α2,6-hypersialylated HepG2 cells endows GnT-III with the anti-migratory ability.  Taken together, our data clearly demonstrate that high expression of α2,6-sialylation on the cell surface could affect the anti-migratory role of GnT-III, which provides an insight into the mechanistic roles of GnT-III in tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpezPxS1SpbGrVg90H21EOLACvtfcHk0lgVjwdRDW9Kww"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XjvFKhsbY%253D&amp;md5=bff582693ddcd9a4ee400490d2595de3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.712836&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.712836%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DExpression%2520of%2520N-Acetylglucosaminyltransferase%2520III%2520Suppresses%2520alpha2%252C3-Sialylation%252C%2520and%2520Its%2520Distinctive%2520Functions%2520in%2520Cell%2520Migration%2520Are%2520Attributed%2520to%2520alpha2%252C6-Sialylation%2520Levels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D11%26spage%3D5708%26epage%3D5720%26doi%3D10.1074%2Fjbc.M115.712836" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcel-Trullols, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi">&nbsp;DOI: 10.3892/ijo.28.5.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3892%2Fijo.28.5.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=16596233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cisr0%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2006&amp;pages=1173-1183&amp;issue=5&amp;author=J.+Carcel-Trullols&amp;title=Characterization+of+the+glycosylation+profile+of+the+human+breast+cancer+cell+line%2C+MDA-231%2C+and+a+bone+colonizing+variant&amp;doi=10.3892%2Fijo.28.5.1173" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant</span></div><div class="casAuthors">Carcel-Trullols, Jaime; Stanley, Joseph S.; Saha, Rinku; Shaaf, Saeid; Bendre, Manali S.; Monzavi-Karbassi, Behjatolah; Suva, Larry J.; Kieber-Emmons, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1183</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The mechanisms that guide organ-specific metastases are not fully established.  The aberrant expression of carbohydrates may play a fundamental role in defining the mol. mechanisms for metastases to distant organs and facilitate pos. interactions within the target organ.  The purpose of the present study was to det. the glycomic profile of a variant of the MDA-MB-231 breast cancer cell line that colonizes the bone and to ascribe mechanistic functions mediated by carbohydrates that might correlate with clin. bone metastases.  The carbohydrate expression profiles of osteolytic MDA-MET breast cancer cells and non-osteolytic parental MDA-MB-231 cells were detd.  MDA-MET cells were derived from MDA-MB-231 cells by in vivo selection of metastatic bone lesions following intracardiac inoculation.  The two related breast cancer cell lines expressed distinct carbohydrate profiles; MDA-MET cells displayed an increased expression of alpha (2,6) linked sialic acid, N-β1-6 GlcNAc, and sialylated Lewis-A antigen, and decreased expression of Galβ1,3GalNAc as detected using a combination of lectins and anti-carbohydrate antibodies.  Microarray anal. demonstrated an increased expression of glycosyltransferase genes, correlative for the distinct glycomic phenotype.  The altered glycomic phenotypes of MDA-MET cells include effects on the differential binding to bone marrow endothelial cells, enhanced ECM binding and an increase in invasive potential.  These data suggest that the glycomic phenotype of MDA-MET cells is assocd. with a select set of accumulated functions that collectively impact on the bone metastases and bone colonization capacity of breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovWg-3xpkHsbVg90H21EOLACvtfcHk0lgVjwdRDW9Kww"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cisr0%253D&amp;md5=ce1e5d34d4917f5fc7f250ab0653aec3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3892%2Fijo.28.5.1173&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.28.5.1173%26sid%3Dliteratum%253Aachs%26aulast%3DCarcel-Trullols%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520glycosylation%2520profile%2520of%2520the%2520human%2520breast%2520cancer%2520cell%2520line%252C%2520MDA-231%252C%2520and%2520a%2520bone%2520colonizing%2520variant%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26issue%3D5%26spage%3D1173%26epage%3D1183%26doi%3D10.3892%2Fijo.28.5.1173" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goupille, C.</span></span> <span> </span><span class="NLM_article-title">Sulfated Glycoaminoglycans and Proteoglycan Syndecan-4 Are Involved in Membrane Fixation of LL-37 and Its Pro-Migratory Effect in Breast Cancer Cells</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">481</span>, <span class="refDoi">&nbsp;DOI: 10.3390/biom9090481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3390%2Fbiom9090481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSntr3M" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=9&amp;publication_year=2019&amp;pages=481&amp;issue=9&amp;author=C.+Habesauthor=G.+Weberauthor=C.+Goupille&amp;title=Sulfated+Glycoaminoglycans+and+Proteoglycan+Syndecan-4+Are+Involved+in+Membrane+Fixation+of+LL-37+and+Its+Pro-Migratory+Effect+in+Breast+Cancer+Cells&amp;doi=10.3390%2Fbiom9090481" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated glycoaminoglycans and proteoglycan syndecan-4 are involved in membrane fixation of LL-37 and its pro-migratory effect in breast cancer cells</span></div><div class="casAuthors">Habes, Chahrazed; Weber, Gunther; Goupille, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">481</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Initially characterized by its antimicrobial activities, LL-37 has also been shown to significantly contribute to tumor development.  On breast cancer cell lines, LL-37 increases intracellular calcium via the TRPV2 channel and their migration via the activation of PI3K/AKT signaling.  Its all-d enantiomer D-LL-37 induces similar effects, which excludes a protein-protein interaction of LL-37 in a classic ligan D-receptor manner.  Its net charge of +6 gave rise to the hypothesis that the peptide uses the neg. charges of sulfoglycans or sialic acids to facilitate its attachment to the cell membrane and to induce its activities.  Whereas several vegetal lectins, specifically attaching to sialylated or sulfated structures, blocked the activities of LL-37 on both calcium increase and cell migration, several sialidases had no effect.  However, the competitive use of free sulfated glycoaminoglycans (GAGs) as chrondroitin and heparin, or treatment of the cell surface with chondroitinase and heparinase resulted in an activity loss of 50-100% for LL-37.  Concordant results were obtained by blocking the synthesis of GAGs with 4-Methylumbelliferyl-fi-D-xyloside, and by suppression of glycan sulfatation by sodium chlorate.  Using a candidate approach by suppressing proteoglycan synthesis using RNA interference, syndecan-4 was shown to be required for the activities of LL-37 and its binding to the cell surface.  This leads to the conclusion that syndecan-4, by means of sulfated GAGs, could act as a receptor for LL-37.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquuGdM51aDa7Vg90H21EOLACvtfcHk0liGsfDqDPU38w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXitFSntr3M&amp;md5=2153324d0f705c723796d8ec54f47229</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fbiom9090481&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9090481%26sid%3Dliteratum%253Aachs%26aulast%3DHabes%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DG.%26aulast%3DGoupille%26aufirst%3DC.%26atitle%3DSulfated%2520Glycoaminoglycans%2520and%2520Proteoglycan%2520Syndecan-4%2520Are%2520Involved%2520in%2520Membrane%2520Fixation%2520of%2520LL-37%2520and%2520Its%2520Pro-Migratory%2520Effect%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26issue%3D9%26spage%3D481%26doi%3D10.3390%2Fbiom9090481" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankenbauer, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmeland, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells</span>. <i>J. Ovarian Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>, <span class="refDoi">&nbsp;DOI: 10.1186/s13048-019-0574-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1186%2Fs13048-019-0574-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31610800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MnnslSgsA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2019&amp;pages=93&amp;issue=1&amp;author=K.+A.+Dorsettauthor=R.+B.+Jonesauthor=K.+E.+Ankenbauerauthor=A.+B.+Hjelmelandauthor=S.+L.+Bellis&amp;title=Sox2+promotes+expression+of+the+ST6Gal-I+glycosyltransferase+in+ovarian+cancer+cells&amp;doi=10.1186%2Fs13048-019-0574-5" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells</span></div><div class="casAuthors">Dorsett Kaitlyn A; Jones Robert B; Ankenbauer Katherine E; Hjelmeland Anita B; Bellis Susan L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of ovarian research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The ST6Gal-I glycosyltransferase, which adds α2-6-linked sialic acids to N-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer.  Prior studies have shown that ST6Gal-I-mediated sialylation of select surface receptors remodels intracellular signaling to impart cancer stem cell (CSC) characteristics.  However, the mechanisms that contribute to ST6Gal-I expression in stem-like cancer cells are poorly understood.  RESULTS:  Herein, we identify the master stem cell transcription factor, Sox2, as a novel regulator of ST6Gal-I expression.  Interestingly, SOX2 and ST6GAL1 are located within the same tumor-associated amplicon, 3q26, and these two genes exhibit coordinate gains in copy number across multiple cancers including ~ 25% of ovarian serious adenocarcinomas.  In conjunction with genetic co-amplification, our studies suggest that Sox2 directly binds the ST6GAL1 promoter to drive transcription.  ST6Gal-I expression is directed by at least four distinct promoters, and we identified the P3 promoter as the predominant promoter utilized by ovarian cancer cells.  Chromatin Immunoprecipitation (ChIP) assays revealed that Sox2 binds regions proximal to the P3 promoter.  To confirm that Sox2 regulates ST6Gal-I expression, Sox2 was either overexpressed or knocked-down in various ovarian cancer cell lines.  Sox2 overexpression induced an increase in ST6Gal-I mRNA and protein, as well as surface α2-6 sialylation, whereas Sox2 knock-down suppressed levels of ST6Gal-I mRNA, protein and surface α2-6 sialylation.  CONCLUSIONS:  These data suggest a process whereby SOX2 and ST6GAL1 are coordinately amplified in cancer cells, with the Sox2 protein then binding the ST6GAL1 promoter to further augment ST6Gal-I expression.  Our collective results provide new insight into mechanisms that upregulate ST6Gal-I expression in ovarian cancer cells, and also point to the possibility that some of the CSC characteristics commonly attributed to Sox2 may, in part, be mediated through the sialyltransferase activity of ST6Gal-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsIuvAgLLgckewzGPswiWOfW6udTcc2eaRLezf3F8sfbntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MnnslSgsA%253D%253D&amp;md5=801bb5c941106ba2a5a16e13003f79f3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs13048-019-0574-5&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13048-019-0574-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BB.%26aulast%3DAnkenbauer%26aufirst%3DK.%2BE.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DSox2%2520promotes%2520expression%2520of%2520the%2520ST6Gal-I%2520glycosyltransferase%2520in%2520ovarian%2520cancer%2520cells%26jtitle%3DJ.%2520Ovarian%2520Res.%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D93%26doi%3D10.1186%2Fs13048-019-0574-5" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilina, O.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41556-020-0552-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41556-020-0552-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=32839548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB38fpvVGisg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2020&amp;pages=1103-1115&amp;issue=9&amp;author=O.+Ilina&amp;title=Cell-cell+adhesion+and+3D+matrix+confinement+determine+jamming+transitions+in+breast+cancer+invasion&amp;doi=10.1038%2Fs41556-020-0552-6" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion</span></div><div class="casAuthors">Ilina Olga; Gritsenko Pavlo G; Vullings Manon; Bakker Gert-Jan; Friedl Peter; Syga Simon; Starruss Jorn; Deutsch Andreas; Lippoldt Jurgen; Grosser Steffen; Kas Josef A; La Porta Caterina A M; Zapperi Stefano; La Porta Caterina A M; La Porta Caterina A M; Chepizhko Oleksandr; Bult Peter; Zapperi Stefano; Zapperi Stefano; Friedl Peter; Friedl Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature cell biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasticity of cancer invasion and metastasis depends on the ability of cancer cells to switch between collective and single-cell dissemination, controlled by cadherin-mediated cell-cell junctions.  In clinical samples, E-cadherin-expressing and -deficient tumours both invade collectively and metastasize equally, implicating additional mechanisms controlling cell-cell cooperation and individualization.  Here, using spatially defined organotypic culture, intravital microscopy of mammary tumours in mice and in silico modelling, we identify cell density regulation by three-dimensional tissue boundaries to physically control collective movement irrespective of the composition and stability of cell-cell junctions.  Deregulation of adherens junctions by downregulation of E-cadherin and p120-catenin resulted in a transition from coordinated to uncoordinated collective movement along extracellular boundaries, whereas single-cell escape depended on locally free tissue space.  These results indicate that cadherins and extracellular matrix confinement cooperate to determine unjamming transitions and stepwise epithelial fluidization towards, ultimately, cell individualization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWuAyF9xu4Q8vLc4ARHEmzfW6udTcc2eaRLezf3F8sfbntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB38fpvVGisg%253D%253D&amp;md5=e6b0a7c6c2bead4b8b46642ddb84d85b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41556-020-0552-6&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41556-020-0552-6%26sid%3Dliteratum%253Aachs%26aulast%3DIlina%26aufirst%3DO.%26atitle%3DCell-cell%2520adhesion%2520and%25203D%2520matrix%2520confinement%2520determine%2520jamming%2520transitions%2520in%2520breast%2520cancer%2520invasion%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2020%26volume%3D22%26issue%3D9%26spage%3D1103%26epage%3D1115%26doi%3D10.1038%2Fs41556-020-0552-6" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oswald, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kas, J. A.</span></span> <span> </span><span class="NLM_article-title">Jamming transitions in cancer</span>. <i>J. Phys. D: Appl. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">483001</span>, <span class="refDoi">&nbsp;DOI: 10.1088/1361-6463/aa8e83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1088%2F1361-6463%2Faa8e83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29628530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Wnsrs%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=50&amp;publication_year=2017&amp;pages=483001&amp;issue=48&amp;author=L.+Oswaldauthor=S.+Grosserauthor=D.+M.+Smithauthor=J.+A.+Kas&amp;title=Jamming+transitions+in+cancer&amp;doi=10.1088%2F1361-6463%2Faa8e83" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Jamming transitions in cancer</span></div><div class="casAuthors">Oswald, Linda; Grosser, Steffen; Smith, David M.; Kas, Josef A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics D: Applied Physics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">483001/1-483001/17</span>CODEN:
                <span class="NLM_cas:coden">JPAPBE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3727</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">The traditional picture of tissues, where they are treated as liqs. defined by properties such as surface tension or viscosity has been redefined during the last few decades by the more fundamental question: under which conditions do tissues display liq.-like or solid-like behavior.  As a result, basic concepts arising from the treatment of tissues as solid matter, such as cellular jamming and glassy tissues, have shifted into the current focus of biophys. research.  Here, we review recent works examg. the phase states of tissue with an emphasis on jamming transitions in cancer.  When metastasis occurs, cells gain the ability to leave the primary tumor and infiltrate other parts of the body.  Recent studies have shown that a linkage between an unjamming transition and tumor progression indeed exists, which could be of importance when designing surgery and treatment approaches for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-zuyf_LYjZbVg90H21EOLACvtfcHk0liGsfDqDPU38w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXot1Wnsrs%253D&amp;md5=f373cafd2c785090ff912f0c511d11fb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1088%2F1361-6463%2Faa8e83&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1361-6463%252Faa8e83%26sid%3Dliteratum%253Aachs%26aulast%3DOswald%26aufirst%3DL.%26aulast%3DGrosser%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DKas%26aufirst%3DJ.%2BA.%26atitle%3DJamming%2520transitions%2520in%2520cancer%26jtitle%3DJ.%2520Phys.%2520D%253A%2520Appl.%2520Phys.%26date%3D2017%26volume%3D50%26issue%3D48%26spage%3D483001%26doi%3D10.1088%2F1361-6463%2Faa8e83" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, D. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">658</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.neo.2017.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.neo.2017.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=28732212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVKhurw%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2017&amp;pages=649-658&amp;issue=8&amp;author=D.+S.+Chandrashekar&amp;title=UALCAN%3A+A+Portal+for+Facilitating+Tumor+Subgroup+Gene+Expression+and+Survival+Analyses&amp;doi=10.1016%2Fj.neo.2017.05.002" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses</span></div><div class="casAuthors">Chandrashekar, Darshan S.; Bashel, Bhuwan; Balasubramanya, Sai Akshaya Hodigere; Creighton, Chad J.; Ponce-Rodriguez, Israel; Chakravarthi, Balabhadrapatruni V. S. K.; Varambally, Sooryanarayana</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-658</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1476-5586</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Genomics data from The Cancer Genome Atlas (TCGA) project has led to the comprehensive mol. characterization of multiple cancer types.  The large sample nos. in TCGA offer an excellent opportunity to address questions assocd. with tumo heterogeneity.  Exploration of the data by cancer researchers and clinicians is imperative to unearth novel therapeutic/diagnostic biomarkers.  Various computational tools have been developed to aid researchers in carrying out specific TCGA data analyses; however there is need for resources to facilitate the study of gene expression variations and survival assocns. across tumors.  Here, we report UALCAN, an easy to use, interactive web-portal to perform to in-depth analyses of TCGA gene expression data.  UALCAN uses TCGA level 3 RNA-seq and clin. data from 31 cancer types.  The portal's user-friendly features allow to perform: (1) analyze relative expression of a query gene(s) across tumor and normal samples, as well as in various tumor sub-groups based on individual cancer stages, tumor grade, race, body wt. or other clinicopathol. features, (2) est. the effect of gene expression level and clinicopathol. features on patient survival; and (3) identify the top over- and under-expressed (up and down-regulated) genes in individual cancer types.  This resource serves as a platform for in silico validation of target genes and for identifying tumor sub-group specific candidate biomarkers.  Thus, UALCAN web-portal could be extremely helpful in accelerating cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-tT7pr8pXeLVg90H21EOLACvtfcHk0ljlBdpQuKMX7Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXovVKhurw%253D&amp;md5=2f22a68f356f2739f01d69851c144359</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2017.05.002&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2017.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DChandrashekar%26aufirst%3DD.%2BS.%26atitle%3DUALCAN%253A%2520A%2520Portal%2520for%2520Facilitating%2520Tumor%2520Subgroup%2520Gene%2520Expression%2520and%2520Survival%2520Analyses%26jtitle%3DNeoplasia%26date%3D2017%26volume%3D19%26issue%3D8%26spage%3D649%26epage%3D658%26doi%3D10.1016%2Fj.neo.2017.05.002" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vukojicic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Precision glycocalyx editing as a strategy for cancer immunotherapy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10309</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.1608069113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.1608069113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27551071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2mtL%252FJ" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=113&amp;publication_year=2016&amp;pages=10304-10309&amp;issue=37&amp;author=H.+Xiaoauthor=E.+C.+Woodsauthor=P.+Vukojicicauthor=C.+R.+Bertozzi&amp;title=Precision+glycocalyx+editing+as+a+strategy+for+cancer+immunotherapy&amp;doi=10.1073%2Fpnas.1608069113" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Precision glycocalyx editing as a strategy for cancer immunotherapy</span></div><div class="casAuthors">Xiao, Han; Woods, Elliot C.; Vukojicic, Petar; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">10304-10309</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cell surface sialosides constitute a central axis of immune modulation that is exploited by tumors to evade both innate and adaptive immune destruction.  Therapeutic strategies that target tumor-assocd. sialosides may therefore potentiate antitumor immunity.  Here, we report the development of antibody-sialidase conjugates that enhance tumor cell susceptibility to antibody-dependent cell-mediated cytotoxicity (ADCC) by selective desialylation of the tumor cell glycocalyx.  We chem. fused a recombinant sialidase to the human epidermal growth factor receptor 2 (HER2)-specific antibody trastuzumab through a C-terminal aldehyde tag.  The antibody-sialidase conjugate desialylated tumor cells in a HER2-dependent manner, reduced binding by natural killer (NK) cell inhibitory sialic acid-binding Ig-like lectin (Siglec) receptors, and enhanced binding to the NK-activating receptor natural killer group 2D (NKG2D).  Sialidase conjugation to trastuzumab enhanced ADCC against tumor cells expressing moderate levels of HER2, suggesting a therapeutic strategy for cancer patients with lower HER2 levels or inherent trastuzumab resistance.  Precision glycocalyx editing with antibody-enzyme conjugates is therefore a promising avenue for cancer immune therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUHDVInbXFDbVg90H21EOLACvtfcHk0ljlBdpQuKMX7Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2mtL%252FJ&amp;md5=d7de30cbe941be8c80d0ceff3d850ce5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1608069113&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1608069113%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DE.%2BC.%26aulast%3DVukojicic%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DPrecision%2520glycocalyx%2520editing%2520as%2520a%2520strategy%2520for%2520cancer%2520immunotherapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D37%26spage%3D10304%26epage%3D10309%26doi%3D10.1073%2Fpnas.1608069113" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanczak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Gunten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laubli, H.</span></span> <span> </span><span class="NLM_article-title">Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">647</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cwx108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcwx108" title="">Crossref</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2017&amp;pages=640-647&amp;issue=9&amp;author=O.+J.+Adamsauthor=M.+A.+Stanczakauthor=S.+von+Guntenauthor=H.+Laubli&amp;title=Targeting+sialic+acid-Siglec+interactions+to+reverse+immune+suppression+in+cancer&amp;doi=10.1093%2Fglycob%2Fcwx108" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwx108&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwx108%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DO.%2BJ.%26aulast%3DStanczak%26aufirst%3DM.%2BA.%26aulast%3Dvon%2BGunten%26aufirst%3DS.%26aulast%3DLaubli%26aufirst%3DH.%26atitle%3DTargeting%2520sialic%2520acid-Siglec%2520interactions%2520to%2520reverse%2520immune%2520suppression%2520in%2520cancer%26jtitle%3DGlycobiology%26date%3D2017%26volume%3D28%26issue%3D9%26spage%3D640%26epage%3D647%26doi%3D10.1093%2Fglycob%2Fcwx108" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santegoets, K. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Houtum, E. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span> <span> </span><span class="NLM_article-title">Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">285</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.it.2020.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.it.2020.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=32139317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt12mtrc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=41&amp;publication_year=2020&amp;pages=274-285&amp;issue=4&amp;author=S.+van%0Ade+Wallauthor=K.+C.+M.+Santegoetsauthor=E.+J.+H.+van+Houtumauthor=C.+Bullauthor=G.+J.+Adema&amp;title=Sialoglycans+and+Siglecs+Can+Shape+the+Tumor+Immune+Microenvironment&amp;doi=10.1016%2Fj.it.2020.02.001" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment</span></div><div class="casAuthors">van de Wall, Stephanie; Santegoets, Kim C. M.; van Houtum, Eline J. H.; Buell, Christian; Adema, Gosse J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">274-285</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sialic acid sugar-carrying glycans, sialoglycans, are aberrantly expressed on many tumor cells and have emerged as potent regulatory mols. involved in creating a tumor-supportive microenvironment.  Sialoglycans can be recognized by sialic acid-binding Ig-like lectins (Siglecs), a family of immunomodulatory receptors.  Most mammalian Siglecs transmit inhibitory signals comparable with the immune checkpoint inhibitor programmed death protein 1 (PD-1), but some are activating.  Recent studies have shown that tumor cells can exploit sialoglycan-Siglec interactions to modulate immune cell function, contributing to an immunosuppressive tumor microenvironment (TME).  Interference with sialoglycan synthesis or sialoglycan-Siglec interactions might improve antitumor immunity.  Many questions regarding specificity, signaling, and regulatory function of sialoglycan-Siglec interactions remain.  We posit that sialoglycans and Siglecs present as potential glyco-immune 'checkpoints' for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBrLGhqrVDLVg90H21EOLACvtfcHk0ljlBdpQuKMX7Q"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BB3cXjt12mtrc%253D&amp;md5=5b58840c7281e0bebbe5563d55bbf4a6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2020.02.001&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2020.02.001%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWall%26aufirst%3DS.%26aulast%3DSantegoets%26aufirst%3DK.%2BC.%2BM.%26aulast%3Dvan%2BHoutum%26aufirst%3DE.%2BJ.%2BH.%26aulast%3DBull%26aufirst%3DC.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26atitle%3DSialoglycans%2520and%2520Siglecs%2520Can%2520Shape%2520the%2520Tumor%2520Immune%2520Microenvironment%26jtitle%3DTrends%2520Immunol.%26date%3D2020%26volume%3D41%26issue%3D4%26spage%3D274%26epage%3D285%26doi%3D10.1016%2Fj.it.2020.02.001" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaschke, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desprez, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span> <span> </span><span class="NLM_article-title">Cell differentiation by extracellular matrix components</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">556</span>, <span class="refDoi">&nbsp;DOI: 10.1016/0076-6879(94)45027-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2F0076-6879%2894%2945027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=7760750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK2MXmsV2hs7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=245&amp;publication_year=1994&amp;pages=535-556&amp;author=R.+J.+Blaschkeauthor=A.+R.+Howlettauthor=P.+Y.+Desprezauthor=O.+W.+Petersenauthor=M.+J.+Bissell&amp;title=Cell+differentiation+by+extracellular+matrix+components&amp;doi=10.1016%2F0076-6879%2894%2945027-7" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cell differentiation by extracellular matrix components</span></div><div class="casAuthors">Blaschke, Ruediger J.; Howlett, Anthony R.; Desprez, Pierre-Yves; Petersen, Ole W.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-56</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnDZBBfPzc7Vg90H21EOLACvtfcHk0liqYstrBt-ylQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK2MXmsV2hs7k%253D&amp;md5=03bf0c86ec3cb45f22b30d67e9a4e67f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2894%2945027-7&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252894%252945027-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlaschke%26aufirst%3DR.%2BJ.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DDesprez%26aufirst%3DP.%2BY.%26aulast%3DPetersen%26aufirst%3DO.%2BW.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DCell%2520differentiation%2520by%2520extracellular%2520matrix%2520components%26jtitle%3DMethods%2520Enzymol.%26date%3D1994%26volume%3D245%26spage%3D535%26epage%3D556%26doi%3D10.1016%2F0076-6879%2894%2945027-7" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cws112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcws112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=22833316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtbjK" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2012&amp;pages=1465-1479&amp;issue=11&amp;author=A.+V.+Everest-Dass&amp;title=Comparative+structural+analysis+of+the+glycosylation+of+salivary+and+buccal+cell+proteins%3A+innate+protection+against+infection+by+Candida+albicans&amp;doi=10.1093%2Fglycob%2Fcws112" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans</span></div><div class="casAuthors">Everest-Dass, Arun V.; Jin, Dayong; Thaysen-Andersen, Morten; Nevalainen, Helena; Kolarich, Daniel; Packer, Nicolle H.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1465-1479</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mucosal epithelial surfaces, such as line the oral cavity, are common sites of microbial colonization by bacteria, yeast and fungi.  The microbial interactions involve adherence between the glycans on the host cells and the carbohydrate-binding proteins of the pathogen.  Saliva constantly bathes the buccal cells of the epithelial surface of the mouth and we postulate that the sugars on the salivary glycoproteins provide an innate host immune mechanism against infection by competitively inhibiting pathogen binding to the cell membranes.  The structures of the N- and O-linked oligosaccharides on the glycoproteins of saliva and buccal cell membranes were analyzed using capillary carbon liq. chromatog.-electrospray ionization MS/MS.  The 190 glycan structures that were characterized were qual. similar, but differed quant., between saliva and epithelial buccal cell membrane proteins.  The similar relative abundance of the terminal glycan epitope structures (e.g. ABO(H) blood group, sialylation and Lewis-type antigens) on saliva and buccal cell membrane glycoproteins indicated that the terminal N- and O-linked glycan substructures in saliva could be acting as decoy-binding receptors to competitively inhibit the attachment of pathogens to the surface of the oral mucosa.  A flow cytometry-based binding assay quantified the interaction between buccal cells and the commensal oral pathogen Candida albicans.  Whole saliva and released glycans from salivary proteins inhibited the interaction of C. albicans with buccal epithelial cells, confirming the protective role of the glycans on salivary glycoproteins against pathogen infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0lyCpCvCRLVg90H21EOLACvtfcHk0liqYstrBt-ylQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtbjK&amp;md5=f343ca64b894e1eeaaf08e0225e96231</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcws112&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcws112%26sid%3Dliteratum%253Aachs%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26atitle%3DComparative%2520structural%2520analysis%2520of%2520the%2520glycosylation%2520of%2520salivary%2520and%2520buccal%2520cell%2520proteins%253A%2520innate%2520protection%2520against%2520infection%2520by%2520Candida%2520albicans%26jtitle%3DGlycobiology%26date%3D2012%26volume%3D22%26issue%3D11%26spage%3D1465%26epage%3D1479%26doi%3D10.1093%2Fglycob%2Fcws112" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Simulation of biological cell sorting using a two-dimensional extended Potts model</span>. <i>Phys. Rev. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2016</span>, <span class="refDoi">&nbsp;DOI: 10.1103/PhysRevLett.69.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1103%2FPhysRevLett.69.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10046374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK38XmtVOmsLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=69&amp;publication_year=1992&amp;pages=2013-2016&amp;issue=13&amp;author=F.+Granerauthor=J.+A.+Glazier&amp;title=Simulation+of+biological+cell+sorting+using+a+two-dimensional+extended+Potts+model&amp;doi=10.1103%2FPhysRevLett.69.2013" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Simulation of biological cell sorting using a two-dimensional extended Potts model</span></div><div class="casAuthors">Graner, Francois; Glazier, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Review Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2013-16</span>CODEN:
                <span class="NLM_cas:coden">PRLTAO</span>;
        ISSN:<span class="NLM_cas:issn">0031-9007</span>.
    </div><div class="casAbstract">The sorting of a mixt. of two types of biol. cells was simulated using a modified version of the large-Q Potts model with differential adhesivity.  The model predicts long-distance cell movement leading to sorting with a logarithmic increase in the length scale of homogeneous clusters.  Sorted clusters then round.  Two successive phases were found: a rapid boundary-driven creation of a low-cohesivity cell monolayer around the aggregate, and a slower boundary-independent internal rearrangement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz9bpz3M2sarVg90H21EOLACvtfcHk0liqYstrBt-ylQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK38XmtVOmsLc%253D&amp;md5=a4035bb5ac84d49af4328d51428c8237</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1103%2FPhysRevLett.69.2013&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1103%252FPhysRevLett.69.2013%26sid%3Dliteratum%253Aachs%26aulast%3DGraner%26aufirst%3DF.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DSimulation%2520of%2520biological%2520cell%2520sorting%2520using%2520a%2520two-dimensional%2520extended%2520Potts%2520model%26jtitle%3DPhys.%2520Rev.%2520Lett.%26date%3D1992%26volume%3D69%26issue%3D13%26spage%3D2013%26epage%3D2016%26doi%3D10.1103%2FPhysRevLett.69.2013" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamdar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span> <span> </span><span class="NLM_article-title">Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19905</span>, <span class="refDoi">&nbsp;DOI: 10.1038/srep19905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fsrep19905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26832069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaitrs%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=6&amp;publication_year=2016&amp;pages=19905&amp;author=S.+Kumarauthor=A.+Kapoorauthor=S.+Desaiauthor=M.+M.+Inamdarauthor=S.+Sen&amp;title=Proteolytic+and+non-proteolytic+regulation+of+collective+cell+invasion%3A+tuning+by+ECM+density+and+organization&amp;doi=10.1038%2Fsrep19905" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization</span></div><div class="casAuthors">Kumar, Sandeep; Kapoor, Aastha; Desai, Sejal; Inamdar, Mandar M.; Sen, Shamik</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19905</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells manoeuvre through extracellular matrixes (ECMs) using different invasion modes, including single cell and collective cell invasion.  These modes rely on MMP-driven ECM proteolysis to make space for cells to move.  How cancer-assocd. alterations in ECM influence the mode of invasion remains unclear.  Further, the sensitivity of the two invasion modes to MMP dynamics remains unexplored.  In this paper, we address these open questions using a multiscale hybrid computational model combining ECM d.-dependent MMP secretion, MMP diffusion, ECM degrdn. by MMP and active cell motility.  Our results demonstrate that in randomly aligned matrixes, collective cell invasion is more efficient than single cell invasion.  Although increase in MMP secretion rate enhances invasiveness independent of cell-cell adhesion, sustenance of collective invasion in dense matrixes requires high MMP secretion rates.  However, matrix alignment can sustain both single cell and collective cell invasion even without ECM proteolysis.  Similar to our in-silico observations, increase in ECM d. and MMP inhibition reduced migration of MCF-7 cells embedded in sandwich gels.  Together, our results indicate that apart from cell intrinsic factors (i.e., high cell-cell adhesion and MMP secretion rates), ECM d. and organization represent two important extrinsic parameters that govern collective cell invasion and invasion plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHNXedHX0P7bVg90H21EOLACvtfcHk0liqYstrBt-ylQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XitFaitrs%253D&amp;md5=99c0b7be25728ed27250d7f73cd706ce</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsrep19905&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19905%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DInamdar%26aufirst%3DM.%2BM.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DProteolytic%2520and%2520non-proteolytic%2520regulation%2520of%2520collective%2520cell%2520invasion%253A%2520tuning%2520by%2520ECM%2520density%2520and%2520organization%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19905%26doi%3D10.1038%2Fsrep19905" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span> <span> </span><span class="NLM_article-title">MMP proteolytic activity regulates cancer invasiveness by modulating integrins</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">14219</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41598-017-14340-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41598-017-14340-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29079818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC1M7lsVKhug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2017&amp;pages=14219&amp;issue=1&amp;author=A.+Dasauthor=M.+Monteiroauthor=A.+Baraiauthor=S.+Kumarauthor=S.+Sen&amp;title=MMP+proteolytic+activity+regulates+cancer+invasiveness+by+modulating+integrins&amp;doi=10.1038%2Fs41598-017-14340-w" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">MMP proteolytic activity regulates cancer invasiveness by modulating integrins</span></div><div class="casAuthors">Das Alakesh; Monteiro Melissa; Barai Amlan; Kumar Sandeep; Sen Shamik</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14219</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer invasion through dense extracellular matrices (ECMs) is mediated by matrix metalloproteinases (MMPs) which degrade the ECM thereby creating paths for migration.  However, how this degradation influences the phenotype of cancer cells is not fully clear.  Here we address this question by probing the function of MMPs in regulating biophysical properties of cancer cells relevant to invasion.  We show that MMP catalytic activity regulates cell spreading, motility, contractility and cortical stiffness by stabilizing integrins at the membrane and activating focal adhesion kinase.  Interestingly, cell rounding and cell softening on stiff gels induced by MMP inhibition is attenuated on MMP pre-conditioned surfaces.  Together, our results suggest that MMP catalytic activity regulates invasiveness of cancer cells by modulating integrins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7eccy12VojHy-c-E1v-fmfW6udTcc2ebY6q4TM4qNC7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC1M7lsVKhug%253D%253D&amp;md5=6a987eb1c21be2d7a1f102f099015649</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-14340-w&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-14340-w%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DA.%26aulast%3DMonteiro%26aufirst%3DM.%26aulast%3DBarai%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DMMP%2520proteolytic%2520activity%2520regulates%2520cancer%2520invasiveness%2520by%2520modulating%2520integrins%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D14219%26doi%3D10.1038%2Fs41598-017-14340-w" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merks, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goligorksy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">54</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.ydbio.2005.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.ydbio.2005.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=16325173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaitrzI" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=289&amp;publication_year=2006&amp;pages=44-54&amp;issue=1&amp;author=R.+M.+Merksauthor=S.+V.+Brodskyauthor=M.+S.+Goligorksyauthor=S.+A.+Newmanauthor=J.+A.+Glazier&amp;title=Cell+elongation+is+key+to+in+silico+replication+of+in+vitro+vasculogenesis+and+subsequent+remodeling&amp;doi=10.1016%2Fj.ydbio.2005.10.003" target="_blank">Google Scholar</a><div class="casRecord" id="
                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling</span></div><div class="casAuthors">Merks, Roeland M. H.; Brodsky, Sergey V.; Goligorksy, Michael S.; Newman, Stuart A.; Glazier, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Vasculogenesis, the de novo growth of the primary vascular network from initially dispersed endothelial cells, is the first step in the development of the circulatory system in vertebrates.  In the first stages of vasculogenesis, endothelial cells elongate and form a network-like structure, called the primary capillary plexus, which subsequently remodels, with the size of the vacancies between ribbons of endothelial cells coarsening over time.  To isolate such intrinsic morphogenetic ability of endothelial cells from its regulation by long-range guidance cues and addnl. cell types, we use an in vitro model of human umbilical vein endothelial cells (HUVEC) in Matrigel.  This quasi-two-dimensional endothelial cell culture model would most closely correspond to vasculogenesis in flat areas of the embryo like the yolk sac.  Several studies have used continuum math. models to explore in vitro vasculogenesis: such models describe cell ensembles but ignore the endothelial cells' shapes and active surface fluctuations.  While these models initially reproduce vascular-like morphologies, they eventually stabilize into a disconnected pattern of vascular "islands".  Also, they fail to reproduce temporally correct network coarsening.  Using a cell-centered computational model, we show that the endothelial cells' elongated shape is key to correct spatiotemporal in silico replication of stable vascular network growth.  We validate our simulation results against HUVEC cultures using time-resolved image anal. and find that our simulations quant. reproduce in vitro vasculogenesis and subsequent in vitro remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQn4LD4El1J7Vg90H21EOLACvtfcHk0lhgP19MJky7hA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaitrzI&amp;md5=020da88954fc4b7f64b9e745d5573558</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2005.10.003&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMerks%26aufirst%3DR.%2BM.%26aulast%3DBrodsky%26aufirst%3DS.%2BV.%26aulast%3DGoligorksy%26aufirst%3DM.%2BS.%26aulast%3DNewman%26aufirst%3DS.%2BA.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DCell%2520elongation%2520is%2520key%2520to%2520in%2520silico%2520replication%2520of%2520in%2520vitro%2520vasculogenesis%2520and%2520subsequent%2520remodeling%26jtitle%3DDev.%2520Biol.%26date%3D2006%26volume%3D289%26issue%3D1%26spage%3D44%26epage%3D54%26doi%3D10.1016%2Fj.ydbio.2005.10.003" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merks, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perryn, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirinifard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e1000163</span>, <span class="refDoi">&nbsp;DOI: 10.1371/journal.pcbi.1000163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1371%2Fjournal.pcbi.1000163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=18802455" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=4&amp;publication_year=2008&amp;pages=e1000163&amp;issue=9&amp;author=R.+M.+Merksauthor=E.+D.+Perrynauthor=A.+Shirinifardauthor=J.+A.+Glazier&amp;title=Contact-inhibited+chemotaxis+in+de+novo+and+sprouting+blood-vessel+growth&amp;doi=10.1371%2Fjournal.pcbi.1000163" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1000163&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1000163%26sid%3Dliteratum%253Aachs%26aulast%3DMerks%26aufirst%3DR.%2BM.%26aulast%3DPerryn%26aufirst%3DE.%2BD.%26aulast%3DShirinifard%26aufirst%3DA.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DContact-inhibited%2520chemotaxis%2520in%2520de%2520novo%2520and%2520sprouting%2520blood-vessel%2520growth%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D9%26spage%3De1000163%26doi%3D10.1371%2Fjournal.pcbi.1000163" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li></ol></div><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yilin  Wang</span>, <span class="hlFld-ContribAuthor ">Piaopiao  Pan</span>, <span class="hlFld-ContribAuthor ">Aneesah  Khan</span>, <span class="hlFld-ContribAuthor ">Çağlar  Çil</span>, <span class="hlFld-ContribAuthor ">Miguel A.  Pineda</span>. </span><span class="cited-content_cbyCitation_article-title">Synovial Fibroblast Sialylation Regulates Cell Migration and Activation of Inflammatory Pathways in Arthritogenesis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2022,</strong> <em>13 </em><a href="https://doi.org/10.3389/fimmu.2022.847581" title="DOI URL">https://doi.org/10.3389/fimmu.2022.847581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2022.847581&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2022.847581%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSynovial%252BFibroblast%252BSialylation%252BRegulates%252BCell%252BMigration%252Band%252BActivation%252Bof%252BInflammatory%252BPathways%252Bin%252BArthritogenesis%26aulast%3DWang%26aufirst%3DYilin%26date%3D2022%26date%3D2022%26volume%3D13" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Bertok</span>, <span class="hlFld-ContribAuthor ">Veronika  Pinkova Gajdosova</span>, <span class="hlFld-ContribAuthor ">Aniko  Bertokova</span>, <span class="hlFld-ContribAuthor ">Natalia  Svecova</span>, <span class="hlFld-ContribAuthor ">Peter  Kasak</span>, <span class="hlFld-ContribAuthor ">Jan  Tkac</span>. </span><span class="cited-content_cbyCitation_article-title">Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Proteomics</span><span> <strong>2021,</strong> <em>71 </em>, 1-30. <a href="https://doi.org/10.1080/14789450.2021.1996231" title="DOI URL">https://doi.org/10.1080/14789450.2021.1996231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14789450.2021.1996231&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14789450.2021.1996231%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Proteomics%26atitle%3DBreast%252Bcancer%252Bglycan%252Bbiomarkers%25253A%252Btheir%252Blink%252Bto%252Btumour%252Bcell%252Bmetabolism%252Band%252Btheir%252Bperspectives%252Bin%252Bclinical%252Bpractice%26aulast%3DBertok%26aufirst%3DTomas%26date%3D2021%26date%3D2021%26volume%3D71%26spage%3D1%26epage%3D30" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Pramanik</span>, <span class="hlFld-ContribAuthor ">M.K.  Jolly</span>, <span class="hlFld-ContribAuthor ">R.  Bhat</span>. </span><span class="cited-content_cbyCitation_article-title">Matrix adhesion and remodeling diversifies modes of cancer invasion across spatial scales. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2021,</strong> <em>524 </em>, 110733. <a href="https://doi.org/10.1016/j.jtbi.2021.110733" title="DOI URL">https://doi.org/10.1016/j.jtbi.2021.110733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2021.110733&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2021.110733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3DMatrix%252Badhesion%252Band%252Bremodeling%252Bdiversifies%252Bmodes%252Bof%252Bcancer%252Binvasion%252Bacross%252Bspatial%252Bscales%26aulast%3DPramanik%26aufirst%3DD.%26date%3D2021%26volume%3D524%26spage%3D110733" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dharma  Pally</span>, <span class="hlFld-ContribAuthor ">Ramray  Bhat</span>. </span><span class="cited-content_cbyCitation_article-title">N-terminal tail prolines of Gal-3 mediate its oligomerization/phase separation. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (25)
                                     <a href="https://doi.org/10.1073/pnas.2107023118" title="DOI URL">https://doi.org/10.1073/pnas.2107023118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2107023118&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2107023118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DN-terminal%252Btail%252Bprolines%252Bof%252BGal-3%252Bmediate%252Bits%252Boligomerization%25252Fphase%252Bseparation%26aulast%3DPally%26aufirst%3DDharma%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D25" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0007.gif" alt="" id="tgr1"><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0001.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. α2,6-Sialic acid heterogeneity in breast cancer. (A) Confocal micrographs showing α2,6-sialic acid (SNA-FITC, green) and α2,3-sialic acid (MAA-TRITC, red) staining of breast cancer sections from two individuals (top and bottom rows) showing heterogeneity in α2,6-sialic acid linkage expression. The nucleus is stained with DAPI (white) (scale bar: 100 μm). (B) Bar graphs showing quantification of individual sialic acid levels from breast cancer sections shown in part A. Error bars represent mean ± SD. (C) Confocal micrographs showing heterogeneity in α2,6-Sial levels (SNA-FITC green) and uniform α2,3-sialic levels (MAA-TRITC, red) in invasive breast cancer cell line MDA-MB-231 using lectin cytochemical fluorescence. Cells are counterstained for nucleus with DAPI (white) and F-actin with phalloidin (Magenta). Insets of a subfield within the images shown in bottom right corner. (D) Lectin-based flow cytometry profiles of MDA-MB-231 cells show bimodal distribution of α2,6-Sial levels (top left) and unimodal distribution of α2,3-Sial levels (top right). Red inset shows moderate levels of α2,6-Sial (left) and unchanged α2,3-Sial (right) in sorted medium 2,6-Sial cells. Orange inset shows higher α2,6-Sial (left) and unchanged α2,3-Sial (right) levels in sorted high 2,6-Sial cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0002.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Medium 2,6-Sial cells show greater plasticity, adhere better to, and invade through ECM. (A) Lectin-based flow cytometry profile of α2,6-Sial levels of medium 2,6-Sial population at three passages (20, 70, and 145) of long-term culture showing a gradual recapitulation of bimodal α2,6-Sial distribution after 70 passages. (B) Lectin-based flow cytometry of high 2,6-Sial at three passages (20, 70, and 145) in long-term culture showing no change in α2,6-Sial even after 145 passages. (C) Bar graph showing lower invasion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) that invaded to the other side of lrECM-coated transwells (<i>n</i> = 3). (D) Graph showing lower adhesion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) to lrECM (<i>n</i> = 3). (E) Graph showing lower adhesion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) to Type 1 collagen (<i>n</i> = 3). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0003.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Medium 2,6-Sial cells invade faster through a 3D pathotypic multi-ECM microenvironment. (A) Confocal micrographs showing medium 2,6-Sial cells invading into fibrillar Type 1 collagen matrix from lrECM-coated multicellular clusters after 24 h. (B) Confocal micrographs showing high 2,6-Sial cells invading into fibrillar Type 1 collagen matrix from lrECM-coated multicellular clusters after 24 h. (A, B) Cells are counter-stained for the nucleus with DAPI (white) and F-actin with phalloidin (magenta) (scale bar: 200 μm). (C) Bright field images taken at 0, 12, 18, and 24 h from time-lapse videography of lrECM-coated clusters of high and medium 2,6-Sial (top and bottom) invading into surrounding Type 1 collagen. (D) Graph showing insignificant differences in collective cell mode of invasion of high (yellow) and medium (red) 2,6-Sial cells as measured by the increase in cluster size obtained from time-lapse videography (<i>n</i> = 3). (E) Graph showing significantly lower invasion of high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) as measured by the number of dispersed single cells in Type 1 collagen normalized to the initial cluster size obtained from lapse videography (<i>n</i> = 3). (F) Graph showing significantly lower mean migratory velocity of single high 2,6-Sial cells (yellow) compared with medium 2,6-Sial cells (red) as measured by manual tracking dynamics obtained from lapse videography (<i>n</i> = 3, <i>N</i> ≥ 15 cells). (G) Confocal micrographs showing differential sorting of medium 2,6-Sial (green) cells invading and dispersing further into the Type 1 collagen ECM while high 2,6-Sial cells (red) form the core of the cluster when these two cells have been mixed in equal proportion and cultured in 3D. (Cells are counter-stained for the nucleus with DAPI (white) and F-actin with phalloidin (magenta) (scale bar: 200 μm). (H) Histogram showing distribution of intercellular distances between high 2,6-Sial cells (red) compared with medium 2,6-Sial cells (yellow). Intercellular distances between medium α2,6-Sial cells are shifted rightwards indicative of a greater spread and farther invasion within 3D matrix microenvironment compared to high 2,6-Sial cells. Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0004.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Differential expression of the <i>ST6GAL1</i> gene. (A) Schematic depiction of key processes involved in the fate and utilization of sialic acids and the genes encoding the enzymes involved in these processes arranged in the temporal order of their function: <i>N</i>-glycan synthesis, sialic acid metabolism and sialyltransferases. (B) Graphs depicting relative mRNA levels of genes involved in <i>N</i>-linked glycosylation <i>DPAGT1</i>, <i>ALG1</i>, <i>ALG3</i>, <i>GANAB</i>, and <i>MAN1A1</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (C) Graphs depicting relative mRNA levels of genes involved in sialic acid metabolism <i>GNE</i>, <i>NANS</i>, <i>CMAS</i>, and <i>NEU1</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (D) Graphs depicting relative mRNA levels of genes involved in 2,3-sialic acid conjugation <i>ST3GAL3</i> and <i>ST3GAL4</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells. (E) Graphs depicting relative mRNA levels of genes involved in 2,6-sialic acid conjugation <i>ST6GAL1</i>, <i>ST6GALNAC2</i>, <i>ST6GALNAC4</i>, and <i>ST6GALNAC6</i>; expression is insignificantly altered between high (yellow) and medium (red) 2,6-Sial cells for all except <i>ST6GAL1</i>, which is significantly lower in medium 2,6-Sial cells compared to high 2,6-Sial cells. Expression of all genes is plotted as 2<sup>–ΔΔct</sup> normalized to unsorted cells. The <i>18S rRNA</i> gene is used as an internal control. Data shown are from five independent biological experiments with at least duplicate samples run in each experiment. Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (****<i>P</i> &lt; 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0005.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. α2,6-Sial levels regulate mesenchymal invasion of high 2,6-Sial cells. (A) Lectin-based flow cytometry profiles showing decreased α2,6-Sial levels upon <i>ST6GAL1</i> gene knockdown in high 2,6-Sial cells. (B) Bright field images taken at 0, 12, 18, and 24 h from time-lapse videography of lrECM-coated clusters of scrambled control and <i>ST6GAL1</i> knocked down high 2,6-Sial cells (shSc-high 2,6-Sial top and sh<i>ST6GAL1</i>-high 2,6-Sial bottom) invading into surrounding Type 1 collagen. (C) Graph showing insignificant differences in the collective cell mode of invasion of shSc-high 2,6-Sial (yellow) and sh<i>ST6GAL1</i>-high 2,6-Sial (brown) cells as measured by the increase in cluster size obtained from time-lapse videography (<i>n</i> = 3). (D) Graph showing significantly lower invasion of shSc-high 2,6-Sial cells (yellow) compared with sh<i>ST6GAL1</i>-high 2,6-Sial cells (red) as measured by the number of dispersed single cells in Type 1 collagen normalized to the initial cluster size obtained from lapse videography (<i>n</i> = 3). (E) Graph showing significantly lower mean migratory velocity of single shSc-high 2,6-Sial cells (yellow) compared with sh<i>ST6GAL1</i>-high 2,6-Sial cells (red) as measured by manual tracking dynamics obtained from lapse videography (<i>n</i> = 3, <i>N</i> ≥ 15 cells). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance (*<i>P</i> ≤ 0.05, **<i>P</i> ≤ 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/cms/10.1021/acscentsci.0c00601/asset/images/medium/oc0c00601_0006.gif" alt="" data-lg-src="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav"><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Multiscale simulations predict that matrix adhesion principally contributes to increased invasion. (A) Snapshots of simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital high 2,6-Sial cells in model Type 1 collagen (green). (B) Snapshots of the simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital medium 2,6-Sial cells in model Type 1 collagen (green). (C) Snapshots of simulation at MCS (0, 200, 400, and 600) of model lrECM-coated (blue) clusters of digital high and medium 2,6-Sial cells mixed in a ratio of 1:1 show a relatively greater invasion and dispersal of digital medium 2,6-Sial cells with digital high 2,6-Sial cells forming the central core. (D) Bar graph showing greater invasion of digital medium 2,6-Sial cells (red) compared with digital high 2,6-Sial cells in their 3D cocultures such as in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure </a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C (<i>n</i> = 3). Error bars denote mean ± SEM. The unpaired Student’s <i>t</i> test was performed for statistical significance. (E) Histograms depicting the intercellular distances of the digital high 2,6-Sial cells (yellow) and those of medium 2,6-Sial cells (red) with the rightward shift of the latter indicating greater dispersal. (F) Graph depicting the invasion of an overall population of cancer cells in 3D (conditions similar to parts A–C) wherein the clusters of digital cells are composed of digital high and medium 2,6-Sial cells in the relative proportion of 100%, 0%; 75%, 25%; 50%, 50%; 25%, 75%; and 0%, 100%, from left to right, respectively. Error bars denote mean ± SEM. Ordinary one-way ANOVA with Tukey’s post-hoc multiple comparisons was performed for statistical significance (*<i>P</i> ≤ 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/cms/10.1021/acscentsci.0c00601/asset/images/large/oc0c00601_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acscentsci.0c00601&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52170" class="dropBlock__holder"></div></div></div></div></div><hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poudel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyamundanda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheang, M. C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadanandam, A.</span></span> <span> </span><span class="NLM_article-title">Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses</span>. <i>NPJ. breast cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">21</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41523-019-0116-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41523-019-0116-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31396557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MvmtlOmug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=5&amp;publication_year=2019&amp;pages=21&amp;author=P.+Poudelauthor=G.+Nyamundandaauthor=Y.+Patilauthor=M.+C.+U.+Cheangauthor=A.+Sadanandam&amp;title=Heterocellular+gene+signatures+reveal+luminal-A+breast+cancer+heterogeneity+and+differential+therapeutic+responses&amp;doi=10.1038%2Fs41523-019-0116-8" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses</span></div><div class="casAuthors">Poudel Pawan; Nyamundanda Gift; Patil Yatish; Sadanandam Anguraj; Nyamundanda Gift; Patil Yatish; Sadanandam Anguraj; Cheang Maggie Chon U</div><div class="citationInfo"><span class="NLM_cas:title">NPJ breast cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21</span>
        ISSN:<span class="NLM_cas:issn">2374-4677</span>.
    </div><div class="casAbstract">Breast cancer is a highly heterogeneous disease.  Although differences between intrinsic breast cancer subtypes have been well studied, heterogeneity within each subtype, especially luminal-A cancers, requires further interrogation to personalize disease management.  Here, we applied well-characterized and cancer-associated heterocellular signatures representing stem, mesenchymal, stromal, immune, and epithelial cell types to breast cancer.  This analysis stratified the luminal-A breast cancer samples into five subtypes with a majority of them enriched for a subtype (stem-like) that has increased stem and stromal cell gene signatures, representing potential luminal progenitor origin.  The enrichment of immune checkpoint genes and other immune cell types in two (including stem-like) of the five heterocellular subtypes of luminal-A tumors suggest their potential response to immunotherapy.  These immune-enriched subtypes of luminal-A tumors (containing only estrogen receptor positive samples) showed good or intermediate prognosis along with the two other differentiated subtypes as assessed using recurrence-free and distant metastasis-free patient survival outcomes.  On the other hand, a partially differentiated subtype of luminal-A breast cancer with transit-amplifying colon-crypt characteristics showed poor prognosis.  Furthermore, published luminal-A subtypes associated with specific somatic copy number alterations and mutations shared similar cellular and mutational characteristics to colorectal cancer subtypes where the heterocellular signatures were derived.  These heterocellular subtypes reveal transcriptome and cell-type based heterogeneity of luminal-A and other breast cancer subtypes that may be useful for additional understanding of the cancer type and potential patient stratification and personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrJ96Nuqm03zEC-75aqa5AfW6udTcc2eaUrdmNjeGY2Lntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MvmtlOmug%253D%253D&amp;md5=f016fee7c1d25cdff7e0a9a02aa18102</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41523-019-0116-8&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41523-019-0116-8%26sid%3Dliteratum%253Aachs%26aulast%3DPoudel%26aufirst%3DP.%26aulast%3DNyamundanda%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DY.%26aulast%3DCheang%26aufirst%3DM.%2BC.%2BU.%26aulast%3DSadanandam%26aufirst%3DA.%26atitle%3DHeterocellular%2520gene%2520signatures%2520reveal%2520luminal-A%2520breast%2520cancer%2520heterogeneity%2520and%2520differential%2520therapeutic%2520responses%26jtitle%3DNPJ.%2520breast%2520cancer%26date%3D2019%26volume%3D5%26spage%3D21%26doi%3D10.1038%2Fs41523-019-0116-8" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegh, W.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Heterogeneity in signaling pathway activity within primary breast cancer and between primary and metastases</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">15s</span>),  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">589</span>, <span class="refDoi">&nbsp;DOI: 10.1200/JCO.2019.37.15_suppl.589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1200%2FJCO.2019.37.15_suppl.589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=30653422" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=37&amp;publication_year=2019&amp;pages=589-589&amp;issue=15s&amp;author=W.+Verhaegh&amp;title=Heterogeneity+in+signaling+pathway+activity+within+primary+breast+cancer+and+between+primary+and+metastases&amp;doi=10.1200%2FJCO.2019.37.15_suppl.589" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            rightTab-cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2019.37.15_suppl.589&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2019.37.15_suppl.589%26sid%3Dliteratum%253Aachs%26aulast%3DVerhaegh%26aufirst%3DW.%26atitle%3DHeterogeneity%2520in%2520signaling%2520pathway%2520activity%2520within%2520primary%2520breast%2520cancer%2520and%2520between%2520primary%2520and%2520metastases%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D15s%26spage%3D589%26epage%3D589%26doi%3D10.1200%2FJCO.2019.37.15_suppl.589" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">766</span>, <span class="refDoi">&nbsp;DOI: 10.1309/AJCPIRL4GUVGK3YX</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1309%2FAJCPIRL4GUVGK3YX" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=25389328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2M3nsVKhsQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=142&amp;publication_year=2014&amp;pages=755-766&amp;issue=6&amp;author=H.+J.+Lee&amp;title=HER2+heterogeneity+affects+trastuzumab+responses+and+survival+in+patients+with+HER2-positive+metastatic+breast+cancer&amp;doi=10.1309%2FAJCPIRL4GUVGK3YX" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer</span></div><div class="casAuthors">Lee Hee Jin; Park So Yeon; Seo An Na; Kim Eun Joo; Jang Min Hye; Suh Koung Jin; Ryu Han Suk; Gong Gyungyub; Kim Yu Jung; Kim Jee Hyun; Im Seock-Ah; Jung Kyung Hae; Park In Ae</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Heterogeneity of HER2 gene amplification is found in a subset of breast cancers.  We investigated the impact of HER2 heterogeneity on trastuzumab responses and clinical outcomes in 112 patients with HER2-positive metastatic breast cancer.  METHODS:  Regional and genetic heterogeneity of HER2 gene amplification was determined in three different areas of each tumor by immunohistochemistry and silver in situ hybridization.  We also assessed the overall levels of HER2 amplification and the proportion of tumor cells with a HER2/CEP17 ratio of more than 2.2 or strong and complete membranous (3+) expression of HER2 protein.  RESULTS:  HER2 regional and genetic heterogeneity based on the HER2/CEP17 ratio was confirmed in 8.7% and 2.7% of cases, respectively.  Poor response to trastuzumab was associated with overall low-level or equivocal amplification, HER2 regional heterogeneity by the HER2/CEP17 ratio, the HER2/CEP17 ratio of more than 2.2 in less than 80% of tumor cells, and HER2 immunohistochemical expression of 3+ in less than 75% of tumor cells.  In survival analyses, low-level or equivocal HER2 amplification, HER2 regional heterogeneity based on the HER2/CEP17 ratio, and the HER2/CEP17 ratio of more than 2.2 in less than 80% of tumor cells were associated with shorter time to progression and lower overall survival in univariate and multivariate analyses.  CONCLUSIONS:  These results suggest that accurate assessment of HER2 status, including HER2 heterogeneity, is important in predicting trastuzumab responses and outcomes in patients with HER2-positive metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK20E-hdrxgBLDWw4HIq2sfW6udTcc2eYe4un_vA8kILntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2M3nsVKhsQ%253D%253D&amp;md5=9735037fa9dad674389e91699d2eac17</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1309%2FAJCPIRL4GUVGK3YX&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FAJCPIRL4GUVGK3YX%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DHER2%2520heterogeneity%2520affects%2520trastuzumab%2520responses%2520and%2520survival%2520in%2520patients%2520with%2520HER2-positive%2520metastatic%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2014%26volume%3D142%26issue%3D6%26spage%3D755%26epage%3D766%26doi%3D10.1309%2FAJCPIRL4GUVGK3YX" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rye, I. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi">&nbsp;DOI: 10.1002/1878-0261.12375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1002%2F1878-0261.12375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=30133130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKlu7c%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2018&amp;pages=1838-1855&amp;issue=11&amp;author=I.+H.+Rye&amp;title=Intratumor+heterogeneity+defines+treatment-resistant+HER2%2B+breast+tumors&amp;doi=10.1002%2F1878-0261.12375" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors</span></div><div class="casAuthors">Rye, Inga H.; Trinh, Anne; Saetersdal, Anna B.; Nebdal, Daniel; Lingjaerde, Ole Christian; Almendro, Vanessa; Polyak, Kornelia; Borresen-Dale, Anne-Lise; Helland, Aaslaug; Markowetz, Florian; Russnes, Hege G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1838-1855</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1878-0261</span>.
    
            (<span class="NLM_cas:orgname">John Wiley &amp; Sons Ltd.</span>)
        </div><div class="casAbstract">Targeted therapy for patients with HER2-pos. (HER2+) breast cancer has improved overall survival, but many patients still suffer relapse and death from the disease.  Intratumor heterogeneity of both estrogen receptor (ER) and HER2 expression has been proposed to play a key role in treatment failure, but little work has been done to comprehensively study this heterogeneity at the single-cell level.  In this study, we explored the clin. impact of intratumor heterogeneity of ER protein expression, HER2 protein expression, and HER2 gene copy no. alterations.  Using combined immunofluorescence and in situ hybridization on tissue sections followed by a validated computational approach, we analyzed more than 13 000 single tumor cells across 37 HER2+ breast tumors.  The samples were taken both before and after neoadjuvant chemotherapy plus HER2-targeted treatment, enabling us to study tumor evolution as well.  We found that intratumor heterogeneity for HER2 copy no. varied substantially between patient samples.  Highly heterogeneous tumors were assocd. with significantly shorter disease-free survival and fewer long-term survivors.  Patients for which HER2 characteristics did not change during treatment had a significantly worse outcome.  This work shows the impact of intratumor heterogeneity in mol. diagnostics for treatment selection in HER2+ breast cancer patients and the power of computational scoring methods to evaluate in situ mol. markers in tissue biopsies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcc-n07s2ikbVg90H21EOLACvtfcHk0lhdSnH7ZpGUbQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXitlKlu7c%253D&amp;md5=10453b2252b82540f88988cbf9d59280</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F1878-0261.12375&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1878-0261.12375%26sid%3Dliteratum%253Aachs%26aulast%3DRye%26aufirst%3DI.%2BH.%26atitle%3DIntratumor%2520heterogeneity%2520defines%2520treatment-resistant%2520HER2%252B%2520breast%2520tumors%26jtitle%3DMol.%2520Oncol.%26date%3D2018%26volume%3D12%26issue%3D11%26spage%3D1838%26epage%3D1855%26doi%3D10.1002%2F1878-0261.12375" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi">&nbsp;DOI: 10.1016/0009-8981(88)90038-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2F0009-8981%2888%2990038-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=3168286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADyaL1M%252FgtlKgtA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=175&amp;publication_year=1988&amp;pages=89-96&amp;issue=1&amp;author=R.+A.+Hawkins&amp;title=Oestrogen+receptors%2C+lactate+dehydrogenase+and+cellularity+in+human+breast+cancer&amp;doi=10.1016%2F0009-8981%2888%2990038-1" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer</span></div><div class="casAuthors">Hawkins R A; Killen E; Tesdale A L; Sangster K; Thomson M; Steele R J; Blackie R A</div><div class="citationInfo"><span class="NLM_cas:title">Clinica chimica acta; international journal of clinical chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    </div><div class="casAbstract">Oestrogen receptor (ER) concentrations in breast tissues are almost universally expressed in relation to total soluble protein, though the latter does not fully correct for gross variations in receptor concentration due to variations in tissue cellularity.  It was considered possible that the concentration of a specific glycolytic enzyme might be a better index and reflection of tumour cellularity.  Measurements of the concentrations of lactate dehydrogenase (LDH), oestrogen receptor and total soluble protein and estimates of tumour cellularity were therefore performed on 98 breast tissues (80 breast cancers, 18 benign tissues).  Cellularity and the concentrations of oestrogen receptor, lactate dehydrogenase and total soluble protein were significantly higher in breast cancers than in the benign tissues.  The concentration of oestrogen receptors (positives only) was, as expected, related to tissue cellularity (correlation coefficient, r = 0.35).  The concentrations of both LDH and total soluble protein were also both strongly related to tissue cellularity (correlation coefficients r = 0.67 and 0.75, respectively), and to each other (r = 0.78).  These results suggest that (1) total soluble protein concentration is a good index of cellularity and (2) there is unlikely to be any additional value in expressing receptor concentrations relative to LDH since the latter appears to be a 'typical' soluble protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_XpsLloQrfresJRIHUP1ofW6udTcc2eYe4un_vA8kILntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADyaL1M%252FgtlKgtA%253D%253D&amp;md5=c2fc7dd6127b114dfbc7e96746cadfcc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0009-8981%2888%2990038-1&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-8981%252888%252990038-1%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DR.%2BA.%26atitle%3DOestrogen%2520receptors%252C%2520lactate%2520dehydrogenase%2520and%2520cellularity%2520in%2520human%2520breast%2520cancer%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D1988%26volume%3D175%26issue%3D1%26spage%3D89%26epage%3D96%26doi%3D10.1016%2F0009-8981%2888%2990038-1" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGranahan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, C.</span></span> <span> </span><span class="NLM_article-title">Biological and therapeutic impact of intratumor heterogeneity in cancer evolution</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">26</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.ccell.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.ccell.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=25584892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVKgug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=27&amp;publication_year=2015&amp;pages=15-26&amp;issue=1&amp;author=N.+McGranahanauthor=C.+Swanton&amp;title=Biological+and+therapeutic+impact+of+intratumor+heterogeneity+in+cancer+evolution&amp;doi=10.1016%2Fj.ccell.2014.12.001" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution</span></div><div class="casAuthors">McGranahan, Nicholas; Swanton, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-26</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Precision medicine requires an understanding of cancer genes and mutational processes, as well as an appreciation of the extent to which these are found heterogeneously in cancer cells during tumor evolution.  Here, we explore the processes shaping the cancer genome, placing these within the context of tumor evolution and their impact on intratumor heterogeneity and drug development.  We review evidence for constraints and contingencies to tumor evolution and highlight the clin. implications of diversity within tumors.  We outline the limitations of genome-driven targeted therapies and explore future strategies, including immune and adaptive approaches, to address this therapeutic challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoad-qEfzG2kLVg90H21EOLACvtfcHk0lhdSnH7ZpGUbQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXntVKgug%253D%253D&amp;md5=2b1cd91dfac32a9b8cab36bdd9af3650</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2014.12.001&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DMcGranahan%26aufirst%3DN.%26aulast%3DSwanton%26aufirst%3DC.%26atitle%3DBiological%2520and%2520therapeutic%2520impact%2520of%2520intratumor%2520heterogeneity%2520in%2520cancer%2520evolution%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26issue%3D1%26spage%3D15%26epage%3D26%26doi%3D10.1016%2Fj.ccell.2014.12.001" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagogo-Jack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Tumour heterogeneity and resistance to cancer therapies</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">94</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrclinonc.2017.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrclinonc.2017.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29115304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOntLbN" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=15&amp;publication_year=2018&amp;pages=81-94&amp;issue=2&amp;author=I.+Dagogo-Jackauthor=A.+T.+Shaw&amp;title=Tumour+heterogeneity+and+resistance+to+cancer+therapies&amp;doi=10.1038%2Fnrclinonc.2017.166" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour heterogeneity and resistance to cancer therapies</span></div><div class="casAuthors">Dagogo-Jack, Ibiayi; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Cancer is a dynamic disease.  During the course of disease, cancers generally become more heterogeneous.  As a result of this heterogeneity, the bulk tumor might include a diverse collection of cells harbouring distinct mol. signatures with differential levels of sensitivity to treatment.  This heterogeneity might result in a non-uniform distribution of genetically distinct tumor-cell subpopulations across and within disease sites (spatial heterogeneity) or temporal variations in the mol. makeup of cancer cells (temporal heterogeneity).  Heterogeneity provides the fuel for resistance; therefore, an accurate assessment of tumor heterogeneity is essential for the development of effective therapies.  Multiregion sequencing, single-cell sequencing, anal. of autopsy samples, and longitudinal anal. of liq. biopsy samples are all emerging technologies with considerable potential to dissect the complex clonal architecture of cancers.  In this Review, we discuss the driving forces behind intratumoral heterogeneity and the current approaches used to combat this heterogeneity and its consequences.  We also explore how clin. assessments of tumor heterogeneity might facilitate the development of more-effective personalized therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGLb_pO6DBXrVg90H21EOLACvtfcHk0lj-UxtcqvdjyQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXhslOntLbN&amp;md5=11d4a70d028f0f37ed90ccef34432961</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2017.166&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2017.166%26sid%3Dliteratum%253Aachs%26aulast%3DDagogo-Jack%26aufirst%3DI.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTumour%2520heterogeneity%2520and%2520resistance%2520to%2520cancer%2520therapies%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26issue%3D2%26spage%3D81%26epage%3D94%26doi%3D10.1038%2Fnrclinonc.2017.166" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, C.</span></span> <span> </span><span class="NLM_article-title">Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome</span>. <i>American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi">&nbsp;DOI: 10.1200/EDBK_158930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1200%2FEDBK_158930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27249716" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=35&amp;publication_year=2016&amp;pages=e141-149&amp;author=S.+Venkatesanauthor=C.+Swanton&amp;title=Tumor+Evolutionary+Principles%3A+How+Intratumor+Heterogeneity+Influences+Cancer+Treatment+and+Outcome&amp;doi=10.1200%2FEDBK_158930" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            rightTab-cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FEDBK_158930&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FEDBK_158930%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DS.%26aulast%3DSwanton%26aufirst%3DC.%26atitle%3DTumor%2520Evolutionary%2520Principles%253A%2520How%2520Intratumor%2520Heterogeneity%2520Influences%2520Cancer%2520Treatment%2520and%2520Outcome%26jtitle%3DAmerican%2520Society%2520of%2520Clinical%2520Oncology%2520educational%2520book.%2520American%2520Society%2520of%2520Clinical%2520Oncology.%2520Annual%2520Meeting%26date%3D2016%26volume%3D35%26spage%3De141%26epage%3D149%26doi%3D10.1200%2FEDBK_158930" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgoulis, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halazonetis, T. D.</span></span> <span> </span><span class="NLM_article-title">Genomic instability--an evolving hallmark of cancer</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">228</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrm2858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrm2858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=20177397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlaisb4%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2010&amp;pages=220-228&amp;issue=3&amp;author=S.+Negriniauthor=V.+G.+Gorgoulisauthor=T.+D.+Halazonetis&amp;title=Genomic+instability%2D%2Dan+evolving+hallmark+of+cancer&amp;doi=10.1038%2Fnrm2858" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic instability - an evolving hallmark of cancer</span></div><div class="casAuthors">Negrini, Simona; Gorgoulis, Vassilis G.; Halazonetis, Thanos D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-228</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genomic instability is a characteristic of most cancers.  In hereditary cancers, genomic instability results from mutations in DNA repair genes and drives cancer development, as predicted by the mutator hypothesis.  In sporadic (non-hereditary) cancers the mol. basis of genomic instability remains unclear, but recent high-throughput sequencing studies suggest that mutations in DNA repair genes are infrequent before therapy, arguing against the mutator hypothesis for these cancers.  Instead, the mutation patterns of the tumor suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwLmWpqeZ3LVg90H21EOLACvtfcHk0lj-UxtcqvdjyQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3cXitlaisb4%253D&amp;md5=c1e1e2ae6a160b377e1f2a512a91a802</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2858&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2858%26sid%3Dliteratum%253Aachs%26aulast%3DNegrini%26aufirst%3DS.%26aulast%3DGorgoulis%26aufirst%3DV.%2BG.%26aulast%3DHalazonetis%26aufirst%3DT.%2BD.%26atitle%3DGenomic%2520instability--an%2520evolving%2520hallmark%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26issue%3D3%26spage%3D220%26epage%3D228%26doi%3D10.1038%2Fnrm2858" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span> <span> </span><span class="NLM_article-title">Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">26148</span>, <span class="refDoi">&nbsp;DOI: 10.7554/eLife.26148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.7554%2FeLife.26148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSjtb7F" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2018&amp;pages=26148&amp;author=S.+Furutaauthor=G.+Renauthor=J.+H.+Maoauthor=M.+J.+Bissell&amp;title=Laminin+signals+initiate+the+reciprocal+loop+that+informs+breast-specific+gene+expression+and+homeostasis+by+activating+NO%2C+p53+and+microRNAs&amp;doi=10.7554%2FeLife.26148" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs</span></div><div class="casAuthors">Furuta, Saori; Ren, Gang; Mao, Jian-Hua; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e26148/1-e26148/40</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">How mammalian tissues maintain their architecture and tissue-specificity is poorly understood.  Previously, we documented both the indispensable role of the extracellular matrix (ECM) protein, laminin-111 (LN1), in the formation of normal breast acini, and the phenotypic reversion of cancer cells to acini-like structures in 3-dimensional (3D) gels with inhibitors of oncogenic pathways.  Here, we asked how laminin (LN) proteins integrate the signaling pathways necessary for morphogenesis.  We report a surprising reciprocal circuitry comprising pos. players: laminin-5 (LN5), nitric oxide (NO), p53, HOXD10 and three microRNAs (miRNAs) - that are involved in the formation of mammary acini in 3D.  Significantly, cancer cells on either 2-dimensional (2D) or 3D and non-malignant cells on 2D plastic do not produce NO and upregulate neg. players: NFκB, EIF5A2, SCA1 and MMP-9 - that disrupt the network.  Introducing exogenous NO, LN5 or individual miRNAs to cancer cells reintegrates these pathways and induces phenotypic reversion in 3D.  These findings uncover the essential elements of breast epithelial architecture, where the balance between pos.- and neg.-players leads to homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cPoIZ_RZJrVg90H21EOLACvtfcHk0lj-UxtcqvdjyQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXisVSjtb7F&amp;md5=edacfb6b133c837436b93f3b4cadebdc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7554%2FeLife.26148&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.26148%26sid%3Dliteratum%253Aachs%26aulast%3DFuruta%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DG.%26aulast%3DMao%26aufirst%3DJ.%2BH.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DLaminin%2520signals%2520initiate%2520the%2520reciprocal%2520loop%2520that%2520informs%2520breast-specific%2520gene%2520expression%2520and%2520homeostasis%2520by%2520activating%2520NO%252C%2520p53%2520and%2520microRNAs%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26spage%3D26148%26doi%3D10.7554%2FeLife.26148" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Weimann, S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2010</span>– <span class="NLM_lpage">2020</span>, <span class="refDoi">&nbsp;DOI: 10.18632/oncotarget.1451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18632%2Foncotarget.1451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24243820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2c7nvFCjsQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=4&amp;publication_year=2013&amp;pages=2010-2020&amp;issue=11&amp;author=S.+Becker-Weimann&amp;title=NFkB+disrupts+tissue+polarity+in+3D+by+preventing+integration+of+microenvironmental+signals&amp;doi=10.18632%2Foncotarget.1451" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals</span></div><div class="casAuthors">Becker-Weimann Sabine; Xiong Gaofeng; Furuta Saori; Han Ju; Kuhn Irene; Akavia Uri-David; Pe'er Dana; Bissell Mina J; Xu Ren</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2010-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The microenvironment of cells controls their phenotype, and thereby the architecture of the emerging multicellular structure or tissue.  We have reported more than a dozen microenvironmental factors whose signaling must be integrated in order to effect an organized, functional tissue morphology.  However, the factors that prevent integration of signaling pathways that merge form and function are still largely unknown.  We have identified nuclear factor kappa B (NFkB) as a transcriptional regulator that disrupts important microenvironmental cues necessary for tissue organization.  We compared the gene expression of organized and disorganized epithelial cells of the HMT-3522 breast cancer progression series: the non-malignant S1 cells that form polarized spheres ('acini'), the malignant T4-2 cells that form large tumor-like clusters, and the 'phenotypically reverted' T4-2 cells that polarize as a result of correction of the microenvironmental signaling.  We identified 180 genes that display an increased expression in disorganized compared to polarized structures.  Network, GSEA and transcription factor binding site analyses suggested that NFkB is a common activator for the 180 genes.  NFkB was found to be activated in disorganized breast cancer cells, and inhibition of microenvironmental signaling via EGFR, beta1 integrin, MMPs, or their downstream signals suppressed its activation.  The postulated role of NFkB was experimentally verified: Blocking the NFkB pathway with a specific chemical inhibitor or shRNA induced polarization and inhibited invasion of breast cancer cells in 3D cultures.  These results may explain why NFkB holds promise as a target for therapeutic intervention: Its inhibition can reverse the oncogenic signaling involved in breast cancer progression and integrate the essential microenvironmental control of tissue architecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUGj0HxqTGKnwOGIfWJ7-GfW6udTcc2ebCuu6a3_IhyLntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2c7nvFCjsQ%253D%253D&amp;md5=b49a3b2679487cfb643e126a44b0c1bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1451&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1451%26sid%3Dliteratum%253Aachs%26aulast%3DBecker-Weimann%26aufirst%3DS.%26atitle%3DNFkB%2520disrupts%2520tissue%2520polarity%2520in%25203D%2520by%2520preventing%2520integration%2520of%2520microenvironmental%2520signals%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26issue%3D11%26spage%3D2010%26epage%3D2020%26doi%3D10.18632%2Foncotarget.1451" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">E4820</span>– <span class="NLM_lpage">4827</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.1609135113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.1609135113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27496330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12nsbrI" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=113&amp;publication_year=2016&amp;pages=E4820-4827&amp;issue=33&amp;author=R.+Bhat&amp;title=Nuclear+repartitioning+of+galectin-1+by+an+extracellular+glycan+switch+regulates+mammary+morphogenesis&amp;doi=10.1073%2Fpnas.1609135113" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis</span></div><div class="casAuthors">Bhat, Ramray; Belardi, Brian; Mori, Hidetoshi; Kuo, Peiwen; Tam, Andrew; Hines, William C.; Le, Quynh-Thu; Bertozzi, Carolyn R.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E4820-E4827</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Branching morphogenesis in the mammary gland is achieved by the migration of epithelial cells through a microenvironment consisting of stromal cells and extracellular matrix (ECM).  Here we show that galectin-1 (Gal-1), an endogenous lectin that recognizes glycans bearing N-acetyllactosamine (LacNAc) epitopes, induces branching migration of mammary epithelia in vivo, ex vivo, and in 3D organotypic cultures.  Surprisingly, Gal-1's effects on mammary patterning were independent of its glycan-binding ability and instead required localization within the nuclei of mammary epithelia.  Nuclear translocation of Gal-1, in turn, was regulated by discrete cell-surface glycans restricted to the front of the mammary end buds.  Specifically, α2,6-sialylation of terminal LacNAc residues in the end buds masked Gal-1 ligands, thereby liberating the protein for nuclear translocation.  Within mammary epithelia, Gal-1 localized within nuclear Gemini bodies and drove epithelial invasiveness.  Conversely, unsialylated LacNAc glycans, enriched in the epithelial ducts, sequestered Gal-1 in the extracellular environment, ultimately attenuating invasive potential.  We also found that malignant breast cells possess higher levels of nuclear Gal-1 and α2,6-SA and lower levels of LacNAc than nonmalignant cells in culture and in vivo and that nuclear localization of Gal-1 promotes a transformed phenotype.  Our findings suggest that differential glycosylation at the level of tissue microanatomy regulates the nuclear function of Gal-1 in the context of mammary gland morphogenesis and in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDomeGTxqfgrVg90H21EOLACvtfcHk0lhwjR0ztR9nTQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28Xht12nsbrI&amp;md5=9cf6d1c1d61f38f972a444b92d94d1e0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1609135113&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1609135113%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DNuclear%2520repartitioning%2520of%2520galectin-1%2520by%2520an%2520extracellular%2520glycan%2520switch%2520regulates%2520mammary%2520morphogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D33%26spage%3DE4820%26epage%3D4827%26doi%3D10.1073%2Fpnas.1609135113" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aub, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span> <span> </span><span class="NLM_article-title">Reactions of normal and leukemic cell surfaces to a wheat germ agglutinin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">402</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.54.2.400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.54.2.400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=5217427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF2MXkvVaqurY%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=54&amp;publication_year=1965&amp;pages=400-402&amp;issue=2&amp;author=J.+C.+Aubauthor=B.+H.+Sanfordauthor=L.+H.+Wang&amp;title=Reactions+of+normal+and+leukemic+cell+surfaces+to+a+wheat+germ+agglutinin&amp;doi=10.1073%2Fpnas.54.2.400" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of normal and leukemic cell surfaces to a wheat germ agglutinin</span></div><div class="casAuthors">Aub, Joseph C.; Sanford, Barbara H.; Wang, Li-Hsia</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">400-2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">After treatment with wheat germ agglutinin, the leukocytes from patients with chronic lymphocytic leukemia exhibited less clumping than controls, while leukocytes from patients with chronic granulocytic leukemia exhibited more clumping.  When relatively pure lymphocytic prepns. were compared with total white cell prepns. from the same control donor, the lymphocyte suspension exhibited significantly less clumping.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9poSrs9iKR7Vg90H21EOLACvtfcHk0lhwjR0ztR9nTQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF2MXkvVaqurY%253D&amp;md5=c635e03858a1a33139062841a53d2298</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.54.2.400&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.54.2.400%26sid%3Dliteratum%253Aachs%26aulast%3DAub%26aufirst%3DJ.%2BC.%26aulast%3DSanford%26aufirst%3DB.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BH.%26atitle%3DReactions%2520of%2520normal%2520and%2520leukemic%2520cell%2520surfaces%2520to%2520a%2520wheat%2520germ%2520agglutinin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1965%26volume%3D54%26issue%3D2%26spage%3D400%26epage%3D402%26doi%3D10.1073%2Fpnas.54.2.400" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aub, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M. N.</span></span> <span> </span><span class="NLM_article-title">Studies on reactivity of tumor and normal cells to a wheat germ agglutinin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">399</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.54.2.396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.54.2.396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=5217426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF2MXkslCru7w%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=54&amp;publication_year=1965&amp;pages=396-399&amp;issue=2&amp;author=J.+C.+Aubauthor=B.+H.+Sanfordauthor=M.+N.+Cote&amp;title=Studies+on+reactivity+of+tumor+and+normal+cells+to+a+wheat+germ+agglutinin&amp;doi=10.1073%2Fpnas.54.2.396" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity of tumor and normal cells to a wheat germ agglutinin</span></div><div class="casAuthors">Aub, Joseph D.; Sanford, Barbara H.; Cote, Marilyn N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">396-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">One mg. of wheat germ agglutinin (I) caused more clumping of L #2 lymphoma cells than of spleen cells from adult strain A mice and caused more clumping of 6C3HED tumor cells than of speen cells from either adult or newborn C3H mice.  Tumor prepns. showed 3-dimensional clumping rather than the monolayer effect seen in normal spleen prepns.  Slight aggregation spontaneously occurring in normal and regenerating liver or epidermis cells was not increased by incubation with I.  Thymus gland, lung, and bone marrow cells gave a slight but definite clumping when exposed to I.  I appeared to detect a cell surface component present in high concn. in ascites tumor cells and in lesser concn. on cells from certain normal tissues.  The difference in reactivity between tumor and normal cells seemed to be due to a cell surface property related to neoplasia rather than to rapid cell growth and division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzc6P_ABuU7Vg90H21EOLACvtfcHk0lhwjR0ztR9nTQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF2MXkslCru7w%253D&amp;md5=986ea88261d10a9787ff1179e1a4d18b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.54.2.396&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.54.2.396%26sid%3Dliteratum%253Aachs%26aulast%3DAub%26aufirst%3DJ.%2BC.%26aulast%3DSanford%26aufirst%3DB.%2BH.%26aulast%3DCote%26aufirst%3DM.%2BN.%26atitle%3DStudies%2520on%2520reactivity%2520of%2520tumor%2520and%2520normal%2520cells%2520to%2520a%2520wheat%2520germ%2520agglutinin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1965%26volume%3D54%26issue%3D2%26spage%3D396%26epage%3D399%26doi%3D10.1073%2Fpnas.54.2.396" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doljanski, F.</span></span> <span> </span><span class="NLM_article-title">Agglutination of normal and rous sarcoma virus-transformed chick embryo cells by concanavalin A and wheat germ agglutinin</span>. <i>Nature: New biology</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>235</i></span> (<span class="NLM_issue">58</span>),  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi">&nbsp;DOI: 10.1038/newbio235184a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnewbio235184a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=4334195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaE38Xht1Giu7s%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=235&amp;publication_year=1972&amp;pages=184-185&amp;issue=58&amp;author=M.+Kapellerauthor=F.+Doljanski&amp;title=Agglutination+of+normal+and+rous+sarcoma+virus-transformed+chick+embryo+cells+by+concanavalin+A+and+wheat+germ+agglutinin&amp;doi=10.1038%2Fnewbio235184a0" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Agglutination of normal and Rous sarcoma virus-transformed chick embryo cells by concanavalin A and wheat germ agglutinin</span></div><div class="casAuthors">Kapeller, M.; Doljanski, F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">58</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Rous sarcoma virus-transformed chick embryo cells were agglutinated in vitro by concanavalin A and by wheat germ agglutinin to a greater degree than normal embryo cells.  Treatment of normal cells with trypsin increased their agglutinability.  Treatment of both normal and transformed embryo cells with neuraminidase decreased the agglutinability of these cells to wheat germ agglutinin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSqaoyNlQH37Vg90H21EOLACvtfcHk0lgVbhsJFnunSQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaE38Xht1Giu7s%253D&amp;md5=69dafe4b85c951b64006c1b4dc31bd27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnewbio235184a0&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio235184a0%26sid%3Dliteratum%253Aachs%26aulast%3DKapeller%26aufirst%3DM.%26aulast%3DDoljanski%26aufirst%3DF.%26atitle%3DAgglutination%2520of%2520normal%2520and%2520rous%2520sarcoma%2520virus-transformed%2520chick%2520embryo%2520cells%2520by%2520concanavalin%2520A%2520and%2520wheat%2520germ%2520agglutinin%26jtitle%3DNature%253A%2520New%2520biology%26date%3D1972%26volume%3D235%26issue%3D58%26spage%3D184%26epage%3D185%26doi%3D10.1038%2Fnewbio235184a0" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meezan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, P. W.</span></span> <span> </span><span class="NLM_article-title">Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2518</span>– <span class="NLM_lpage">2524</span>, <span class="refDoi">&nbsp;DOI: 10.1021/bi00834a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00834a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text"></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaF1MXktlOjtLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=8&amp;publication_year=1969&amp;pages=2518-2524&amp;issue=6&amp;author=E.+Meezanauthor=H.+C.+Wuauthor=P.+H.+Blackauthor=P.+W.+Robbins&amp;title=Comparative+studies+on+the+carbohydrate-containing+membrane+components+of+normal+and+virus-transformed+mouse+fibroblasts.+II.+Separation+of+glycoproteins+and+glycopeptides+by+sephadex+chromatography&amp;doi=10.1021%2Fbi00834a039" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts.  II.  Separation of glycoproteins and glycopeptides by Sephadex chromatography</span></div><div class="casAuthors">Meezan, Elias; Wu, Henry C.; Black, Paul H.; Robbins, Phillips W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2518-24</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Anal. of membrane carbohydrates has revealed that following SV-40 virus transformation of mouse fibroblast 3T3, there is a marked decrease in most neutral and amino sugars, especially sialic acid and N-acetylgalactosamine.  To examine this change in the compn. of membrane glycoproteins in greater detail, we have fractionated the labeled membrane fractions derived from 3T3 and transformed 3T3 lines on Sephadex G-150 in the presence of Na dodecyl sulfate.  In addn., membrane glycoproteins were digested with the proteolytic enzyme, Pronase, followed by the fractionation of the glycopeptide mixt. on Sephadex G-50.  The possible mechanisms by which these changes in the compn. of membrane glycoproteins are brought about are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQQLTKZLAh9LVg90H21EOLACvtfcHk0lgVbhsJFnunSQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaF1MXktlOjtLc%253D&amp;md5=9909b8f880ff079c00b57266eda89a45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00834a039&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00834a039%26sid%3Dliteratum%253Aachs%26aulast%3DMeezan%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%2BC.%26aulast%3DBlack%26aufirst%3DP.%2BH.%26aulast%3DRobbins%26aufirst%3DP.%2BW.%26atitle%3DComparative%2520studies%2520on%2520the%2520carbohydrate-containing%2520membrane%2520components%2520of%2520normal%2520and%2520virus-transformed%2520mouse%2520fibroblasts.%2520II.%2520Separation%2520of%2520glycoproteins%2520and%2520glycopeptides%2520by%2520sephadex%2520chromatography%26jtitle%3DBiochemistry%26date%3D1969%26volume%3D8%26issue%3D6%26spage%3D2518%26epage%3D2524%26doi%3D10.1021%2Fbi00834a039" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghorne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerbel, R. S.</span></span> <span> </span><span class="NLM_article-title">Beta 1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>236</i></span> (<span class="NLM_issue">4801</span>),  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">585</span>, <span class="refDoi">&nbsp;DOI: 10.1126/science.2953071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1126%2Fscience.2953071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=2953071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaL2sXkt1Wgu7o%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=236&amp;publication_year=1987&amp;pages=582-585&amp;issue=4801&amp;author=J.+W.+Dennisauthor=S.+Laferteauthor=C.+Waghorneauthor=M.+L.+Breitmanauthor=R.+S.+Kerbel&amp;title=Beta+1%E2%80%936+branching+of+Asn-linked+oligosaccharides+is+directly+associated+with+metastasis&amp;doi=10.1126%2Fscience.2953071" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">β1-6 Branching of Asn-linked oligosaccharides is directly associated with metastasis</span></div><div class="casAuthors">Dennis, James W.; Laferte, Suzanne; Waghorne, Carol; Breitman, Martin L.; Kerbel, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">4801</span>),
    <span class="NLM_cas:pages">582-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Glycosylation mutants of a metastatic murine tumor cell line were selected that are deficient in both β1-6 GlcNAc transferase activity and metastatic potential in situ.  Moreover, induction of increased β1-6 branching in clones of a nonmetastatic murine mammary carcinoma correlated strongly with acquisition of metastatic potential.  Increased β1-6-linked branching of complex-type oligosaccharides on cell surface glycoprotein gp130 may be an important feature of tumor progression related to increased metastatic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPNUWfQDx1Z7Vg90H21EOLACvtfcHk0lgVbhsJFnunSQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaL2sXkt1Wgu7o%253D&amp;md5=c21edc2e9759a677349d0985f7c0f855</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.2953071&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2953071%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DLaferte%26aufirst%3DS.%26aulast%3DWaghorne%26aufirst%3DC.%26aulast%3DBreitman%26aufirst%3DM.%2BL.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DBeta%25201%25E2%2580%25936%2520branching%2520of%2520Asn-linked%2520oligosaccharides%2520is%2520directly%2520associated%2520with%2520metastasis%26jtitle%3DScience%26date%3D1987%26volume%3D236%26issue%3D4801%26spage%3D582%26epage%3D585%26doi%3D10.1126%2Fscience.2953071" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, J. W.</span></span> <span> </span><span class="NLM_article-title">N-Glycans in cancer progression</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">760</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cwn071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcwn071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=18701722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOgtL3O" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=18&amp;publication_year=2008&amp;pages=750-760&amp;issue=10&amp;author=K.+S.+Lauauthor=J.+W.+Dennis&amp;title=N-Glycans+in+cancer+progression&amp;doi=10.1093%2Fglycob%2Fcwn071" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-Glycans in cancer progression</span></div><div class="casAuthors">Lau, Ken S.; Dennis, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">750-760</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  N-Glycan branching in the medial-Golgi generates ligands for lattice-forming lectins (e.g., galectins) that regulate surface levels of glycoproteins including epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) receptors.  Moreover, functional classes of glycoproteins differ in N-glycan multiplicities (no. of N-glycans/peptide), a genetically encoded feature of glycoproteins that interacts with metabolic flux (UDP-GlcNAc) and N-glycan branching to differentially regulate surface levels.  Oncogenesis increases β1,6-N-acetylglucosaminyltransferase V (encoded by Mgat5) expression, and its high-affinity galectin ligands promote surface retention of growth receptors with a reduced dependence on UDP-GlcNAc.  Mgat5-/- tumor cells are less metastatic in vivo and less responsive to cytokines in vitro, but undergo secondary changes that support tumor cell proliferation.  These include loss of Caveolin-1, a neg. regulator of EGF signaling, and increased reactive oxygen species, an inhibitor of phosphotyrosine phosphatases.  These studies suggest a systems approach to cancer treatment where the surface distribution of receptors is targeted through metab. and N-glycan branching to induce growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDXBMo0EpfuLVg90H21EOLACvtfcHk0lgVbhsJFnunSQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOgtL3O&amp;md5=c4acb5992531f12a072445c6a4540d9d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwn071&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwn071%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DK.%2BS.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26atitle%3DN-Glycans%2520in%2520cancer%2520progression%26jtitle%3DGlycobiology%26date%3D2008%26volume%3D18%26issue%3D10%26spage%3D750%26epage%3D760%26doi%3D10.1093%2Fglycob%2Fcwn071" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, M.</span></span> <span> </span><span class="NLM_article-title">Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration</span>. <i>Cancer research</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6837</span>– <span class="NLM_lpage">6845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12460896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahs7w%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=62&amp;publication_year=2002&amp;pages=6837-6845&amp;issue=23&amp;author=H.+B.+Guoauthor=I.+Leeauthor=M.+Kamarauthor=S.+K.+Akiyamaauthor=M.+Pierce&amp;title=Aberrant+N-glycosylation+of+beta1+integrin+causes+reduced+alpha5beta1+integrin+clustering+and+stimulates+cell+migration" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant N-glycosylation of β1 integrin causes reduced α5β1 integrin clustering and stimulates cell migration</span></div><div class="casAuthors">Guo, Hua-Bei; Lee, Intaek; Kamar, Maria; Akiyama, Steven K.; Pierce, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6837-6845</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Altered expression of cell surface N-linked oligosaccharides is assocd. with the oncogenic transformation of many types of animal cells.  One of the most common forms of glycosylation in transformed cells and human tumors is the highly elevated β1,6 branching of N-linked oligosaccharides caused by increased transcription of N-acetylglucosaminyltransferase V (GnT-V).  To characterize the effects of increased β1,6 branching on cell-matrix adhesion-mediated phenotypes, human fibrosarcoma HT1080 cells were transfected with retroviral systems encoding GnT-V that used both noninducible and tetracycline-inducible promoters.  Increased GnT-V expression resulted in a &gt;25% inhibition of cell attachment to and a &gt;50% inhibition of cell spreading on fibronectin.  Both cell adhesion and spreading were suppressed by function-blocking antibodies specific for the α5 and β1 integrin subunits of the fibronectin receptor.  Cell migration toward fibronectin and invasion through Matrigel were both substantially stimulated in cells with induced expression of GnT-V.  Induction of GnT-V had no effect on the level of cell surface expression of α5 and β1 integrin subunits but did result in a more diffuse staining of the α5 and β1 integrin subunits on the cell surface, suggesting that inhibition of integrin clustering may be causing these cells to be less adhesive and more motile.  Surprisingly, there was no detectable expression of N-linked β1,6 branching on the α5 subunit purified from HT1080 cells before and after induction of GnT-V; by contrast, however, the β1 subunit showed a basal level of β1,6 branching that was greatly increased after induction of GnT-V.  These results suggest that changes in N-linked β1,6 branching that occur during oncogenesis alter cell-matrix adhesion and migration by modulating integrin clustering and subsequent signal transduction pathways.  These effects most likely result from altered N-linked carbohydrate expression on the β1 integrin subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNmfa-r3MsNrVg90H21EOLACvtfcHk0lhTtKp4n7ueUg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XpsVahs7w%253D&amp;md5=39c475975156814c578867376b757aa3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%2BB.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DKamar%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DS.%2BK.%26aulast%3DPierce%26aufirst%3DM.%26atitle%3DAberrant%2520N-glycosylation%2520of%2520beta1%2520integrin%2520causes%2520reduced%2520alpha5beta1%2520integrin%2520clustering%2520and%2520stimulates%2520cell%2520migration%26jtitle%3DCancer%2520research%26date%3D2002%26volume%3D62%26issue%3D23%26spage%3D6837%26epage%3D6845" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ugorski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskowska, A.</span></span> <span> </span><span class="NLM_article-title">Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells</span>. <i>Acta biochimica Polonica</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi">&nbsp;DOI: 10.18388/abp.2002_3788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18388%2Fabp.2002_3788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12362971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFCrtbo%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=49&amp;publication_year=2002&amp;pages=303-311&amp;issue=2&amp;author=M.+Ugorskiauthor=A.+Laskowska&amp;title=Sialyl+Lewis%28a%29%3A+a+tumor-associated+carbohydrate+antigen+involved+in+adhesion+and+metastatic+potential+of+cancer+cells&amp;doi=10.18388%2Fabp.2002_3788" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sialyl Lewisa: a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells</span></div><div class="casAuthors">Ugorski, Maciej; Laskowska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Neoplastic transformation is often assocd. with characteristic changes in the expression of the sialyl Lewisa and sialyl Lewisx antigens, representing typical tumor-assocd. carbohydrate antigens.  High amts. of sialyl Lewisa are present in human adenocarcinomas of the colon, pancreas and stomach.  A growing amt. of data suggests that this carbohydrate structure is the ligand for E-selectin.  Sialylated Lewis structures present on the surface of tumor cells are carried by the carbohydrate chains of glycoproteins and glycolipids.  There are several lines of evidence showing that sialyl Lewisa is responsible for the adhesion of human cancer cells to endothelium.  E-selectin present on endothelial cells mediates these interactions.  Selectins and their carbohydrate ligands can thus play an important role in the selective homing of tumor cells during metastasis.  However, the presence of sialyl Lewisa antigen on the surface of tumor cells and their adhesion to E-selectin-expressing cells in in vitro adhesion assay by itself can not be directly related to metastatic properties of all cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8aHkD0BR_V7Vg90H21EOLACvtfcHk0lhTtKp4n7ueUg"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD38XlsFCrtbo%253D&amp;md5=9fb132cc58516488e6c85e8410c25e1c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.18388%2Fabp.2002_3788&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2002_3788%26sid%3Dliteratum%253Aachs%26aulast%3DUgorski%26aufirst%3DM.%26aulast%3DLaskowska%26aufirst%3DA.%26atitle%3DSialyl%2520Lewis%2528a%2529%253A%2520a%2520tumor-associated%2520carbohydrate%2520antigen%2520involved%2520in%2520adhesion%2520and%2520metastatic%2520potential%2520of%2520cancer%2520cells%26jtitle%3DActa%2520biochimica%2520Polonica%26date%3D2002%26volume%3D49%26issue%3D2%26spage%3D303%26epage%3D311%26doi%3D10.18388%2Fabp.2002_3788" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, D. J.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of glycosylation in cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">35478</span>– <span class="NLM_lpage">35489</span>, <span class="refDoi">&nbsp;DOI: 10.18632/oncotarget.8155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.18632%2Foncotarget.8155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27007155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC28fivFSquw%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2016&amp;pages=35478-35489&amp;issue=23&amp;author=J.+Munkleyauthor=D.+J.+Elliott&amp;title=Hallmarks+of+glycosylation+in+cancer&amp;doi=10.18632%2Foncotarget.8155" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of glycosylation in cancer</span></div><div class="casAuthors">Munkley Jennifer; Elliott David J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">35478-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aberrant glycosylation plays a fundamental role in key pathological steps of tumour development and progression.  Glycans have roles in cancer cell signalling, tumour cell dissociation and invasion, cell-matrix interactions, angiogenesis, metastasis and immune modulation.  Aberrant glycosylation is often cited as a 'hallmark of cancer' but is notably absent from both the original hallmarks of cancer and from the next generation of emerging hallmarks.  This review discusses how glycosylation is clearly an enabling characteristic that is causally associated with the acquisition of all the hallmark capabilities.  Rather than aberrant glycosylation being itself a hallmark of cancer, another perspective is that glycans play a role in every recognised cancer hallmark.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1KZr0A02av5SWdIdmEou5fW6udTcc2eb4TAszVD05Abntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC28fivFSquw%253D%253D&amp;md5=defcd3e7c63c03725d2846f730288713</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8155&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8155%26sid%3Dliteratum%253Aachs%26aulast%3DMunkley%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DD.%2BJ.%26atitle%3DHallmarks%2520of%2520glycosylation%2520in%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D23%26spage%3D35478%26epage%3D35489%26doi%3D10.18632%2Foncotarget.8155" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Brok, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span> <span> </span><span class="NLM_article-title">Sialic acids sweeten a tumor’s life</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3199</span>– <span class="NLM_lpage">3204</span>, <span class="refDoi">&nbsp;DOI: 10.1158/0008-5472.CAN-14-0728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1158%2F0008-5472.CAN-14-0728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24830719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2cjjtVyquw%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=74&amp;publication_year=2014&amp;pages=3199-3204&amp;issue=12&amp;author=C.+Bullauthor=M.+A.+Stoelauthor=M.+H.+den+Brokauthor=G.+J.+Adema&amp;title=Sialic+acids+sweeten+a+tumor%E2%80%99s+life&amp;doi=10.1158%2F0008-5472.CAN-14-0728" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids sweeten a tumor's life</span></div><div class="casAuthors">Bull Christian; Stoel Marieke A; den Brok Martijn H; Adema Gosse J</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3199-204</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over four decades ago, specific tumor characteristics were ascribed to the increased expression of sialic acid sugars on the surface of cancer cells, and this led to the definition of sialic acids as potential therapeutic targets.  Recent advances in glycobiology and cancer research have defined the key processes underlying aberrant expression of sialic acids in cancer, and its consequences, more precisely.  These consequences include effects on tumor growth, escape from apoptosis, metastasis formation, and resistance to therapy.  Collectively, these novel insights provide further rationale for the design and development of therapeutic approaches that interfere with excessively high expression of sialic acids in cancer cells.  Strategies to target aberrant sialylation in cancer, however, have evolved comparatively slowly.  Here, we review recent findings that emphasize the detrimental effects of hypersialylation on multiple aspects of tumor growth and behavior.  We also discuss novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNLUHKArjTl4FEOhA_Im3cfW6udTcc2eb4TAszVD05Abntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2cjjtVyquw%253D%253D&amp;md5=2bdc9202b38cecb569cb9e061ebd0202</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0728&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0728%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DC.%26aulast%3DStoel%26aufirst%3DM.%2BA.%26aulast%3Dden%2BBrok%26aufirst%3DM.%2BH.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26atitle%3DSialic%2520acids%2520sweeten%2520a%2520tumor%25E2%2580%2599s%2520life%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D12%26spage%3D3199%26epage%3D3204%26doi%3D10.1158%2F0008-5472.CAN-14-0728" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas</span>. <i>Cancer research</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4605</span>– <span class="NLM_lpage">4611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=11389097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlWjsb4%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=61&amp;publication_year=2001&amp;pages=4605-4611&amp;issue=11&amp;author=F.+Schneider&amp;title=Overexpression+of+sialyltransferase+CMP-sialic+acid%3AGalbeta1%2C3GalNAc-R+alpha6-Sialyltransferase+is+related+to+poor+patient+survival+in+human+colorectal+carcinomas" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of sialyltransferase CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinomas</span></div><div class="casAuthors">Schneider, Frank; Kemmner, Wolfgang; Haensch, Wolfgang; Franke, Gudrun; Gretschel, Stephan; Karsten, Uwe; Schlag, Peter Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4605-4611</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thomsen-Friedenreich (TF)-related blood group antigens, such as TF, Tn, and their sialylated variants, belong to a family of tumor-assocd. carbohydrates.  The aim of the present study was to examine tumor-assocd. alterations of glycosyltransferases involved in the biosynthesis of the TF glycotope in colorectal carcinomas.  To this end, glycosyltransferase expression was examd. in 40 cases of colorectal carcinoma specimens classified according to the WHO/Union International Contre Cancer guidelines and in "normal" mucosa of the same patients.  Occurrence of TF glycotope was examd. by immunohistochem. with the monoclonal antibody A78-G/A7.  Expression of sialyltransferases CMP-sialic acid:Galβ1,3GalNAc-R α3-sialyltransferase I and II (ST3Gal-I and ST3Gal-II) and CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase (ST6GalNAc-II) and of core 2 β1,6-N-acetylglucosaminyltransferase was detd. by reverse transcription-PCR in the same cryostat sections used for immunohistochem.  Addnl., α2,3-sialyltransferase enzyme activity was studied in each of these tissues.  The TF glycotope was detected in 7% of the normal mucosa, but in 57% of the carcinoma samples.  Expression of α2,3-sialyltransferases ST3Gal-I, ST3Gal-II, and enzyme activity of α2,3-sialyltransferase was significantly increased (P &lt; 0.001) in carcinoma specimens compared with normal mucosa.  ST3Gal-I mRNA expression was significantly increased (P = 0.05) in cases showing invasion of lymph vessels.  Expression of ST6GalNAc-II was significantly increased (P = 0.04) in cases with metastases to lymph nodes along the vascular trunk.  Moreover, ST6GalNAc-II expression provides an prognostic factor for patient survival (log rank, P = 0.02).  In an attempt to study the functional relevance of the glycosyltransferases for TF biosynthesis, SW480 colorectal cells were transfected with each of the enzymes, and cell surface expression of the TF glycotope was examd. by flow cytometry.  The presence of TF was not altered by transfection of the cells with either sialyltransferase ST3Gal-I or ST3Gal-II.  However, successful transfection with core 2 β1,6-N-acetylglucosaminyltransferase led to reduced expression of TF.  In contrast, increased cell surface expression of TF was found after ST6GalNAc-II transfection.  Thus, expression of TF on the cell surface of SW480 colorectal carcinoma cells depends on the ratio of core 2 β1,6-N-acetylglucosaminyltransferase and ST6GalNAc-II.  Earlier immunohistol. studies demonstrated that TF is a prognostic factor for patient survival.  Our results suggest that sialyltransferase ST6GalNAc-II is of crucial relevance for the prognostic significance of TF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruG_wEv86DVbVg90H21EOLACvtfcHk0lgbzDtu1B41XQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3MXktlWjsb4%253D&amp;md5=42be917413cddb7ad36fe03b8a3a78c6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26atitle%3DOverexpression%2520of%2520sialyltransferase%2520CMP-sialic%2520acid%253AGalbeta1%252C3GalNAc-R%2520alpha6-Sialyltransferase%2520is%2520related%2520to%2520poor%2520patient%2520survival%2520in%2520human%2520colorectal%2520carcinomas%26jtitle%3DCancer%2520research%26date%3D2001%26volume%3D61%26issue%3D11%26spage%3D4605%26epage%3D4611" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4663</span>– <span class="NLM_lpage">4673</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M116.763862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M116.763862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=28154177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVClt7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=292&amp;publication_year=2017&amp;pages=4663-4673&amp;issue=11&amp;author=C.+M.+Britainauthor=K.+A.+Dorsettauthor=S.+L.+Bellis&amp;title=The+Glycosyltransferase+ST6Gal-I+Protects+Tumor+Cells+against+Serum+Growth+Factor+Withdrawal+by+Enhancing+Survival+Signaling+and+Proliferative+Potential&amp;doi=10.1074%2Fjbc.M116.763862" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential</span></div><div class="casAuthors">Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4663-4673</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A hallmark of cancer cells is the ability to survive and proliferate when challenged with stressors such as growth factor insufficiency.  In this study, we report a novel glycosylation-dependent mechanism that protects tumor cells from serum growth factor withdrawal.  Our results suggest that the β-galactoside α-2,6-sialyltransferase 1 (ST6Gal-I) sialyltransferase, which is up-regulated in numerous cancers, promotes the survival of serum-starved cells.  Using ovarian and pancreatic cancer cell models with ST6Gal-I overexpression or knockdown, we find that serum-starved cells with high ST6Gal-I levels exhibit increased activation of prosurvival signaling mols., including pAkt, p-p70S6K, and pNFκB.  Correspondingly, ST6Gal-I activity augments the expression of tumor-promoting pNFκB transcriptional targets such as IL-6, IL-8, and the apoptosis inhibitor cIAP2.  ST6Gal-I also potentiates expression of the cell cycle regulator cyclin D2, leading to increased phosphorylation and inactivation of the cell cycle inhibitor pRb.  Consistent with these results, serum-starved cells with high ST6Gal-I expression maintain a greater no. of S phase cells compared with low ST6Gal-I expressors, reflecting enhanced proliferation.  Finally, selective enrichment in clonal variants with high ST6Gal-I expression is obsd. upon prolonged serum deprivation, supporting the concept that ST6Gal-I confers a survival advantage.  Collectively, these results implicate a functional role for ST6Gal-I in fostering tumor cell survival within the serum-depleted tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdlfzgyqvv5bVg90H21EOLACvtfcHk0lgbzDtu1B41XQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXksVClt7k%253D&amp;md5=40b8a982cab7c622eea8df4edcf67a4d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.763862&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.763862%26sid%3Dliteratum%253Aachs%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Glycosyltransferase%2520ST6Gal-I%2520Protects%2520Tumor%2520Cells%2520against%2520Serum%2520Growth%2520Factor%2520Withdrawal%2520by%2520Enhancing%2520Survival%2520Signaling%2520and%2520Proliferative%2520Potential%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D11%26spage%3D4663%26epage%3D4673%26doi%3D10.1074%2Fjbc.M116.763862" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdbrooks, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death</span>. <i>J. Ovarian Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>, <span class="refDoi">&nbsp;DOI: 10.1186/s13048-018-0385-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1186%2Fs13048-018-0385-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29402301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtlKgt78%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2018&amp;pages=12&amp;issue=1&amp;author=C.+M.+Britainauthor=A.+T.+Holdbrooksauthor=J.+C.+Andersonauthor=C.+D.+Willeyauthor=S.+L.+Bellis&amp;title=Sialylation+of+EGFR+by+the+ST6Gal-I+sialyltransferase+promotes+EGFR+activation+and+resistance+to+gefitinib-mediated+cell+death&amp;doi=10.1186%2Fs13048-018-0385-0" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death</span></div><div class="casAuthors">Britain, Colleen M.; Holdbrooks, Andrew T.; Anderson, Joshua C.; Willey, Christopher D.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ovarian Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12/1-12/11</span>CODEN:
                <span class="NLM_cas:coden">JOROBL</span>;
        ISSN:<span class="NLM_cas:issn">1757-2215</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The ST6Gal-I sialyltransferase is upregulated in numerous cancers, and high expression of this enzyme correlates with poor patient prognosis in various malignancies, including ovarian cancer.  Through its sialylation of a select cohort of cell surface receptors, ST6Gal-I modulates cell signaling to promote tumor cell survival.  The goal of the present study was to investigate the influence of ST6Gal-I on another important receptor that controls cancer cell behavior, EGFR.  Addnl., the effect of ST6Gal-I on cancer cells treated with the common EGFR inhibitor, gefitinib, was evaluated.  Results: Using the OV4 ovarian cancer cell line, which lacks endogenous ST6Gal-I expression, a kinomics assay revealed that cells with forced overexpression of ST6Gal-I exhibited increased global tyrosine kinase activity, a finding confirmed by immunoblotting whole cell lysates with an anti-phosphotyrosine antibody.  Interestingly, the kinomics assay suggested that one of the most highly activated tyrosine kinases in ST6Gal-I-overexpressing OV4 cells was EGFR.  Based on these findings, addnl. analyses were performed to investigate the effect of ST6Gal-I on EGFR activation.  To this end, we utilized, in addn. to OV4 cells, the SKOV3 ovarian cancer cell line, engineered with both ST6Gal-I overexpression and knockdown, as well as the BxPC3 pancreatic cancer cell line with knockdown of ST6Gal-I.  In all three cell lines, we detd. that EGFR is a substrate of ST6Gal-I, and that the sialylation status of EGFR directly correlates with ST6Gal-I expression.  Cells with differential ST6Gal-I expression were subsequently evaluated for EGFR tyrosine phosphorylation.  Cells with high ST6Gal-I expression were found to have elevated levels of basal and EGF-induced EGFR activation.  Conversely, knockdown of ST6Gal-I greatly attenuated EGFR activation, both basally and post EGF treatment.  Finally, to illustrate the functional importance of ST6Gal-I in regulating EGFR-dependent survival, cells were treated with gefitinib, an EGFR inhibitor widely used for cancer therapy.  These studies showed that ST6Gal-I promotes resistance to gefitinib-mediated apoptosis, as measured by caspase activity assays.  Conclusion: Results herein indicate that ST6Gal-I promotes EGFR activation and protects against gefitinib-mediated cell death.  Establishing the tumor-assocd. ST6Gal-I sialyltransferase as a regulator of EGFR provides novel insight into the role of glycosylation in growth factor signaling and chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkYMTfSrx9MLVg90H21EOLACvtfcHk0lgbzDtu1B41XQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXjtlKgt78%253D&amp;md5=2f4046fe0062a90b1f9e9aa8a0f42b3a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13048-018-0385-0&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13048-018-0385-0%26sid%3Dliteratum%253Aachs%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DHoldbrooks%26aufirst%3DA.%2BT.%26aulast%3DAnderson%26aufirst%3DJ.%2BC.%26aulast%3DWilley%26aufirst%3DC.%2BD.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DSialylation%2520of%2520EGFR%2520by%2520the%2520ST6Gal-I%2520sialyltransferase%2520promotes%2520EGFR%2520activation%2520and%2520resistance%2520to%2520gefitinib-mediated%2520cell%2520death%26jtitle%3DJ.%2520Ovarian%2520Res.%26date%3D2018%26volume%3D11%26issue%3D1%26spage%3D12%26doi%3D10.1186%2Fs13048-018-0385-0" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holdbrooks, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britain, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1622</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M117.801480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M117.801480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29233887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVygtbc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=293&amp;publication_year=2018&amp;pages=1610-1622&amp;issue=5&amp;author=A.+T.+Holdbrooksauthor=C.+M.+Britainauthor=S.+L.+Bellis&amp;title=ST6Gal-I+sialyltransferase+promotes+tumor+necrosis+factor+%28TNF%29-mediated+cancer+cell+survival+via+sialylation+of+the+TNF+receptor+1+%28TNFR1%29+death+receptor&amp;doi=10.1074%2Fjbc.M117.801480" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor</span></div><div class="casAuthors">Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1610-1622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of the tumor necrosis factor receptor 1 (TNFR1) death receptor by TNF induces either cell survival or cell death.  However, the mechanisms mediating these distinct outcomes remain poorly understood.  In this study, we report that the ST6Gal-I sialyltransferase, an enzyme up-regulated in numerous cancers, sialylates TNFR1 and thereby protects tumor cells from TNF-induced apoptosis.  Using pancreatic and ovarian cancer cells with ST6Gal-I knockdown or overexpression, we detd. that α2-6 sialylation of TNFR1 had no effect on early TNF-induced signaling events, including the rapid activation of NF-κB, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and Akt (occurring within 15 min).  However, upon extended TNF treatment (6-24 h), cells with high ST6Gal-I levels exhibited resistance to TNF-induced apoptosis, as indicated by morphol. evidence of cell death and decreased activation of caspases 8 and 3.  Correspondingly, at these later time points, high ST6Gal-I expressers displayed sustained activation of the survival mols. Akt and NF-κB.  Addnl., extended TNF treatment resulted in the selective enrichment of clonal variants with high ST6Gal-I expression, further substantiating a role for ST6Gal-I in cell survival.  Given that TNFR1 internalization is known to be essential for apoptosis induction, whereas survival signaling is initiated by TNFR1 at the plasma membrane, we examd. TNFR1 localization.  The α2-6 sialylation of TNFR1 was found to inhibit TNF-induced TNFR1 internalization.  Thus, by restraining TNFR1 at the cell surface via sialylation, ST6Gal-I acts as a functional switch to divert signaling toward survival.  These collective findings point to a novel glycosylation-dependent mechanism that regulates the cellular response to TNF and may promote cancer cell survival within TNF-rich tumor microenvironments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCCVFycP7j7Vg90H21EOLACvtfcHk0lgbzDtu1B41XQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXnsVygtbc%253D&amp;md5=b84f832eb8a9c3d4143bb03fe796a945</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.801480&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.801480%26sid%3Dliteratum%253Aachs%26aulast%3DHoldbrooks%26aufirst%3DA.%2BT.%26aulast%3DBritain%26aufirst%3DC.%2BM.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DST6Gal-I%2520sialyltransferase%2520promotes%2520tumor%2520necrosis%2520factor%2520%2528TNF%2529-mediated%2520cancer%2520cell%2520survival%2520via%2520sialylation%2520of%2520the%2520TNF%2520receptor%25201%2520%2528TNFR1%2529%2520death%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D5%26spage%3D1610%26epage%3D1622%26doi%3D10.1074%2Fjbc.M117.801480" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmeland, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1alpha signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5659</span>– <span class="NLM_lpage">5667</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.RA117.001194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.RA117.001194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29475939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCnt78%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=293&amp;publication_year=2018&amp;pages=5659-5667&amp;issue=15&amp;author=R.+B.+Jonesauthor=K.+A.+Dorsettauthor=A.+B.+Hjelmelandauthor=S.+L.+Bellis&amp;title=The+ST6Gal-I+sialyltransferase+protects+tumor+cells+against+hypoxia+by+enhancing+HIF-1alpha+signaling&amp;doi=10.1074%2Fjbc.RA117.001194" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling</span></div><div class="casAuthors">Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5659-5667</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant cell surface glycosylation is prevalent in tumor cells, and there is ample evidence that glycans have functional roles in carcinogenesis.  Nonetheless, many mol. details remain unclear.  Tumor cells frequently exhibit increased α2-6 sialylation on N-glycans, a modification that is added by the ST6Gal-I sialyltransferase, and emerging evidence suggests that ST6Gal-I-mediated sialylation promotes the survival of tumor cells exposed to various cell stressors.  Here we report that ST6Gal-I protects cancer cells from hypoxic stress.  It is well known that hypoxia-inducible factor 1α (HIF-1α) is stabilized in hypoxic cells, and, in turn, HIF-1α directs the transcription of genes important for cell survival.  To investigate a putative role for ST6Gal-I in the hypoxic response, we examd. HIF-1α accumulation in ovarian and pancreatic cancer cells in ST6Gal-I overexpression or knockdown expts.  We found that ST6Gal-I activity augmented HIF-1α accumulation in cells grown in a hypoxic environment or treated with two chem. hypoxia mimetics, deferoxamine and dimethyloxalylglycine.  Correspondingly, hypoxic cells with high ST6Gal-I expression had increased mRNA levels of HIF-1α transcriptional targets, including the glucose transporter genes GLUT1 and GLUT3 and the glycolytic enzyme gene PDHK1.  Interestingly, high ST6Gal-I-expressing cells also had an increased pool of HIF-1α mRNA, suggesting that ST6Gal-I may influence HIF-1α expression.  Finally, cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function.  Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaqolpN98gCbVg90H21EOLACvtfcHk0ljpOjHfuXX4IQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCnt78%253D&amp;md5=7575dac1c67ed0ea6868841d70ccc92b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.001194&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.001194%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BB.%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DThe%2520ST6Gal-I%2520sialyltransferase%2520protects%2520tumor%2520cells%2520against%2520hypoxia%2520by%2520enhancing%2520HIF-1alpha%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26issue%3D15%26spage%3D5659%26epage%3D5667%26doi%3D10.1074%2Fjbc.RA117.001194" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Recchi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harduin-Lepers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boilly-Marer, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delannoy, P.</span></span> <span> </span><span class="NLM_article-title">Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">27</span>, <span class="refDoi">&nbsp;DOI: 10.1023/A:1006983214918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1023%2FA%3A1006983214918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=9530953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1WmsLw%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=15&amp;publication_year=1998&amp;pages=19-27&amp;issue=1&amp;author=M.+A.+Recchiauthor=A.+Harduin-Lepersauthor=Y.+Boilly-Marerauthor=A.+Verbertauthor=P.+Delannoy&amp;title=Multiplex+RT-PCR+method+for+the+analysis+of+the+expression+of+human+sialyltransferases%3A+application+to+breast+cancer+cells&amp;doi=10.1023%2FA%3A1006983214918" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells</span></div><div class="casAuthors">Recchi, Marie-Ange; Harduin-Lepers, Anne; Boilly-Marer, Yolande; Verbert, Andre; Delannoy, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Chapman &amp; Hall</span>)
        </div><div class="casAbstract">In many cases of human cancer, the appearance of hypersialylated glycan structures is related to a precise stage of the disease; this may depend on altered regulation of one or more sialyltransferases genes.  Since several distinct sialyltransferase enzymes arising from different unique genes transfer sialic acid residues in the same linkage onto the same acceptor, it is impossible to precisely det. which enzyme is involved in the obsd. phenotype based on enzymic assays.  We have developed a very sensitive and highly reproducible multiplex reverse transcriptase-polymerase chain reaction technique in order to monitor the expression of four human sialyltransferases genes ST6Gal I, ST3Gal I, ST3Gal III and ST3GaL IV in small cell samples.  Multiplex PCR amplification using specific primers for each sialyltransferase and detection of amplification products by PAGE is a method that is fast and easy to handle and has proven to be useful for establishing sialyltransferase patterns of expression in breast immortalized cell line HBL 100 as well as in breast cancer cell lines MCF-7/6, MCF-7/AZ and MDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRIkb5nv21nrVg90H21EOLACvtfcHk0ljpOjHfuXX4IQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK1cXhs1WmsLw%253D&amp;md5=34e9db11dbc2af4ea3c51531448be7e6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006983214918&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006983214918%26sid%3Dliteratum%253Aachs%26aulast%3DRecchi%26aufirst%3DM.%2BA.%26aulast%3DHarduin-Lepers%26aufirst%3DA.%26aulast%3DBoilly-Marer%26aufirst%3DY.%26aulast%3DVerbert%26aufirst%3DA.%26aulast%3DDelannoy%26aufirst%3DP.%26atitle%3DMultiplex%2520RT-PCR%2520method%2520for%2520the%2520analysis%2520of%2520the%2520expression%2520of%2520human%2520sialyltransferases%253A%2520application%2520to%2520breast%2520cancer%2520cells%26jtitle%3DGlycoconjugate%2520J.%26date%3D1998%26volume%3D15%26issue%3D1%26spage%3D19%26epage%3D27%26doi%3D10.1023%2FA%3A1006983214918" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">dos-Santos, P. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool</span>. <i>International journal of clinical and experimental pathology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2337</span>– <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=24966944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC2cfmvFeisQ%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2014&amp;pages=2337-2349&amp;issue=5&amp;author=P.+B.+dos-Santos&amp;title=Lectin+histochemistry+reveals+SNA+as+a+prognostic+carbohydrate-dependent+probe+for+invasive+ductal+carcinoma+of+the+breast%3A+a+clinicopathological+and+immunohistochemical+auxiliary+tool" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool</span></div><div class="casAuthors">dos-Santos Petra B; Vieira-de-Mello Gabriela S; Zanetti Juliana S; Ribeiro-Silva A Alfredo; Rego Moacyr B M; Beltrao Eduardo Isidoro Carneiro</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2337-49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased sialylation and β1,6-branched oligosaccharides has been associated with a variety of structural changes in cell surface carbohydrates, most notably in tumorigenesis.  Lectins are defined as proteins that preferentially recognize and bind carbohydrate complexes protruding from glycolipids and glycoproteins.  This interaction with carbohydrates can be as specific as the interaction between antigen and antibody.  Due to this type of interaction lectins have been used as experimental auxiliary tools in histopathological diagnosis of cancer.  This study was designed to evaluate the differential expression of sialic acids and β1,6-N-acetylglucosaminyltransferase V (MGAT5) in invasive (IDC) and in situ (DCIS) ductal carcinoma of the breast and its possible application as prognostic biomarkers.  A possible transition between pre-malign and malign lesions was evaluated using DCIS samples.  Biopsies were analyzed regarding the expression of MUC1, p53, Ki-67, estrogen receptor, progesterone receptor, HER-2 and MGAT5. α2,6-linked sialic acids residues recognized by SNA lectin was overexpressed in 33.3% of IDC samples and it was related with Ki-67 (p=0.042), PR (p=0.029), lymphnodes status (p=0.017) and death (p=0.011).  Regarding survival analysis SNA was the only lectin able to correlate with specific-disease survival and disease-free survival (p=0.024 and p=0.041, respectively), besides, it presents itself as an independent variable by Cox Regression analysis (p= 0.004).  Comparing IDC and DCIS cases, only SNA showed different staining pattern (p=0.034).  The presence of sialic acids on tumor cell surface can be an indicative of poor prognosis and our study provides further evidence that SNA lectin can be used as a prognostic probe in IDC and DCIS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREjKhcKo39aLmQt-ICR3qNfW6udTcc2eZn3RO3cJPKSrntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC2cfmvFeisQ%253D%253D&amp;md5=f70c8693719bb839ef6e13e40913a84b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Ddos-Santos%26aufirst%3DP.%2BB.%26atitle%3DLectin%2520histochemistry%2520reveals%2520SNA%2520as%2520a%2520prognostic%2520carbohydrate-dependent%2520probe%2520for%2520invasive%2520ductal%2520carcinoma%2520of%2520the%2520breast%253A%2520a%2520clinicopathological%2520and%2520immunohistochemical%2520auxiliary%2520tool%26jtitle%3DInternational%2520journal%2520of%2520clinical%2520and%2520experimental%2520pathology%26date%3D2014%26volume%3D7%26issue%3D5%26spage%3D2337%26epage%3D2349" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolarich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. P.</span></span> <span> </span><span class="NLM_article-title">Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">906</span>, <span class="refDoi">&nbsp;DOI: 10.1007/s13361-013-0610-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1007%2Fs13361-013-0610-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=23605685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWnu74%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=24&amp;publication_year=2013&amp;pages=895-906&amp;issue=6&amp;author=A.+V.+Everest-Dassauthor=J.+L.+Abrahamsauthor=D.+Kolarichauthor=N.+H.+Packerauthor=M.+P.+Campbell&amp;title=Structural+feature+ions+for+distinguishing+N-+and+O-linked+glycan+isomers+by+LC-ESI-IT+MS%2FMS&amp;doi=10.1007%2Fs13361-013-0610-4" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Feature Ions for Distinguishing N- and O-Linked Glycan Isomers by LC-ESI-IT MS/MS</span></div><div class="casAuthors">Everest-Dass, Arun V.; Abrahams, Jodie L.; Kolarich, Daniel; Packer, Nicolle H.; Campbell, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">895-906</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glycomics is the comprehensive study of glycan expression in an organism, cell, or tissue that relies on effective anal. technologies to understand glycan structure-function relationships.  Owing to the macro- and micro-heterogeneity of oligosaccharides, detailed structure characterization has required an orthogonal approach, such as a combination of specific exoglycosidase digestions, LC-MS/MS, and the development of bioinformatic resources to comprehensively profile a complex biol. sample.  Liq. chromatog.-electrospray ionization-mass spectrometry (LC-ESI-MS/MS) has emerged as a key tool in the structural anal. of oligosaccharides because of its high sensitivity, resoln., and robustness.  Here, we present a strategy that uses LC-ESI-MS/MS to characterize over 200 N- and O-glycans from human saliva glycoproteins, complemented by sequential exoglycosidase treatment, to further verify the annotated glycan structures.  Fragment-specific substructure diagnostic ions were collated from an extensive screen of the literature available on the detailed structural characterization of oligosaccharides and, together with other specific glycan structure feature ions derived from cross-ring and glycosidic-linkage fragmentation, were used to characterize the glycans and differentiate isomers.  The availability of such annotated mass spectrometric fragmentation spectral libraries of glycan structures, together with such substructure diagnostic ions, will be key inputs for the future development of the automated elucidation of oligosaccharide structures from MS/MS data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRDmrLxquDobVg90H21EOLACvtfcHk0lhuFravhjESPw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWnu74%253D&amp;md5=c95e05a8b094cfbe74d5ff369492122a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs13361-013-0610-4&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13361-013-0610-4%26sid%3Dliteratum%253Aachs%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26aulast%3DAbrahams%26aufirst%3DJ.%2BL.%26aulast%3DKolarich%26aufirst%3DD.%26aulast%3DPacker%26aufirst%3DN.%2BH.%26aulast%3DCampbell%26aufirst%3DM.%2BP.%26atitle%3DStructural%2520feature%2520ions%2520for%2520distinguishing%2520N-%2520and%2520O-linked%2520glycan%2520isomers%2520by%2520LC-ESI-IT%2520MS%252FMS%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2013%26volume%3D24%26issue%3D6%26spage%3D895%26epage%3D906%26doi%3D10.1007%2Fs13361-013-0610-4" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anugraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, N. H.</span></span> <span> </span><span class="NLM_article-title">A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">561</span>, <span class="refDoi">&nbsp;DOI: 10.1002/rcm.7130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1002%2Frcm.7130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26212272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsl2ltLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=29&amp;publication_year=2015&amp;pages=545-561&amp;issue=7&amp;author=M.+Anugrahamauthor=A.+V.+Everest-Dassauthor=F.+Jacobauthor=N.+H.+Packer&amp;title=A+platform+for+the+structural+characterization+of+glycans+enzymatically+released+from+glycosphingolipids+extracted+from+tissue+and+cells&amp;doi=10.1002%2Frcm.7130" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells</span></div><div class="casAuthors">Anugraham, Merrina; Everest-Dass, Arun Vijay; Jacob, Francis; Packer, Nicolle H.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">545-561</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley &amp; Sons Ltd.</span>)
        </div><div class="casAbstract">Glycosphingolipids (GSLs) constitute a highly diverse class of glyco-conjugates which are involved in many aspects of cell membrane function and disease.  The isolation, detection and structural characterization of the carbohydrate (glycan) component of GSLs are particularly challenging given their structural heterogeneity and thus rely on the development of sensitive, anal. technologies.  Neutral and acidic GSL stds. were immobilized onto polyvinylidene difluoride (PVDF) membranes and glycans were enzymically released using endoglycoceramidase II (EGCase II), sepd. by porous graphitized carbon (PGC) liq. chromatog. and structurally characterized by neg. ion mode electrospray ionization tandem mass spectrometry (PGC-LC/ESI-MS/MS).  This approach was then employed for GSLs isolated from 100 mg of serous and endometrioid cancer tissue and from cell line (107 cells) samples.  Glycans were released from GSL stds. comprised of ganglio-, asialo-ganglio- and the relatively resistant globo-series glycans, using as little as 1 mU of enzyme and 2 μg of GSL.  The platform of anal. was then applied to GSLs isolated from tissue and cell line samples and the released isomeric and isobaric glycan structures were chromatog. resolved on PGC and characterized by comparison with the MS2 fragment ion spectra of the glycan stds. and by application of known structural MS2 fragment ions.  This approach identified several (neo-)lacto-, globo- and ganglio-series glycans and facilitated the discrimination of isomeric structures contg. Lewis A, H type 1 and type 2 blood group antigens and sialyl-tetraosylceramides.  Thus, the authors describe a relatively simple, detergent-free, enzymic release of glycans from PVDF-immobilized GSLs, followed by the detailed structural anal. afforded by PGC-LC-ESI-MS/MS, to offer a versatile method for the anal. of tumor and cell-derived GSL-glycans.  The method uses the potential of MS2 fragmentation in neg. ion ESI mode to characterize, in detail, the biol. relevant glycan structures derived from GSLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg26oLtoZ6CrVg90H21EOLACvtfcHk0lhuFravhjESPw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2MXnsl2ltLc%253D&amp;md5=3b57e3a5e6bb1e56c4cbcf351c166d4f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Frcm.7130&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.7130%26sid%3Dliteratum%253Aachs%26aulast%3DAnugraham%26aufirst%3DM.%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26aulast%3DJacob%26aufirst%3DF.%26aulast%3DPacker%26aufirst%3DN.%2BH.%26atitle%3DA%2520platform%2520for%2520the%2520structural%2520characterization%2520of%2520glycans%2520enzymatically%2520released%2520from%2520glycosphingolipids%2520extracted%2520from%2520tissue%2520and%2520cells%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D545%26epage%3D561%26doi%3D10.1002%2Frcm.7130" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, K.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>160</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">277</span>, <span class="refDoi">&nbsp;DOI: 10.1083/jcb.200209006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1083%2Fjcb.200209006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=12527751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntValtg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=160&amp;publication_year=2003&amp;pages=267-277&amp;issue=2&amp;author=K.+Wolf&amp;title=Compensation+mechanism+in+tumor+cell+migration%3A+mesenchymal-amoeboid+transition+after+blocking+of+pericellular+proteolysis&amp;doi=10.1083%2Fjcb.200209006" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis</span></div><div class="casAuthors">Wolf, Katarina; Mazo, Irina; Leung, Harry; Engelke, Katharina; von Andrian, Ulrich H.; Deryugina, Elena I.; Strongin, Alex Y.; Brocker, Eva-B.; Friedl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Invasive tumor dissemination in vitro and in vivo involves the proteolytic degrdn. of ECM barriers.  This process, however, is only incompletely attenuated by protease inhibitor-based treatment, suggesting the existence of migratory compensation strategies.  In three-dimensional collagen matrixes, spindle-shaped proteolytically potent HT-1080 fibrosarcoma and MDA-MB-231 carcinoma cells exhibited a constitutive mesenchymal-type movement including the coclustering of β1 integrins and MT1-matrix metalloproteinase (MMP) at fiber binding sites and the generation of tube-like proteolytic degrdn. tracks.  Near-total inhibition of MMPs, serine proteases, cathepsins, and other proteases, however, induced a conversion toward spherical morphol. at near undiminished migration rates.  Sustained protease-independent migration resulted from a flexible amoeba-like shape change, i.e., propulsive squeezing through preexisting matrix gaps and formation of constriction rings in the absence of matrix degrdn., concomitant loss of clustered β1 integrins and MT1-MMP from fiber binding sites, and a diffuse cortical distribution of the actin cytoskeleton.  Acquisition of protease-independent amoeboid dissemination was confirmed for HT-1080 cells injected into the mouse dermis monitored by intravital multiphoton microscopy.  In conclusion, the transition from proteolytic mesenchymal toward nonproteolytic amoeboid movement highlights a supramol. plasticity mechanism in cell migration and further represents a putative escape mechanism in tumor cell dissemination after abrogation of pericellular proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZ7CU1-dKYLVg90H21EOLACvtfcHk0lhuFravhjESPw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD3sXntValtg%253D%253D&amp;md5=a0142d3cd1f3875bdf38bbc791f84f00</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200209006&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200209006%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DK.%26atitle%3DCompensation%2520mechanism%2520in%2520tumor%2520cell%2520migration%253A%2520mesenchymal-amoeboid%2520transition%2520after%2520blocking%2520of%2520pericellular%2520proteolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D160%26issue%3D2%26spage%3D267%26epage%3D277%26doi%3D10.1083%2Fjcb.200209006" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussos, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condeelis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patsialou, A.</span></span> <span> </span><span class="NLM_article-title">Chemotaxis in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">587</span>, <span class="refDoi">&nbsp;DOI: 10.1038/nrc3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fnrc3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=21779009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqu7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=11&amp;publication_year=2011&amp;pages=573-587&amp;issue=8&amp;author=E.+T.+Roussosauthor=J.+S.+Condeelisauthor=A.+Patsialou&amp;title=Chemotaxis+in+cancer&amp;doi=10.1038%2Fnrc3078" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotaxis in cancer</span></div><div class="casAuthors">Roussos, Evanthia T.; Condeelis, John S.; Patsialou, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-587</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotaxis of tumor cells and stromal cells in the surrounding microenvironment is an essential component of tumor dissemination during progression and metastasis.  This Review summarizes how chemotaxis directs the different behaviors of tumor cells and stromal cells in vivo, how mol. pathways regulate chemotaxis in tumor cells and how chemotaxis choreographs cell behavior to shape the tumor microenvironment and to det. metastatic spread.  The central importance of chemotaxis in cancer progression is highlighted by discussion of the use of chemotaxis as a prognostic marker, a treatment end point and a target of therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZGjvz9RLTLVg90H21EOLACvtfcHk0lg-YzVrBmtkeQ"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqu7k%253D&amp;md5=5e5add3b8567ced0d8593005f5dda63e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrc3078&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3078%26sid%3Dliteratum%253Aachs%26aulast%3DRoussos%26aufirst%3DE.%2BT.%26aulast%3DCondeelis%26aufirst%3DJ.%2BS.%26aulast%3DPatsialou%26aufirst%3DA.%26atitle%3DChemotaxis%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D8%26spage%3D573%26epage%3D587%26doi%3D10.1038%2Fnrc3078" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pally, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramanik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span> <span> </span><span class="NLM_article-title">An Interplay Between Reaction-Diffusion and Cell-Matrix Adhesion Regulates Multiscale Invasion in Early Breast Carcinomatosis</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">790</span>, <span class="refDoi">&nbsp;DOI: 10.3389/fphys.2019.00790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3389%2Ffphys.2019.00790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31456688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MritlGnug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=10&amp;publication_year=2019&amp;pages=790&amp;author=D.+Pallyauthor=D.+Pramanikauthor=R.+Bhat&amp;title=An+Interplay+Between+Reaction-Diffusion+and+Cell-Matrix+Adhesion+Regulates+Multiscale+Invasion+in+Early+Breast+Carcinomatosis&amp;doi=10.3389%2Ffphys.2019.00790" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">An Interplay Between Reaction-Diffusion and Cell-Matrix Adhesion Regulates Multiscale Invasion in Early Breast Carcinomatosis</span></div><div class="casAuthors">Pally Dharma; Pramanik Durjay; Bhat Ramray</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">790</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">The progression of cancer in the breast involves multiple reciprocal interactions between malignantly transformed epithelia, surrounding untransformed but affected stromal cells, and the extracellular matrix (ECM) that is remodeled during the process.  A quantitative understanding of the relative contribution of such interactions to phenotypes associated with cancer cells can be arrived at through the construction of increasingly complex experimental and computational models.  Herein, we introduce a multiscale three-dimensional (3D) organo- and pathotypic experimental assay that approximates, to an unprecedented extent, the histopathological complexity of a tumor disseminating into its surrounding stromal milieu via both bulk and solitary motility dynamics.  End point and time-lapse microscopic observations of this assay allow us to study the earliest steps of cancer invasion as well as the dynamical interactions between the epithelial and stromal compartments.  We then simulate our experimental observations using the modeling environment Compucell3D that is based on the Glazier-Graner-Hogeweg model.  The computational model, which comprises adhesion between cancer cells and the matrices, cell proliferation and apoptosis, and matrix remodeling through reaction-diffusion-based morphogen dynamics, is first trained to phenocopy controls run with the experimental model, wherein one or the other matrices have been removed.  The trained computational model successfully predicts phenotypes of the experimental counterparts that are subjected to pharmacological treatments (inhibition of N-linked glycosylation and matrix metalloproteinase activity) and scaffold modulation (alteration of collagen density).  Further parametric exploration-based simulations suggest that specific permissive regimes of cell-cell and cell-matrix adhesions, operating in the context of a reaction-diffusion-regulated ECM dynamics, promote multiscale invasion of breast cancer cells and determine the extent to which the latter migrate through their surrounding stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrPMdFlkaVVKqcneEtCi92fW6udTcc2eYj7zw2uknlj7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MritlGnug%253D%253D&amp;md5=59032af92ede895ef6c4d9ed669ccb33</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2019.00790&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2019.00790%26sid%3Dliteratum%253Aachs%26aulast%3DPally%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DD.%26aulast%3DBhat%26aufirst%3DR.%26atitle%3DAn%2520Interplay%2520Between%2520Reaction-Diffusion%2520and%2520Cell-Matrix%2520Adhesion%2520Regulates%2520Multiscale%2520Invasion%2520in%2520Early%2520Breast%2520Carcinomatosis%26jtitle%3DFront.%2520Physiol.%26date%3D2019%26volume%3D10%26spage%3D790%26doi%3D10.3389%2Ffphys.2019.00790" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swat, M. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Multi-scale modeling of tissues using CompuCell3D</span>. <i>Methods Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">366</span>, <span class="refDoi">&nbsp;DOI: 10.1016/B978-0-12-388403-9.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2FB978-0-12-388403-9.00013-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=22482955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC38rjtVWmtA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=110&amp;publication_year=2012&amp;pages=325-366&amp;author=M.+H.+Swat&amp;title=Multi-scale+modeling+of+tissues+using+CompuCell3D&amp;doi=10.1016%2FB978-0-12-388403-9.00013-8" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-scale modeling of tissues using CompuCell3D</span></div><div class="casAuthors">Swat Maciej H; Thomas Gilberto L; Belmonte Julio M; Shirinifard Abbas; Hmeljak Dimitrij; Glazier James A</div><div class="citationInfo"><span class="NLM_cas:title">Methods in cell biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">325-66</span>
        ISSN:<span class="NLM_cas:issn">0091-679X</span>.
    </div><div class="casAbstract">The study of how cells interact to produce tissue development, homeostasis, or diseases was, until recently, almost purely experimental.  Now, multi-cell computer simulation methods, ranging from relatively simple cellular automata to complex immersed-boundary and finite-element mechanistic models, allow in silico study of multi-cell phenomena at the tissue scale based on biologically observed cell behaviors and interactions such as movement, adhesion, growth, death, mitosis, secretion of chemicals, chemotaxis, etc.  This tutorial introduces the lattice-based Glazier-Graner-Hogeweg (GGH) Monte Carlo multi-cell modeling and the open-source GGH-based CompuCell3D simulation environment that allows rapid and intuitive modeling and simulation of cellular and multi-cellular behaviors in the context of tissue formation and subsequent dynamics.  We also present a walkthrough of four biological models and their associated simulations that demonstrate the capabilities of the GGH and CompuCell3D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStC5HD2PcSO1HFYivNCdPRfW6udTcc2eYj7zw2uknlj7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC38rjtVWmtA%253D%253D&amp;md5=066d92984b194f748c0a24791efdf5e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-388403-9.00013-8&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-388403-9.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DSwat%26aufirst%3DM.%2BH.%26atitle%3DMulti-scale%2520modeling%2520of%2520tissues%2520using%2520CompuCell3D%26jtitle%3DMethods%2520Cell%2520Biol.%26date%3D2012%26volume%3D110%26spage%3D325%26epage%3D366%26doi%3D10.1016%2FB978-0-12-388403-9.00013-8" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, J. P.</span></span> <span> </span><span class="NLM_article-title">Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the sigma1 Cell Attachment Protein and Can Be Overcome by Mutation of sigma1</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">01380-19</span>, <span class="refDoi">&nbsp;DOI: 10.1128/JVI.01380-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1128%2FJVI.01380-19" title="">Crossref</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=93&amp;publication_year=2019&amp;pages=01380-19&amp;issue=22&amp;author=J.+P.+Fernandes&amp;title=Breast+Tumor-Associated+Metalloproteases+Restrict+Reovirus+Oncolysis+by+Cleaving+the+sigma1+Cell+Attachment+Protein+and+Can+Be+Overcome+by+Mutation+of+sigma1&amp;doi=10.1128%2FJVI.01380-19" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            rightTab-cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FJVI.01380-19&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01380-19%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DJ.%2BP.%26atitle%3DBreast%2520Tumor-Associated%2520Metalloproteases%2520Restrict%2520Reovirus%2520Oncolysis%2520by%2520Cleaving%2520the%2520sigma1%2520Cell%2520Attachment%2520Protein%2520and%2520Can%2520Be%2520Overcome%2520by%2520Mutation%2520of%2520sigma1%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26issue%3D22%26spage%3D01380-19%26doi%3D10.1128%2FJVI.01380-19" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. Y.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">483</span>, <span class="refDoi">&nbsp;DOI: 10.1158/0008-5472.CAN-10-1303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1158%2F0008-5472.CAN-10-1303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=21224350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKlsg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=71&amp;publication_year=2011&amp;pages=473-483&amp;issue=2&amp;author=J.+Y.+Chen&amp;title=A+novel+sialyltransferase+inhibitor+suppresses+FAK%2Fpaxillin+signaling+and+cancer+angiogenesis+and+metastasis+pathways&amp;doi=10.1158%2F0008-5472.CAN-10-1303" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways</span></div><div class="casAuthors">Chen, Jia-Yang; Tang, Yen-An; Huang, Sin-Ming; Juan, Hsueh-Fen; Wu, Li-Wha; Sun, Ying-Chieh; Wang, Szu-Chi; Wu, Kuan-Wei; Balraj, Gopula; Chang, Tzu-Ting; Li, Wen-Shan; Cheng, Hung-Chi; Wang, Yi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">473-483</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increased sialyltransferase (ST) activity promotes cancer cell metastasis, and overexpression of cell surface sialic acid correlates with poor prognosis in cancer patients.  To seek therapies targeting metastasis for cancer treatment, the authors developed a novel ST inhibitor, Lith-O-Asp, and investigated its antimetastatic and antiangiogenic effects and mechanisms.  The authors found that cells treated with Lith-O-Asp showed a redn. of activity on various ST enzymes by in vitro and cell-based activity analyses.  Lith-O-Asp inhibited migration and invasion abilities in various cancer cell lines and showed inhibitory effect on the angiogenic activity of human umbilical vein endothelial cells.  Indeed, Lith-O-Asp treatment consequently delayed cancer cell metastasis in exptl. and spontaneous metastasis assays in animal models.  Importantly, Lith-O-Asp decreased the sialic acid modification of integrin-β1 and inhibited the expression of phospho-FAK, phospho-paxillin, and the matrix metalloprotease (MMP) 2 and MMP9.  Lith-O-Asp attenuated the Rho GTPase activity leading to actin dynamic impairment.  In addn., 2DE-MS/MS and immunoblotting analyses showed that Lith-O-Asp altered the protein expression level and phosphorylation status of various proteins involved in crucial metastasis and angiogenesis pathways such as vimentin and RNase/angiogenin inhibitor RNH1.  Furthermore, Lith-O-Asp treatment significantly inhibited the invasive ability exerted by ectopic overexpression of various ST enzymes catalyzing α-2,6- or α-2,3-sialylation.  The authors' results provide compelling evidence that the potential pan-ST inhibitor, Lith-O-Asp, suppressed cancer cell metastasis likely by inhibiting FAK/paxillin signaling and expressing anti-angiogenesis factors.  Lith-O-Asp is worthy for further testing as a novel anti-metastasis drug for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHsvswFr4pJrVg90H21EOLACvtfcHk0ljkreh_8rTKUw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKlsg%253D%253D&amp;md5=85a6f8640aee350afc36180d7765a3ab</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1303&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1303%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BY.%26atitle%3DA%2520novel%2520sialyltransferase%2520inhibitor%2520suppresses%2520FAK%252Fpaxillin%2520signaling%2520and%2520cancer%2520angiogenesis%2520and%2520metastasis%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D2%26spage%3D473%26epage%3D483%26doi%3D10.1158%2F0008-5472.CAN-10-1303" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Expression of N-Acetylglucosaminyltransferase III Suppresses alpha2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to alpha2,6-Sialylation Levels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5708</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi">&nbsp;DOI: 10.1074/jbc.M115.712836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1074%2Fjbc.M115.712836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26801611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFKhsbY%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=291&amp;publication_year=2016&amp;pages=5708-5720&amp;issue=11&amp;author=J.+Lu&amp;title=Expression+of+N-Acetylglucosaminyltransferase+III+Suppresses+alpha2%2C3-Sialylation%2C+and+Its+Distinctive+Functions+in+Cell+Migration+Are+Attributed+to+alpha2%2C6-Sialylation+Levels&amp;doi=10.1074%2Fjbc.M115.712836" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels</span></div><div class="casAuthors">Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Kameyama, Akihiko; Gu, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5708-5720</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Acetylglucosaminyltransferase III (GnT-III), which catalyzes the addn. of the bisecting GlcNAc branch on N-glycans, is usually described as a metastasis suppressor.  Overexpression of GnT-III inhibited migration in multiple types of tumor cells.  However, these results seem controversial to the clin. observations for the increased expression of GnT-III in human hepatomas, glioma, and ovarian cancers.  Here, we present evidence that these inconsistencies are mainly attributed to the different expression pattern of cell sialylation.  In detail, we show that overexpression of GnT-III significantly inhibits α2,3-sialylation but not α2,6-sialylation.  The migratory ability of cells without or with a low level of α2,6-sialylation is consistently suppressed after GnT-III overexpression.  In contrast, the effects of GnT-III overexpression are variable in tumor cells that are highly α2,6-sialylated.  Overexpression of GnT-III promotes the cell migration in glioma cells U-251 and hepatoma cells HepG2, although it has little influence in human breast cancer cell MDA-MB-231 and gastric cancer cell MKN-45.  Interestingly, up-regulation of α2,6-sialylation by overexpressing β-galactoside α2,6-sialyltransferase 1 in the α2,6-hyposialylated HeLa-S3 cells abolishes the anti-migratory effects of GnT-III.  Conversely, depletion of α2,6-sialylation by knock-out of β-galactoside α2,6-sialyltranferase 1 in α2,6-hypersialylated HepG2 cells endows GnT-III with the anti-migratory ability.  Taken together, our data clearly demonstrate that high expression of α2,6-sialylation on the cell surface could affect the anti-migratory role of GnT-III, which provides an insight into the mechanistic roles of GnT-III in tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpezPxS1SpbGrVg90H21EOLACvtfcHk0ljkreh_8rTKUw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XjvFKhsbY%253D&amp;md5=bff582693ddcd9a4ee400490d2595de3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.712836&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.712836%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DExpression%2520of%2520N-Acetylglucosaminyltransferase%2520III%2520Suppresses%2520alpha2%252C3-Sialylation%252C%2520and%2520Its%2520Distinctive%2520Functions%2520in%2520Cell%2520Migration%2520Are%2520Attributed%2520to%2520alpha2%252C6-Sialylation%2520Levels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D11%26spage%3D5708%26epage%3D5720%26doi%3D10.1074%2Fjbc.M115.712836" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcel-Trullols, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi">&nbsp;DOI: 10.3892/ijo.28.5.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3892%2Fijo.28.5.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=16596233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cisr0%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2006&amp;pages=1173-1183&amp;issue=5&amp;author=J.+Carcel-Trullols&amp;title=Characterization+of+the+glycosylation+profile+of+the+human+breast+cancer+cell+line%2C+MDA-231%2C+and+a+bone+colonizing+variant&amp;doi=10.3892%2Fijo.28.5.1173" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant</span></div><div class="casAuthors">Carcel-Trullols, Jaime; Stanley, Joseph S.; Saha, Rinku; Shaaf, Saeid; Bendre, Manali S.; Monzavi-Karbassi, Behjatolah; Suva, Larry J.; Kieber-Emmons, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1183</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The mechanisms that guide organ-specific metastases are not fully established.  The aberrant expression of carbohydrates may play a fundamental role in defining the mol. mechanisms for metastases to distant organs and facilitate pos. interactions within the target organ.  The purpose of the present study was to det. the glycomic profile of a variant of the MDA-MB-231 breast cancer cell line that colonizes the bone and to ascribe mechanistic functions mediated by carbohydrates that might correlate with clin. bone metastases.  The carbohydrate expression profiles of osteolytic MDA-MET breast cancer cells and non-osteolytic parental MDA-MB-231 cells were detd.  MDA-MET cells were derived from MDA-MB-231 cells by in vivo selection of metastatic bone lesions following intracardiac inoculation.  The two related breast cancer cell lines expressed distinct carbohydrate profiles; MDA-MET cells displayed an increased expression of alpha (2,6) linked sialic acid, N-β1-6 GlcNAc, and sialylated Lewis-A antigen, and decreased expression of Galβ1,3GalNAc as detected using a combination of lectins and anti-carbohydrate antibodies.  Microarray anal. demonstrated an increased expression of glycosyltransferase genes, correlative for the distinct glycomic phenotype.  The altered glycomic phenotypes of MDA-MET cells include effects on the differential binding to bone marrow endothelial cells, enhanced ECM binding and an increase in invasive potential.  These data suggest that the glycomic phenotype of MDA-MET cells is assocd. with a select set of accumulated functions that collectively impact on the bone metastases and bone colonization capacity of breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovWg-3xpkHsbVg90H21EOLACvtfcHk0ljkreh_8rTKUw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cisr0%253D&amp;md5=ce1e5d34d4917f5fc7f250ab0653aec3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3892%2Fijo.28.5.1173&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.28.5.1173%26sid%3Dliteratum%253Aachs%26aulast%3DCarcel-Trullols%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520glycosylation%2520profile%2520of%2520the%2520human%2520breast%2520cancer%2520cell%2520line%252C%2520MDA-231%252C%2520and%2520a%2520bone%2520colonizing%2520variant%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26issue%3D5%26spage%3D1173%26epage%3D1183%26doi%3D10.3892%2Fijo.28.5.1173" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goupille, C.</span></span> <span> </span><span class="NLM_article-title">Sulfated Glycoaminoglycans and Proteoglycan Syndecan-4 Are Involved in Membrane Fixation of LL-37 and Its Pro-Migratory Effect in Breast Cancer Cells</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">481</span>, <span class="refDoi">&nbsp;DOI: 10.3390/biom9090481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.3390%2Fbiom9090481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSntr3M" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=9&amp;publication_year=2019&amp;pages=481&amp;issue=9&amp;author=C.+Habesauthor=G.+Weberauthor=C.+Goupille&amp;title=Sulfated+Glycoaminoglycans+and+Proteoglycan+Syndecan-4+Are+Involved+in+Membrane+Fixation+of+LL-37+and+Its+Pro-Migratory+Effect+in+Breast+Cancer+Cells&amp;doi=10.3390%2Fbiom9090481" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated glycoaminoglycans and proteoglycan syndecan-4 are involved in membrane fixation of LL-37 and its pro-migratory effect in breast cancer cells</span></div><div class="casAuthors">Habes, Chahrazed; Weber, Gunther; Goupille, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">481</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Initially characterized by its antimicrobial activities, LL-37 has also been shown to significantly contribute to tumor development.  On breast cancer cell lines, LL-37 increases intracellular calcium via the TRPV2 channel and their migration via the activation of PI3K/AKT signaling.  Its all-d enantiomer D-LL-37 induces similar effects, which excludes a protein-protein interaction of LL-37 in a classic ligan D-receptor manner.  Its net charge of +6 gave rise to the hypothesis that the peptide uses the neg. charges of sulfoglycans or sialic acids to facilitate its attachment to the cell membrane and to induce its activities.  Whereas several vegetal lectins, specifically attaching to sialylated or sulfated structures, blocked the activities of LL-37 on both calcium increase and cell migration, several sialidases had no effect.  However, the competitive use of free sulfated glycoaminoglycans (GAGs) as chrondroitin and heparin, or treatment of the cell surface with chondroitinase and heparinase resulted in an activity loss of 50-100% for LL-37.  Concordant results were obtained by blocking the synthesis of GAGs with 4-Methylumbelliferyl-fi-D-xyloside, and by suppression of glycan sulfatation by sodium chlorate.  Using a candidate approach by suppressing proteoglycan synthesis using RNA interference, syndecan-4 was shown to be required for the activities of LL-37 and its binding to the cell surface.  This leads to the conclusion that syndecan-4, by means of sulfated GAGs, could act as a receptor for LL-37.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquuGdM51aDa7Vg90H21EOLACvtfcHk0ljkreh_8rTKUw"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1MXitFSntr3M&amp;md5=2153324d0f705c723796d8ec54f47229</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fbiom9090481&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9090481%26sid%3Dliteratum%253Aachs%26aulast%3DHabes%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DG.%26aulast%3DGoupille%26aufirst%3DC.%26atitle%3DSulfated%2520Glycoaminoglycans%2520and%2520Proteoglycan%2520Syndecan-4%2520Are%2520Involved%2520in%2520Membrane%2520Fixation%2520of%2520LL-37%2520and%2520Its%2520Pro-Migratory%2520Effect%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26issue%3D9%26spage%3D481%26doi%3D10.3390%2Fbiom9090481" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorsett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankenbauer, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjelmeland, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, S. L.</span></span> <span> </span><span class="NLM_article-title">Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells</span>. <i>J. Ovarian Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>, <span class="refDoi">&nbsp;DOI: 10.1186/s13048-019-0574-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1186%2Fs13048-019-0574-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=31610800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB3MnnslSgsA%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2019&amp;pages=93&amp;issue=1&amp;author=K.+A.+Dorsettauthor=R.+B.+Jonesauthor=K.+E.+Ankenbauerauthor=A.+B.+Hjelmelandauthor=S.+L.+Bellis&amp;title=Sox2+promotes+expression+of+the+ST6Gal-I+glycosyltransferase+in+ovarian+cancer+cells&amp;doi=10.1186%2Fs13048-019-0574-5" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells</span></div><div class="casAuthors">Dorsett Kaitlyn A; Jones Robert B; Ankenbauer Katherine E; Hjelmeland Anita B; Bellis Susan L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of ovarian research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The ST6Gal-I glycosyltransferase, which adds α2-6-linked sialic acids to N-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer.  Prior studies have shown that ST6Gal-I-mediated sialylation of select surface receptors remodels intracellular signaling to impart cancer stem cell (CSC) characteristics.  However, the mechanisms that contribute to ST6Gal-I expression in stem-like cancer cells are poorly understood.  RESULTS:  Herein, we identify the master stem cell transcription factor, Sox2, as a novel regulator of ST6Gal-I expression.  Interestingly, SOX2 and ST6GAL1 are located within the same tumor-associated amplicon, 3q26, and these two genes exhibit coordinate gains in copy number across multiple cancers including ~ 25% of ovarian serious adenocarcinomas.  In conjunction with genetic co-amplification, our studies suggest that Sox2 directly binds the ST6GAL1 promoter to drive transcription.  ST6Gal-I expression is directed by at least four distinct promoters, and we identified the P3 promoter as the predominant promoter utilized by ovarian cancer cells.  Chromatin Immunoprecipitation (ChIP) assays revealed that Sox2 binds regions proximal to the P3 promoter.  To confirm that Sox2 regulates ST6Gal-I expression, Sox2 was either overexpressed or knocked-down in various ovarian cancer cell lines.  Sox2 overexpression induced an increase in ST6Gal-I mRNA and protein, as well as surface α2-6 sialylation, whereas Sox2 knock-down suppressed levels of ST6Gal-I mRNA, protein and surface α2-6 sialylation.  CONCLUSIONS:  These data suggest a process whereby SOX2 and ST6GAL1 are coordinately amplified in cancer cells, with the Sox2 protein then binding the ST6GAL1 promoter to further augment ST6Gal-I expression.  Our collective results provide new insight into mechanisms that upregulate ST6Gal-I expression in ovarian cancer cells, and also point to the possibility that some of the CSC characteristics commonly attributed to Sox2 may, in part, be mediated through the sialyltransferase activity of ST6Gal-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsIuvAgLLgckewzGPswiWOfW6udTcc2eYPp6A1NVKhR7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB3MnnslSgsA%253D%253D&amp;md5=801bb5c941106ba2a5a16e13003f79f3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs13048-019-0574-5&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13048-019-0574-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorsett%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BB.%26aulast%3DAnkenbauer%26aufirst%3DK.%2BE.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DBellis%26aufirst%3DS.%2BL.%26atitle%3DSox2%2520promotes%2520expression%2520of%2520the%2520ST6Gal-I%2520glycosyltransferase%2520in%2520ovarian%2520cancer%2520cells%26jtitle%3DJ.%2520Ovarian%2520Res.%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D93%26doi%3D10.1186%2Fs13048-019-0574-5" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilina, O.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41556-020-0552-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41556-020-0552-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=32839548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BB38fpvVGisg%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2020&amp;pages=1103-1115&amp;issue=9&amp;author=O.+Ilina&amp;title=Cell-cell+adhesion+and+3D+matrix+confinement+determine+jamming+transitions+in+breast+cancer+invasion&amp;doi=10.1038%2Fs41556-020-0552-6" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion</span></div><div class="casAuthors">Ilina Olga; Gritsenko Pavlo G; Vullings Manon; Bakker Gert-Jan; Friedl Peter; Syga Simon; Starruss Jorn; Deutsch Andreas; Lippoldt Jurgen; Grosser Steffen; Kas Josef A; La Porta Caterina A M; Zapperi Stefano; La Porta Caterina A M; La Porta Caterina A M; Chepizhko Oleksandr; Bult Peter; Zapperi Stefano; Zapperi Stefano; Friedl Peter; Friedl Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature cell biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasticity of cancer invasion and metastasis depends on the ability of cancer cells to switch between collective and single-cell dissemination, controlled by cadherin-mediated cell-cell junctions.  In clinical samples, E-cadherin-expressing and -deficient tumours both invade collectively and metastasize equally, implicating additional mechanisms controlling cell-cell cooperation and individualization.  Here, using spatially defined organotypic culture, intravital microscopy of mammary tumours in mice and in silico modelling, we identify cell density regulation by three-dimensional tissue boundaries to physically control collective movement irrespective of the composition and stability of cell-cell junctions.  Deregulation of adherens junctions by downregulation of E-cadherin and p120-catenin resulted in a transition from coordinated to uncoordinated collective movement along extracellular boundaries, whereas single-cell escape depended on locally free tissue space.  These results indicate that cadherins and extracellular matrix confinement cooperate to determine unjamming transitions and stepwise epithelial fluidization towards, ultimately, cell individualization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWuAyF9xu4Q8vLc4ARHEmzfW6udTcc2eYPp6A1NVKhR7ntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BB38fpvVGisg%253D%253D&amp;md5=e6b0a7c6c2bead4b8b46642ddb84d85b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41556-020-0552-6&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41556-020-0552-6%26sid%3Dliteratum%253Aachs%26aulast%3DIlina%26aufirst%3DO.%26atitle%3DCell-cell%2520adhesion%2520and%25203D%2520matrix%2520confinement%2520determine%2520jamming%2520transitions%2520in%2520breast%2520cancer%2520invasion%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2020%26volume%3D22%26issue%3D9%26spage%3D1103%26epage%3D1115%26doi%3D10.1038%2Fs41556-020-0552-6" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oswald, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kas, J. A.</span></span> <span> </span><span class="NLM_article-title">Jamming transitions in cancer</span>. <i>J. Phys. D: Appl. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">483001</span>, <span class="refDoi">&nbsp;DOI: 10.1088/1361-6463/aa8e83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1088%2F1361-6463%2Faa8e83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29628530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Wnsrs%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=50&amp;publication_year=2017&amp;pages=483001&amp;issue=48&amp;author=L.+Oswaldauthor=S.+Grosserauthor=D.+M.+Smithauthor=J.+A.+Kas&amp;title=Jamming+transitions+in+cancer&amp;doi=10.1088%2F1361-6463%2Faa8e83" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Jamming transitions in cancer</span></div><div class="casAuthors">Oswald, Linda; Grosser, Steffen; Smith, David M.; Kas, Josef A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics D: Applied Physics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">483001/1-483001/17</span>CODEN:
                <span class="NLM_cas:coden">JPAPBE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3727</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">The traditional picture of tissues, where they are treated as liqs. defined by properties such as surface tension or viscosity has been redefined during the last few decades by the more fundamental question: under which conditions do tissues display liq.-like or solid-like behavior.  As a result, basic concepts arising from the treatment of tissues as solid matter, such as cellular jamming and glassy tissues, have shifted into the current focus of biophys. research.  Here, we review recent works examg. the phase states of tissue with an emphasis on jamming transitions in cancer.  When metastasis occurs, cells gain the ability to leave the primary tumor and infiltrate other parts of the body.  Recent studies have shown that a linkage between an unjamming transition and tumor progression indeed exists, which could be of importance when designing surgery and treatment approaches for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-zuyf_LYjZbVg90H21EOLACvtfcHk0lgkq610smNp_w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC1cXot1Wnsrs%253D&amp;md5=f373cafd2c785090ff912f0c511d11fb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1088%2F1361-6463%2Faa8e83&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1361-6463%252Faa8e83%26sid%3Dliteratum%253Aachs%26aulast%3DOswald%26aufirst%3DL.%26aulast%3DGrosser%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DKas%26aufirst%3DJ.%2BA.%26atitle%3DJamming%2520transitions%2520in%2520cancer%26jtitle%3DJ.%2520Phys.%2520D%253A%2520Appl.%2520Phys.%26date%3D2017%26volume%3D50%26issue%3D48%26spage%3D483001%26doi%3D10.1088%2F1361-6463%2Faa8e83" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, D. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">658</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.neo.2017.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.neo.2017.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=28732212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVKhurw%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2017&amp;pages=649-658&amp;issue=8&amp;author=D.+S.+Chandrashekar&amp;title=UALCAN%3A+A+Portal+for+Facilitating+Tumor+Subgroup+Gene+Expression+and+Survival+Analyses&amp;doi=10.1016%2Fj.neo.2017.05.002" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses</span></div><div class="casAuthors">Chandrashekar, Darshan S.; Bashel, Bhuwan; Balasubramanya, Sai Akshaya Hodigere; Creighton, Chad J.; Ponce-Rodriguez, Israel; Chakravarthi, Balabhadrapatruni V. S. K.; Varambally, Sooryanarayana</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-658</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1476-5586</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Genomics data from The Cancer Genome Atlas (TCGA) project has led to the comprehensive mol. characterization of multiple cancer types.  The large sample nos. in TCGA offer an excellent opportunity to address questions assocd. with tumo heterogeneity.  Exploration of the data by cancer researchers and clinicians is imperative to unearth novel therapeutic/diagnostic biomarkers.  Various computational tools have been developed to aid researchers in carrying out specific TCGA data analyses; however there is need for resources to facilitate the study of gene expression variations and survival assocns. across tumors.  Here, we report UALCAN, an easy to use, interactive web-portal to perform to in-depth analyses of TCGA gene expression data.  UALCAN uses TCGA level 3 RNA-seq and clin. data from 31 cancer types.  The portal's user-friendly features allow to perform: (1) analyze relative expression of a query gene(s) across tumor and normal samples, as well as in various tumor sub-groups based on individual cancer stages, tumor grade, race, body wt. or other clinicopathol. features, (2) est. the effect of gene expression level and clinicopathol. features on patient survival; and (3) identify the top over- and under-expressed (up and down-regulated) genes in individual cancer types.  This resource serves as a platform for in silico validation of target genes and for identifying tumor sub-group specific candidate biomarkers.  Thus, UALCAN web-portal could be extremely helpful in accelerating cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-tT7pr8pXeLVg90H21EOLACvtfcHk0lgkq610smNp_w"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC2sXovVKhurw%253D&amp;md5=2f22a68f356f2739f01d69851c144359</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2017.05.002&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2017.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DChandrashekar%26aufirst%3DD.%2BS.%26atitle%3DUALCAN%253A%2520A%2520Portal%2520for%2520Facilitating%2520Tumor%2520Subgroup%2520Gene%2520Expression%2520and%2520Survival%2520Analyses%26jtitle%3DNeoplasia%26date%3D2017%26volume%3D19%26issue%3D8%26spage%3D649%26epage%3D658%26doi%3D10.1016%2Fj.neo.2017.05.002" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vukojicic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Precision glycocalyx editing as a strategy for cancer immunotherapy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10309</span>, <span class="refDoi">&nbsp;DOI: 10.1073/pnas.1608069113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1073%2Fpnas.1608069113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=27551071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2mtL%252FJ" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=113&amp;publication_year=2016&amp;pages=10304-10309&amp;issue=37&amp;author=H.+Xiaoauthor=E.+C.+Woodsauthor=P.+Vukojicicauthor=C.+R.+Bertozzi&amp;title=Precision+glycocalyx+editing+as+a+strategy+for+cancer+immunotherapy&amp;doi=10.1073%2Fpnas.1608069113" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Precision glycocalyx editing as a strategy for cancer immunotherapy</span></div><div class="casAuthors">Xiao, Han; Woods, Elliot C.; Vukojicic, Petar; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">10304-10309</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cell surface sialosides constitute a central axis of immune modulation that is exploited by tumors to evade both innate and adaptive immune destruction.  Therapeutic strategies that target tumor-assocd. sialosides may therefore potentiate antitumor immunity.  Here, we report the development of antibody-sialidase conjugates that enhance tumor cell susceptibility to antibody-dependent cell-mediated cytotoxicity (ADCC) by selective desialylation of the tumor cell glycocalyx.  We chem. fused a recombinant sialidase to the human epidermal growth factor receptor 2 (HER2)-specific antibody trastuzumab through a C-terminal aldehyde tag.  The antibody-sialidase conjugate desialylated tumor cells in a HER2-dependent manner, reduced binding by natural killer (NK) cell inhibitory sialic acid-binding Ig-like lectin (Siglec) receptors, and enhanced binding to the NK-activating receptor natural killer group 2D (NKG2D).  Sialidase conjugation to trastuzumab enhanced ADCC against tumor cells expressing moderate levels of HER2, suggesting a therapeutic strategy for cancer patients with lower HER2 levels or inherent trastuzumab resistance.  Precision glycocalyx editing with antibody-enzyme conjugates is therefore a promising avenue for cancer immune therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUHDVInbXFDbVg90H21EOLACvtfcHk0lgD0mQQ-Nrtug"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2mtL%252FJ&amp;md5=d7de30cbe941be8c80d0ceff3d850ce5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1608069113&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1608069113%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DE.%2BC.%26aulast%3DVukojicic%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DPrecision%2520glycocalyx%2520editing%2520as%2520a%2520strategy%2520for%2520cancer%2520immunotherapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D37%26spage%3D10304%26epage%3D10309%26doi%3D10.1073%2Fpnas.1608069113" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanczak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Gunten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laubli, H.</span></span> <span> </span><span class="NLM_article-title">Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">647</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cwx108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcwx108" title="">Crossref</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2017&amp;pages=640-647&amp;issue=9&amp;author=O.+J.+Adamsauthor=M.+A.+Stanczakauthor=S.+von+Guntenauthor=H.+Laubli&amp;title=Targeting+sialic+acid-Siglec+interactions+to+reverse+immune+suppression+in+cancer&amp;doi=10.1093%2Fglycob%2Fcwx108" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            rightTab-cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwx108&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwx108%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DO.%2BJ.%26aulast%3DStanczak%26aufirst%3DM.%2BA.%26aulast%3Dvon%2BGunten%26aufirst%3DS.%26aulast%3DLaubli%26aufirst%3DH.%26atitle%3DTargeting%2520sialic%2520acid-Siglec%2520interactions%2520to%2520reverse%2520immune%2520suppression%2520in%2520cancer%26jtitle%3DGlycobiology%26date%3D2017%26volume%3D28%26issue%3D9%26spage%3D640%26epage%3D647%26doi%3D10.1093%2Fglycob%2Fcwx108" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santegoets, K. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Houtum, E. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adema, G. J.</span></span> <span> </span><span class="NLM_article-title">Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">285</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.it.2020.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.it.2020.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=32139317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt12mtrc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=41&amp;publication_year=2020&amp;pages=274-285&amp;issue=4&amp;author=S.+van%0Ade+Wallauthor=K.+C.+M.+Santegoetsauthor=E.+J.+H.+van+Houtumauthor=C.+Bullauthor=G.+J.+Adema&amp;title=Sialoglycans+and+Siglecs+Can+Shape+the+Tumor+Immune+Microenvironment&amp;doi=10.1016%2Fj.it.2020.02.001" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment</span></div><div class="casAuthors">van de Wall, Stephanie; Santegoets, Kim C. M.; van Houtum, Eline J. H.; Buell, Christian; Adema, Gosse J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">274-285</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sialic acid sugar-carrying glycans, sialoglycans, are aberrantly expressed on many tumor cells and have emerged as potent regulatory mols. involved in creating a tumor-supportive microenvironment.  Sialoglycans can be recognized by sialic acid-binding Ig-like lectins (Siglecs), a family of immunomodulatory receptors.  Most mammalian Siglecs transmit inhibitory signals comparable with the immune checkpoint inhibitor programmed death protein 1 (PD-1), but some are activating.  Recent studies have shown that tumor cells can exploit sialoglycan-Siglec interactions to modulate immune cell function, contributing to an immunosuppressive tumor microenvironment (TME).  Interference with sialoglycan synthesis or sialoglycan-Siglec interactions might improve antitumor immunity.  Many questions regarding specificity, signaling, and regulatory function of sialoglycan-Siglec interactions remain.  We posit that sialoglycans and Siglecs present as potential glyco-immune 'checkpoints' for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBrLGhqrVDLVg90H21EOLACvtfcHk0lgD0mQQ-Nrtug"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BB3cXjt12mtrc%253D&amp;md5=5b58840c7281e0bebbe5563d55bbf4a6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2020.02.001&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2020.02.001%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWall%26aufirst%3DS.%26aulast%3DSantegoets%26aufirst%3DK.%2BC.%2BM.%26aulast%3Dvan%2BHoutum%26aufirst%3DE.%2BJ.%2BH.%26aulast%3DBull%26aufirst%3DC.%26aulast%3DAdema%26aufirst%3DG.%2BJ.%26atitle%3DSialoglycans%2520and%2520Siglecs%2520Can%2520Shape%2520the%2520Tumor%2520Immune%2520Microenvironment%26jtitle%3DTrends%2520Immunol.%26date%3D2020%26volume%3D41%26issue%3D4%26spage%3D274%26epage%3D285%26doi%3D10.1016%2Fj.it.2020.02.001" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaschke, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desprez, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span> <span> </span><span class="NLM_article-title">Cell differentiation by extracellular matrix components</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">556</span>, <span class="refDoi">&nbsp;DOI: 10.1016/0076-6879(94)45027-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2F0076-6879%2894%2945027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=7760750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK2MXmsV2hs7k%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=245&amp;publication_year=1994&amp;pages=535-556&amp;author=R.+J.+Blaschkeauthor=A.+R.+Howlettauthor=P.+Y.+Desprezauthor=O.+W.+Petersenauthor=M.+J.+Bissell&amp;title=Cell+differentiation+by+extracellular+matrix+components&amp;doi=10.1016%2F0076-6879%2894%2945027-7" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cell differentiation by extracellular matrix components</span></div><div class="casAuthors">Blaschke, Ruediger J.; Howlett, Anthony R.; Desprez, Pierre-Yves; Petersen, Ole W.; Bissell, Mina J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-56</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnDZBBfPzc7Vg90H21EOLACvtfcHk0lgD0mQQ-Nrtug"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK2MXmsV2hs7k%253D&amp;md5=03bf0c86ec3cb45f22b30d67e9a4e67f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2894%2945027-7&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252894%252945027-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlaschke%26aufirst%3DR.%2BJ.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DDesprez%26aufirst%3DP.%2BY.%26aulast%3DPetersen%26aufirst%3DO.%2BW.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26atitle%3DCell%2520differentiation%2520by%2520extracellular%2520matrix%2520components%26jtitle%3DMethods%2520Enzymol.%26date%3D1994%26volume%3D245%26spage%3D535%26epage%3D556%26doi%3D10.1016%2F0076-6879%2894%2945027-7" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Everest-Dass, A. V.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi">&nbsp;DOI: 10.1093/glycob/cws112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1093%2Fglycob%2Fcws112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=22833316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtbjK" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2012&amp;pages=1465-1479&amp;issue=11&amp;author=A.+V.+Everest-Dass&amp;title=Comparative+structural+analysis+of+the+glycosylation+of+salivary+and+buccal+cell+proteins%3A+innate+protection+against+infection+by+Candida+albicans&amp;doi=10.1093%2Fglycob%2Fcws112" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans</span></div><div class="casAuthors">Everest-Dass, Arun V.; Jin, Dayong; Thaysen-Andersen, Morten; Nevalainen, Helena; Kolarich, Daniel; Packer, Nicolle H.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1465-1479</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mucosal epithelial surfaces, such as line the oral cavity, are common sites of microbial colonization by bacteria, yeast and fungi.  The microbial interactions involve adherence between the glycans on the host cells and the carbohydrate-binding proteins of the pathogen.  Saliva constantly bathes the buccal cells of the epithelial surface of the mouth and we postulate that the sugars on the salivary glycoproteins provide an innate host immune mechanism against infection by competitively inhibiting pathogen binding to the cell membranes.  The structures of the N- and O-linked oligosaccharides on the glycoproteins of saliva and buccal cell membranes were analyzed using capillary carbon liq. chromatog.-electrospray ionization MS/MS.  The 190 glycan structures that were characterized were qual. similar, but differed quant., between saliva and epithelial buccal cell membrane proteins.  The similar relative abundance of the terminal glycan epitope structures (e.g. ABO(H) blood group, sialylation and Lewis-type antigens) on saliva and buccal cell membrane glycoproteins indicated that the terminal N- and O-linked glycan substructures in saliva could be acting as decoy-binding receptors to competitively inhibit the attachment of pathogens to the surface of the oral mucosa.  A flow cytometry-based binding assay quantified the interaction between buccal cells and the commensal oral pathogen Candida albicans.  Whole saliva and released glycans from salivary proteins inhibited the interaction of C. albicans with buccal epithelial cells, confirming the protective role of the glycans on salivary glycoproteins against pathogen infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0lyCpCvCRLVg90H21EOLACvtfcHk0lgD0mQQ-Nrtug"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtbjK&amp;md5=f343ca64b894e1eeaaf08e0225e96231</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcws112&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcws112%26sid%3Dliteratum%253Aachs%26aulast%3DEverest-Dass%26aufirst%3DA.%2BV.%26atitle%3DComparative%2520structural%2520analysis%2520of%2520the%2520glycosylation%2520of%2520salivary%2520and%2520buccal%2520cell%2520proteins%253A%2520innate%2520protection%2520against%2520infection%2520by%2520Candida%2520albicans%26jtitle%3DGlycobiology%26date%3D2012%26volume%3D22%26issue%3D11%26spage%3D1465%26epage%3D1479%26doi%3D10.1093%2Fglycob%2Fcws112" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Simulation of biological cell sorting using a two-dimensional extended Potts model</span>. <i>Phys. Rev. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2016</span>, <span class="refDoi">&nbsp;DOI: 10.1103/PhysRevLett.69.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1103%2FPhysRevLett.69.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10046374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADyaK38XmtVOmsLc%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=69&amp;publication_year=1992&amp;pages=2013-2016&amp;issue=13&amp;author=F.+Granerauthor=J.+A.+Glazier&amp;title=Simulation+of+biological+cell+sorting+using+a+two-dimensional+extended+Potts+model&amp;doi=10.1103%2FPhysRevLett.69.2013" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Simulation of biological cell sorting using a two-dimensional extended Potts model</span></div><div class="casAuthors">Graner, Francois; Glazier, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Review Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2013-16</span>CODEN:
                <span class="NLM_cas:coden">PRLTAO</span>;
        ISSN:<span class="NLM_cas:issn">0031-9007</span>.
    </div><div class="casAbstract">The sorting of a mixt. of two types of biol. cells was simulated using a modified version of the large-Q Potts model with differential adhesivity.  The model predicts long-distance cell movement leading to sorting with a logarithmic increase in the length scale of homogeneous clusters.  Sorted clusters then round.  Two successive phases were found: a rapid boundary-driven creation of a low-cohesivity cell monolayer around the aggregate, and a slower boundary-independent internal rearrangement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz9bpz3M2sarVg90H21EOLACvtfcHk0lgPaDvUPuv3eA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADyaK38XmtVOmsLc%253D&amp;md5=a4035bb5ac84d49af4328d51428c8237</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1103%2FPhysRevLett.69.2013&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1103%252FPhysRevLett.69.2013%26sid%3Dliteratum%253Aachs%26aulast%3DGraner%26aufirst%3DF.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DSimulation%2520of%2520biological%2520cell%2520sorting%2520using%2520a%2520two-dimensional%2520extended%2520Potts%2520model%26jtitle%3DPhys.%2520Rev.%2520Lett.%26date%3D1992%26volume%3D69%26issue%3D13%26spage%3D2013%26epage%3D2016%26doi%3D10.1103%2FPhysRevLett.69.2013" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamdar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span> <span> </span><span class="NLM_article-title">Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19905</span>, <span class="refDoi">&nbsp;DOI: 10.1038/srep19905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fsrep19905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=26832069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaitrs%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=6&amp;publication_year=2016&amp;pages=19905&amp;author=S.+Kumarauthor=A.+Kapoorauthor=S.+Desaiauthor=M.+M.+Inamdarauthor=S.+Sen&amp;title=Proteolytic+and+non-proteolytic+regulation+of+collective+cell+invasion%3A+tuning+by+ECM+density+and+organization&amp;doi=10.1038%2Fsrep19905" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization</span></div><div class="casAuthors">Kumar, Sandeep; Kapoor, Aastha; Desai, Sejal; Inamdar, Mandar M.; Sen, Shamik</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19905</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells manoeuvre through extracellular matrixes (ECMs) using different invasion modes, including single cell and collective cell invasion.  These modes rely on MMP-driven ECM proteolysis to make space for cells to move.  How cancer-assocd. alterations in ECM influence the mode of invasion remains unclear.  Further, the sensitivity of the two invasion modes to MMP dynamics remains unexplored.  In this paper, we address these open questions using a multiscale hybrid computational model combining ECM d.-dependent MMP secretion, MMP diffusion, ECM degrdn. by MMP and active cell motility.  Our results demonstrate that in randomly aligned matrixes, collective cell invasion is more efficient than single cell invasion.  Although increase in MMP secretion rate enhances invasiveness independent of cell-cell adhesion, sustenance of collective invasion in dense matrixes requires high MMP secretion rates.  However, matrix alignment can sustain both single cell and collective cell invasion even without ECM proteolysis.  Similar to our in-silico observations, increase in ECM d. and MMP inhibition reduced migration of MCF-7 cells embedded in sandwich gels.  Together, our results indicate that apart from cell intrinsic factors (i.e., high cell-cell adhesion and MMP secretion rates), ECM d. and organization represent two important extrinsic parameters that govern collective cell invasion and invasion plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHNXedHX0P7bVg90H21EOLACvtfcHk0lgPaDvUPuv3eA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BC28XitFaitrs%253D&amp;md5=99c0b7be25728ed27250d7f73cd706ce</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsrep19905&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19905%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKapoor%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DInamdar%26aufirst%3DM.%2BM.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DProteolytic%2520and%2520non-proteolytic%2520regulation%2520of%2520collective%2520cell%2520invasion%253A%2520tuning%2520by%2520ECM%2520density%2520and%2520organization%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19905%26doi%3D10.1038%2Fsrep19905" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span> <span> </span><span class="NLM_article-title">MMP proteolytic activity regulates cancer invasiveness by modulating integrins</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">14219</span>, <span class="refDoi">&nbsp;DOI: 10.1038/s41598-017-14340-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1038%2Fs41598-017-14340-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=29079818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A280%3ADC%252BC1M7lsVKhug%253D%253D" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2017&amp;pages=14219&amp;issue=1&amp;author=A.+Dasauthor=M.+Monteiroauthor=A.+Baraiauthor=S.+Kumarauthor=S.+Sen&amp;title=MMP+proteolytic+activity+regulates+cancer+invasiveness+by+modulating+integrins&amp;doi=10.1038%2Fs41598-017-14340-w" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">MMP proteolytic activity regulates cancer invasiveness by modulating integrins</span></div><div class="casAuthors">Das Alakesh; Monteiro Melissa; Barai Amlan; Kumar Sandeep; Sen Shamik</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14219</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer invasion through dense extracellular matrices (ECMs) is mediated by matrix metalloproteinases (MMPs) which degrade the ECM thereby creating paths for migration.  However, how this degradation influences the phenotype of cancer cells is not fully clear.  Here we address this question by probing the function of MMPs in regulating biophysical properties of cancer cells relevant to invasion.  We show that MMP catalytic activity regulates cell spreading, motility, contractility and cortical stiffness by stabilizing integrins at the membrane and activating focal adhesion kinase.  Interestingly, cell rounding and cell softening on stiff gels induced by MMP inhibition is attenuated on MMP pre-conditioned surfaces.  Together, our results suggest that MMP catalytic activity regulates invasiveness of cancer cells by modulating integrins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7eccy12VojHy-c-E1v-fmfW6udTcc2ea5umX2FlOSRLntkvexoksv"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A280%3ADC%252BC1M7lsVKhug%253D%253D&amp;md5=6a987eb1c21be2d7a1f102f099015649</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-14340-w&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-14340-w%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DA.%26aulast%3DMonteiro%26aufirst%3DM.%26aulast%3DBarai%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DMMP%2520proteolytic%2520activity%2520regulates%2520cancer%2520invasiveness%2520by%2520modulating%2520integrins%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D14219%26doi%3D10.1038%2Fs41598-017-14340-w" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merks, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goligorksy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">54</span>, <span class="refDoi">&nbsp;DOI: 10.1016/j.ydbio.2005.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1016%2Fj.ydbio.2005.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=16325173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaitrzI" title="">CAS</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=289&amp;publication_year=2006&amp;pages=44-54&amp;issue=1&amp;author=R.+M.+Merksauthor=S.+V.+Brodskyauthor=M.+S.+Goligorksyauthor=S.+A.+Newmanauthor=J.+A.+Glazier&amp;title=Cell+elongation+is+key+to+in+silico+replication+of+in+vitro+vasculogenesis+and+subsequent+remodeling&amp;doi=10.1016%2Fj.ydbio.2005.10.003" target="_blank">Google Scholar</a><div class="casRecord" id="
                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling</span></div><div class="casAuthors">Merks, Roeland M. H.; Brodsky, Sergey V.; Goligorksy, Michael S.; Newman, Stuart A.; Glazier, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Vasculogenesis, the de novo growth of the primary vascular network from initially dispersed endothelial cells, is the first step in the development of the circulatory system in vertebrates.  In the first stages of vasculogenesis, endothelial cells elongate and form a network-like structure, called the primary capillary plexus, which subsequently remodels, with the size of the vacancies between ribbons of endothelial cells coarsening over time.  To isolate such intrinsic morphogenetic ability of endothelial cells from its regulation by long-range guidance cues and addnl. cell types, we use an in vitro model of human umbilical vein endothelial cells (HUVEC) in Matrigel.  This quasi-two-dimensional endothelial cell culture model would most closely correspond to vasculogenesis in flat areas of the embryo like the yolk sac.  Several studies have used continuum math. models to explore in vitro vasculogenesis: such models describe cell ensembles but ignore the endothelial cells' shapes and active surface fluctuations.  While these models initially reproduce vascular-like morphologies, they eventually stabilize into a disconnected pattern of vascular "islands".  Also, they fail to reproduce temporally correct network coarsening.  Using a cell-centered computational model, we show that the endothelial cells' elongated shape is key to correct spatiotemporal in silico replication of stable vascular network growth.  We validate our simulation results against HUVEC cultures using time-resolved image anal. and find that our simulations quant. reproduce in vitro vasculogenesis and subsequent in vitro remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder ®" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQn4LD4El1J7Vg90H21EOLACvtfcHk0lgPaDvUPuv3eA"> &gt;&gt; More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&amp;resolution=options&amp;coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaitrzI&amp;md5=020da88954fc4b7f64b9e745d5573558</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2005.10.003&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMerks%26aufirst%3DR.%2BM.%26aulast%3DBrodsky%26aufirst%3DS.%2BV.%26aulast%3DGoligorksy%26aufirst%3DM.%2BS.%26aulast%3DNewman%26aufirst%3DS.%2BA.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DCell%2520elongation%2520is%2520key%2520to%2520in%2520silico%2520replication%2520of%2520in%2520vitro%2520vasculogenesis%2520and%2520subsequent%2520remodeling%26jtitle%3DDev.%2520Biol.%26date%3D2006%26volume%3D289%26issue%3D1%26spage%3D44%26epage%3D54%26doi%3D10.1016%2Fj.ydbio.2005.10.003" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merks, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perryn, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirinifard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, J. A.</span></span> <span> </span><span class="NLM_article-title">Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e1000163</span>, <span class="refDoi">&nbsp;DOI: 10.1371/journal.pcbi.1000163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=10.1371%2Fjournal.pcbi.1000163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facscentsci.0c00601&amp;key=18802455" title="">PubMed</a>],&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=4&amp;publication_year=2008&amp;pages=e1000163&amp;issue=9&amp;author=R.+M.+Merksauthor=E.+D.+Perrynauthor=A.+Shirinifardauthor=J.+A.+Glazier&amp;title=Contact-inhibited+chemotaxis+in+de+novo+and+sprouting+blood-vessel+growth&amp;doi=10.1371%2Fjournal.pcbi.1000163" target="_blank">Google Scholar</a><div class="casRecord empty" id="
                            rightTab-cas_R
                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1000163&amp;type=refOpenUrl&amp;url=https%3A%2F%2Flibkey.io%2Flibraries%2F163%2Fopenurl%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1000163%26sid%3Dliteratum%253Aachs%26aulast%3DMerks%26aufirst%3DR.%2BM.%26aulast%3DPerryn%26aufirst%3DE.%2BD.%26aulast%3DShirinifard%26aufirst%3DA.%26aulast%3DGlazier%26aufirst%3DJ.%2BA.%26atitle%3DContact-inhibited%2520chemotaxis%2520in%2520de%2520novo%2520and%2520sprouting%2520blood-vessel%2520growth%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D9%26spage%3De1000163%26doi%3D10.1371%2Fjournal.pcbi.1000163" title="OpenURL INDIANA UNIV BLOOMINGTON" onclick="newWindow(this.href);return false" class="button_primary"><span>open URL</span></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25">Supporting Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04661"></div></div></div></div></div><hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acscentsci.0c00601?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscentsci.0c00601</a>.</p><ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Negative/sugar control for lectin histochemistry, lectin cytochemistry, lectin-based flow cytometry, gating of single cells in flow cytometry, the specificity of SNA and MAA lectins, α2,6- and α2,3- Sial linkage profiles and adhesion of BT-549 to type 1 collagen; extracted ion chromatograms for <i>N</i>-glycans, <i>O</i>-glycans, and glycosphingolipids; and lectins and primers used in the study (<a class="ext-link" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Video S1: Time-lapse videography of high 2,6-Sial cells (<a class="ext-link" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_004.mp4">MP4</a>)</p></li><li><p class="inline">Video S2: Time-lapse videography of medium 2,6-Sial cells (<a class="ext-link" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_003.mp4">MP4</a>)</p></li><li><p class="inline">Video S3: Time-lapse videography of shSc-high 2,6-Sial cells (<a class="ext-link" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_002.mp4">MP4</a>)</p></li><li><p class="inline">Video S4: Time-lapse videography of sh<i>ST6GAL1</i>-high 2,6-Sial cells (<a class="ext-link" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_005.mp4">MP4</a>)</p></li></ul><p></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_001.pdf">oc0c00601_si_001.pdf (1.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_002.mp4">oc0c00601_si_002.mp4 (7.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_003.mp4">oc0c00601_si_003.mp4 (6.3 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_004.mp4">oc0c00601_si_004.mp4 (6.85 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acscentsci.0c00601/suppl_file/oc0c00601_si_005.mp4">oc0c00601_si_005.mp4 (7.36 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms &amp; Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facscentsci.0c00601&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Facscii.2021.7.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3BrequestedJournal%3Ajournal%3Aacscii%3Barticle%3Aarticle%3A10.1021%2Facscentsci.0c00601%3Bwebsite%3Awebsite%3Aacspubs%3Bjournal%3Ajournal%3Aacscii%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acscentsci.0c00601" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2022<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS &amp; Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support &amp; Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"><input type="hidden" name="appID" value="literatum" class="appID"><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"><input type="hidden" name="clientID" value="atypon-lives" class="clientID"><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onclick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        <!-- <div id="gdpr-message-container">
			<a id="closebtn" href="#"><i class="icon-times-circle-o"></i></a> -->
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        <!-- </div> -->
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        <!-- AdRoll Pixel -->
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>

<!-- Twitter universal website tag code -->
<!-- Commented out for ACHS-6152
<script>
    !function(e,t,n,s,u,a){e.twq||(s=e.twq=function(){s.exe?s.exe.apply(s,arguments):s.queue.push(arguments);
    },s.version='1.1',s.queue=[],u=t.createElement(n),u.async=!0,u.src='//static.ads-twitter.com/uwt.js',
    a=t.getElementsByTagName(n)[0],a.parentNode.insertBefore(u,a))}(window,document,'script');
    // Insert Twitter Pixel ID and Standard Event data below
    twq('init','o3njp');
    twq('track','PageView');
</script>
-->
<!-- Facebook Pixel Code -->
<!-- Commented out for ACHS-6152
<script>
    !function(f,b,e,v,n,t,s)
    {if(f.fbq)return;n=f.fbq=function(){n.callMethod?
    n.callMethod.apply(n,arguments):n.queue.push(arguments)};
    if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';
    n.queue=[];t=b.createElement(e);t.async=!0;
    t.src=v;s=b.getElementsByTagName(e)[0];
    s.parentNode.insertBefore(t,s)}(window, document,'script',
    'https://connect.facebook.net/en_US/fbevents.js');
    fbq('init', '529840281033320');
    fbq('track', 'PageView');
</script>
<noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=529840281033320&amp;ev=PageView&amp;noscript=1"
/></noscript>
-->





        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
var currentJournal = "ACS Central Science";
$(".citationLinks > a").click(function(e){
    if($(this).text() === "ACS Full Text ") {
        ga('send', 'event', 'Reference _Click', 'ACS Full Text', currentJournal);
    }
    else if($(this).text() === "Crossref") {
        ga('send', 'event', 'Reference _Click', 'Crossref', currentJournal);
    }
    else if($(this).text() === "CAS") {
        ga('send', 'event', 'Reference _Click', 'CAS', currentJournal);
    }
    else if($(this).text() === "PubMed") {
        ga('send', 'event', 'Reference _Click', 'PubMed', currentJournal);
    }
    else if($(this).text() === "Google Scholar") {
        ga('send', 'event', 'Reference _Click', 'Google Scholar', currentJournal);
    }
    else if($(this).hasClass("issue-item_open-url") === true) {
        ga('send', 'event', 'Reference _Click', 'OpenURL', currentJournal);
    }
});
</script>






        
        



        
    





        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        <div tabindex="0" class="showMenuAlertMsg-popup"><div class="pairing-affiliations-popup-content"><div class="pairing-affiliations-header"><button type="button" class="close paringAffClose"><i aria-hidden="true" class="icon-close_thin"></i></button></div><div class="responsrMsg"></div></div></div>




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	dartInstitutionType = 'education';
</script>
        </div>
    





        
        



        
    





        
        <script>
// LIT-455776 workaround
// Moving the popup before the header content for tab accessibility
document.addEventListener('DOMContentLoaded', () => {
    const headerNode = $('.header_content');
    const popupNode = $('.pairing-affiliations-popup');

    if (!headerNode.length || !popupNode.length)
        return;

    popupNode.insertBefore(headerNode);  
});
</script> 
        </div>
    </div>





	
    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-d93b9088814c7fcd2f1c.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-9dee82777d6af4ace557.js"></script>
<script type="text/javascript" src="/wro/l6j1~product.js"></script>

















<script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon="{&quot;rayId&quot;:&quot;70617b525da0209d&quot;,&quot;token&quot;:&quot;0562ec7bcba14d1cae3543aa43d6e749&quot;,&quot;version&quot;:&quot;2021.12.0&quot;,&quot;si&quot;:100}" crossorigin="anonymous"></script>


<div style="visibility: hidden; height: 1px; width: 1px; position: absolute; top: -9999px; z-index: 100000;" id="_atssh"><iframe id="_atssh738" title="AddThis utility frame" style="height: 1px; width: 1px; position: absolute; top: 0px; z-index: 100000; border: 0px none; left: 0px;" src="https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html#rand=0.5929293942589927&amp;iit=1651669882652&amp;tmr=load%3D1651669882393%26core%3D1651669882438%26main%3D1651669882645%26ifr%3D1651669882658&amp;cb=0&amp;cdn=0&amp;md=0&amp;kw=&amp;ab=-&amp;dh=pubs.acs.org&amp;dr=&amp;du=https%3A%2F%2Fpubs.acs.org%2Fdoi%2F10.1021%2Facscentsci.0c00601&amp;href=https%3A%2F%2Fpubs.acs.org%2Fdoi%2F10.1021%2Facscentsci.0c00601&amp;dt=Heterogeneity%20in%202%2C6-Linked%20Sialic%20Acids%20Potentiates%20Invasion%20of%20Breast%20Cancer%20Epithelia&amp;dbg=0&amp;cap=tc%3D0%26ab%3D0&amp;inst=1&amp;jsl=1&amp;prod=undefined&amp;lng=en&amp;ogt=site_name%2Ctype%3DArticle%2Cdescription%2Cimage%2Ctitle%2Curl&amp;pc=men&amp;pub=xa-4faab26f2cff13a7&amp;ssl=1&amp;sid=62727b7aba475c87&amp;srf=0.01&amp;ver=300&amp;xck=0&amp;xtr=0&amp;og=url%3Dhttps%253A%252F%252Fpubs.acs.org%252Fdoi%252Ffull%252F10.1021%252Facscentsci.0c00601%26title%3DHeterogeneity%2520in%25202%252C6-Linked%2520Sialic%2520Acids%2520Potentiates%2520Invasion%2520of%2520Breast%2520Cancer%2520Epithelia%26image%3Dhttps%253A%252F%252Fpubs.acs.org%252Fcms%252F10.1021%252Facscentsci.0c00601%252Fasset%252Fimages%252Facscentsci.0c00601.social.jpeg_v03%26description%3DHeterogeneity%2520in%2520phenotypes%2520of%2520malignantly%2520transformed%2520cells%2520and%2520aberrant%2520glycan%2520expression%2520on%2520their%2520surface%2520are%2520two%2520prominent%2520hallmarks%2520of%2520cancers%2520that%2520have%2520hitherto%2520not%2520been%2520linked%2520to%2520each%2520other.%2520In%2520this%2520paper%252C%2520we%2520identify%2520differential%2520levels%2520of%2520a%2520specific%2520glycan%2520linkage%253A%2520%25CE%25B12%252C6-linked%2520sialic%2520acids%2520within%2520breast%2520cancer%2520cells%2520in%2520vivo%2520and%2520in%2520culture.%2520Upon%2520sorting%2520out%2520two%2520populations%2520with%2520moderate%252C%2520and%2520relatively%2520higher%252C%2520cell%2520surface%2520%25CE%25B12%252C6-linked%2520sialic%2520acid%2520levels%2520from%2520the%2520triple-negative%2520breast%2520cancer%2520cell%2520line%2520MDA-MB-231%252C%2520both%2520populations%2520(denoted%2520as%2520medium%2520and%2520high%25202%252C6-Sial%2520cells%252C%2520respectively)%2520stably%2520retained%2520their%2520levels%2520in%2520early%2520passages.%2520Upon%2520continuous%2520culturing%252C%2520medium%25202%252C6-Sial%2520cells%2520recapitulated%2520the%2520heterogeneity%2520of%2520the%2520unsorted%2520line%2520whereas%2520high%25202%252C6-Sial%2520cells%2520showed%2520no%2520such%2520tendency.%2520Compared%2520with%2520high%25202%252C6-Sial%2520cells%252C%2520the%2520medium%25202%252C6-Sial%2520counterparts%2520showed%2520greater%2520adhesion%2520to%2520reconstituted%2520extracellular%2520matrices%2520(ECMs)%2520and%2520invaded%2520faster%2520as%2520single%2520cells.%2520The%2520level%2520of%2520%25CE%25B12%252C6-linked%2520sialic%2520acids%2520in%2520the%2520two%2520sublines%2520was%2520found%2520to%2520be%2520consistent%2520with%2520the%2520expression%2520of%2520a%2520specific%2520glycosyl%2520transferase%252C%2520ST6GAL1.%2520Stably%2520knocking%2520down%2520ST6GAL1%2520in%2520the%2520high%25202%252C6-Sial%2520cells%2520enhanced%2520their%2520invasiveness.%2520When%2520cultured%2520together%252C%2520medium%25202%252C6-Sial%2520cells%2520differentially%2520migrated%2520to%2520the%2520edge%2520of%2520growing%2520tumoroid-like%2520cocultures%252C%2520whereas%2520high%25202%252C6-Sial%2520cells%2520formed%2520the%2520central%2520bulk.%2520Multiscale%2520simulations%2520in%2520a%2520Cellular%2520Potts%2520model-based%2520computational%2520environment%2520calibrated%2520to%2520our%2520experimental%2520findings%2520suggest%2520that%2520differential%2520levels%2520of%2520cell%25E2%2580%2593ECM%2520adhesion%252C%2520likely%2520regulated%2520by%2520%25CE%25B12%252C6-linked%2520sialic%2520acids%252C%2520facilitate%2520niches%2520of%2520highly%2520invasive%2520cells%2520to%2520efficiently%2520migrate%2520centrifugally%2520as%2520the%2520invasive%2520front%2520of%2520a%2520malignant%2520breast%2520tumor.%26type%3DArticle%26site_name%3DACS%2520Publications&amp;csi=undefined&amp;rev=v8.28.8-wp&amp;ct=1&amp;xld=1&amp;xd=1"></iframe></div><style id="service-icons-0"></style></body></html>